<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2026-01-12 09:25:26 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>138</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>76</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="Identifying host factors that mediate protection against newly-emergent viruses is needed for improved pandemic preparedness. Here, we analysed pre- and early post-exposure immune factors associated with resisting SARS-CoV-2 infection after human challenge in seronegative individuals, using multiplex protein, cytometric and RNA sequencing approaches in the nasopharynx and circulation. Pre-existing cross-reactive antibodies correlate poorly with clinical outcome. Instead, protection is associated with heightened nasopharyngeal CCL13 levels locally produced by conventional dendritic cells and monocytes, along with cross-reactive T cells and less differentiated NK cells. Conditional independence network analysis implicates nasal CCL13 as the central node connected to pre-existing non-structural protein-specific T cells by CD1c+ DCs. In those who became infected, baseline cross-reactive T cell and less differentiated NK cell frequencies also correlate with shorter infection duration. Thus, pre-existing mucosal chemokine levels may promote rapid innate and innate-like responses that effectively block infection. ClinicalTrials.gov identifier NCT04865237. Human challenge studies with SARS-CoV-2 have shown changes in the innate and adaptive immune response. Here the authors are examining potential correlates of infection in virus challenged recipients by assessing baseline immune parameters and how this predicts virus control.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/491d4d516b113109ac72078677aee9124493f965" target='_blank'>
              Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Helen R. Wagstaffe, R. Thwaites, Jasmin K. Sidhu, Rik G. H. Lindeboom, Lorenz Kretschmer, Kaylee B. Worlock, L. Dratva, Ao Huang, S. Ascough, L. Papargyris, Richard McKendry, Ashley M. Collins, Jiayun Xu, Nana-Marie Lemm, Ben Killingley, M. Kalinova, Alex J. Mann, A. Catchpole, Leo Swadling, J. Tsang, MK Maini, M. Noursadeghi, Marko Z. Nikolić, Sarah A. Teichmann, P. Openshaw, Christopher Chiu
          </td>
          <td>2025-12-07</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89e57c5a7f035383eefb5a4b2a2612ea3055f379" target='_blank'>
              Myeloid PINK1 represses mtDNA release and immune signaling that impacts neuronal pathology in patient-derived idiopathic PD models
              </a>
            </td>
          <td>
            S. Recinto, A. MacDonald, Shobina Premachandran, Lin Liu, Armin Bayati, Lilia Rodriguez, Mai Nguyen, Florence Petit, Sriparna Mukherjee, Julien Larmanjat, Alexis Allot, Moein Yaqubi, Peter McPherson, T. Durcan, S. Gruenheid, L. Trudeau, J. Drouin-Ouellet, Heidi M. McBride, J. Stratton
          </td>
          <td>2026-01-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Cytomegalovirus is the leading viral cause of congenital infection with neurological sequelae. Effective medical treatments are limited due to an inadequate understanding of the underlying pathogenesis. Here, we applied single-cell transcriptomics to analyze neonatal mouse brains with congenital cytomegalovirus infection (cCMV). We profiled cCMV in 22 cell types and identified neural progenitor cells (NPCs) and monocyte-derived macrophages (MDMs) as the most commonly infected cells. Infected NPCs exhibited dysregulated neurodevelopment-associated signaling pathways, correlating with viral transcript levels that indicate viral replication levels. Genes associated with phagocytosis and antigen presentation were downregulated exclusively in infected MDMs but remained largely unaffected in microglia and barrier-associated macrophages regardless of infection status. Analysis of intrinsic and induced interferon-stimulated gene expression revealed great heterogeneity across cell types but no direct correlation with cCMV susceptibility. Furthermore, our findings indicate that interferon type II is crucial for the control of cCMV and consequent cortical damage and calcification in the neonatal brain. This study advances our understanding of cCMV tropism and the molecular details of cCMV-induced neurodevelopmental impairment, cerebral immune response, and brain pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37e868bb50c4bf02ba4bc61b84aaec7d5968b07e" target='_blank'>
              Molecular features of congenital cytomegalovirus infection in neonatal mouse brain at single-cell resolution
              </a>
            </td>
          <td>
            Meng-Jie Mei, Yue-Peng Zhou, Yu-Ting Pan, Jin-yan Sun, Wen-Bo Zeng, Tong Wu, M. McVoy, William J. Britt, Wen Zhou, Bo Yang, Xuan Jiang, Simon Rayner, Han Cheng, Min-Hua Luo
          </td>
          <td>2025-11-17</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f2da4d4f0c7553db626f5b050820f95d44bcc37" target='_blank'>
              Single-cell multi-omic landscape reveals anatomical-specific immune features in adult and pediatric sepsis
              </a>
            </td>
          <td>
            Qian Ye, Xiaofei Lai, Yuliang Liu, Zhengtao Zhang, Yueqiang Fu, Jie Luo, Chengjun Liu, Jun Duan, Hao Ding, Yuhan Liu, Zhi Ao, Yang Tao, Shanmu Ai, Wei Huang, Lei Jiang, Yi Liu, Fang Xu, Ju Cao
          </td>
          <td>2025-12-03</td>
          <td>Nature Immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Long COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome coronavirus 2 infection. Current hypotheses for the pathogenesis of LC include persistent virus, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction and complement activation. We performed immunological, virological, transcriptomic and proteomic analyses from a cohort of 142 individuals between 2020 and 2021, including uninfected controls (n = 35), acutely infected individuals (n = 54), convalescent controls (n = 24) and patients with LC (n = 28). The LC group was characterized by persistent immune activation and proinflammatory responses for more than 180 days after initial infection compared with convalescent controls, including upregulation of JAK-STAT, interleukin-6, complement, metabolism and T cell exhaustion pathways. Similar findings were observed in a second cohort enrolled between 2023 and 2024, including convalescent controls (n = 20) and patients with LC (n = 18). These data suggest that LC is characterized by persistent activation of chronic inflammatory pathways, suggesting new therapeutic targets and potential biomarkers of disease. Long COVID (LC) involves a spectrum of chronic symptoms after resolution of acute severe acute respiratory syndrome coronavirus 2 infection. Barouch and colleagues show that LC is characterized by persistent activation of chronic inflammatory pathways and T cell exhaustion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aab56a374cbf5ee6260c69533626e491afa089f3" target='_blank'>
              Long COVID involves activation of proinflammatory and immune exhaustion pathways
              </a>
            </td>
          <td>
            Malika Aid, Valentin Boero-Teyssier, K. McMahan, Rammy Dong, Michael Doyle, Nazim Belabbaci, E. Borducchi, A. Y. Collier, J. Mullington, D. Barouch
          </td>
          <td>2025-12-12</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>117</td>
        </tr>

        <tr id="Abstract After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a minority of patients experience persistent or emerging symptoms, termed ‘long coronavirus disease (COVID)’ or post-acute sequelae of COVID-19. The molecular causes of long COVID remain unclear, but disrupted immune functions, such as inflammation and immune deficit, have been posited as factors. In this retrospective cohort study, we measured markers of immune function in a group of patients with long COVID up to 40 months post infection. As proxies for immune function, we measured serum antibody levels, antibody neutralizing capability and production of IFN gamma (IFN-γ) and IL-2 against SARS-CoV-2 and other viral peptides. As expected, serum antibody levels increased over time with vaccinations and reinfections with later variants of SARS-CoV-2. Patients also showed corresponding increasing SARS-CoV-2-specific IL-2 responses and stable IFN-γ responses. We observed no significant differences in immune responses among patients with ongoing long COVID, those who had recovered from it or individuals who recovered from acute COVID-19. Overall, we found no indication of a reduction in these aspects of immune function after SARS-CoV-2 infection. This study provides a valuable foundation for further research aimed at understanding the causes of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd9f2a9af816e4527bff007fe6bd487c949ce190" target='_blank'>
              Robust antibody and T cell responses tracked longitudinally in patients with long COVID
              </a>
            </td>
          <td>
            M. Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Ben Krishna, N. Sithole
          </td>
          <td>2025-12-01</td>
          <td>The Journal of General Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Acute viral infections are usually cleared by an efficient anti-pathogen immune response, following which immune homeostasis is restored. Occasionally, such pathogen-induced immune response fails to abate despite clinical recovery, but how this occurs in humans has not been thoroughly investigated. Here, we perform a detailed analysis of T cell homeostasis following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which reveals persistent activation and dyshomeostasis of CD4+ and CD8+ T cells for 6–12 months after acute infection. Compared to steady-state and unlike T cell responses following vaccination, interleukin (IL)−2 receptor and IL-7 receptor expression remains altered on both SARS-CoV-2-specific and bystander T cells for 6–12 months after acute infection. These alterations correlate with increased IL-7 and IL-15 serum levels and are reproduced by in vitro stimulation by IL-7 and IL-15, but surprisingly not by IL-2. Collectively, our study demonstrates prolonged T cell dyshomeostasis driven by dysregulated homeostatic cytokine signals following acute viral infection. Acute viral infections induce the activation and expansion of virus-specific T cells which eventually abate, but in some situations can persist. Here the authors show a dysregulation of homeostatic cytokine receptors in patients with prolonged T cell activation following acute SARS-CoV-2 infection">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b30b34de10d73c9f922bb678272c07c41f6fdb9" target='_blank'>
              Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans
              </a>
            </td>
          <td>
            Laura Ceglarek, Patrick Taeschler, Alp Inci, Yves Zurbuchen, Sarah Adamo, Carlo Cervia-Hasler, M. E. Raeber, O. Boyman
          </td>
          <td>2025-11-27</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/674509938f9c563edb49d12a46467f6b4538fa2f" target='_blank'>
              Single-Cell Dissection of Immunometabolic Rewiring in the Porcine Ileum during Salmonella Typhimurium Infection
              </a>
            </td>
          <td>
            José M. Suárez-Cárdenas, Tomàs Montserrat-Ayuso, Mónica Alfonso-Núñez, A. Esteve-Codina, Raúl Fernández-Rodríguez, Antonio Romero-Guillén, Tránsito García-García, Cristina Arce, Amparo Martínez Martínez, Juan J. Garrido, S. Zaldívar-López
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1f2f4806c4c9f5ee207406f2f653b5c11d67d7" target='_blank'>
              Persistent CD4+ T cell functional deficits during recovery from prolonged symptomatic SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Jadith Ziegler, Christina Lawrence, Sean Turner, Nathan P. Pezant, Nancy Redinger, Carla Guthridge, Kenneth Smith, Jingrong Chen, J. Guthridge, Judith A. James, Susannah Rankin, Linda F. Thompson, A. Farris, S. Kovats
          </td>
          <td>2025-12-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) remains a leading cause of chronic neurological impairment, yet the cellular mechanisms underlying long-term neurodegeneration in TBI remain incompletely understood. Astrocytes, the most abundant glial cell type, are central to maintaining neuroglial and neurovascular homeostasis. Following TBI, however, astrocytic activation contributes to sustained inflammation and neurotoxicity. In this study, we employed immunohistochemistry and RNA sequencing to longitudinally profile astrocyte morphology and transcriptional states at acute (2 days), subacute (2 weeks), and chronic (1 year) stages after controlled cortical impact in mice. We identified a temporally evolving astrocyte response—beginning with a pro-inflammatory profile acutely, transitioning through a profile suggestive of mixed inflammatory and neurodegenerative signatures subacutely, and culminating in a chronic state marked generally by expression of Alzheimer’s and Parkinson’s disease-associated genes. Notably, a subset of astrocyte-derived progenitor cells also was found up to one-year post-injury, expressing markers associated with neurogenesis. These findings reveal that astrocyte activation is not transient but persists chronically, undergoing a dynamic shift from inflammation to degeneration. The observed parallels between astrocyte states in chronic TBI and neurodegenerative disorders underscore their potential role in post-traumatic cognitive decline and highlight astrocyte-targeted interventions as a promising avenue for therapeutic development. Transcriptomic analysis of astrocytes in the acute, subacute, and chronic phases after traumatic brain injury reveal an evolving dynamic shift from neuroinflammation to neurodegeneration, and to a limited extent, regeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c70e1566bf8218bb883f7cd7c00852baff7513e" target='_blank'>
              Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration
              </a>
            </td>
          <td>
            Hadi Abou-El-Hassan, Taha Yahya, Benjamin E. Zusman, Omar Albastaki, Harm T. Imkamp, Jessica J. Ye, Francesca Percopo, Jonathan R Christenson, Maryam H. Al Mansi, Kuan-Jung Lu, Galina Gabriely, Bruna K. Tatematsu, K. Habashy, Juliana R Lopes, A. Maghzi, R. M. Rezende, F. Quintana, Howard L. Weiner, Saef Izzy
          </td>
          <td>2025-12-01</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d6eba017d5f90627970b16b5a61725ba67c3fc0" target='_blank'>
              Rab27-dependent egress of SARS-CoV-2 via secretory amphisomes
              </a>
            </td>
          <td>
            W. Nijenhuis, Hugo G. J. Damstra, Emma J van Grinsven, Patrique Praest, Mariëlle M.P. van Grinsven, Zahra E. Soltani, D. D. de Jong, J. Symons, G. D. Amatngalim, Frederik J. Verweij, A. Akhmanova, M. Nijhuis, Jeffrey M. Beekman, R. Lebbink, L. Kapitein
          </td>
          <td>2025-12-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34649c6562aa2175c877d0871438b8882a670ac3" target='_blank'>
              Integrated single-cell analysis reveals interferon-driven immune signatures in a DENV1 human infection model
              </a>
            </td>
          <td>
            A. Vermeersch, T. Verdonckt, C. Struyfs, E. De Meester, A. Waickman, , K. Ariën, O. Lagatie, F. van Nieuwerburgh
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f17946ac3dbb8efa92226c7ce4112035350abc3" target='_blank'>
              STAT1-Mediated Regulation of IL-17A/CEBPB/NF-κB Axis in HIV-1 Infected Human Cerebral Organoids Reveals Therapeutic Targets for Neuroprotection
              </a>
            </td>
          <td>
            Karthick Chennakesavan, Malaroviyam Samikkannu, Shreyan Gupta, Olasunkanmi Israel Tayo, Arpan Acharya, James J. Cai, S. Byrareddy, T. Samikkannu
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic. While it has been speculated that higher infection rates resulted from increased hospitalizations throughout the pandemic or greater use of antibiotics, precisely why rates remain high today has remained unexplained. Mitochondrial dysfunction is known to occur post-COVID and may disrupt immune responses. Within T cells, SARS-CoV-2 infection is linked to low mitochondrial membrane potential, increased mitochondrial apoptosis, and decreased mitochondrial respiration, which together impact cellular activation and function beyond the acute phase of illness. Here, we demonstrate that decreased mitochondrial function in antigen-specific T cells post-COVID may contribute to higher infection susceptibility by metabolically immobilizing T cell memory responses. Using donor-matched peripheral blood samples from 31 COVID-naïve individuals who subsequently contracted COVID-19, we tracked how influenza A (IAV), Staphylococcus aureus (SA), and Varicella-zoster virus (VZV) T cell responses were impacted by COVID-19 infection. We found that gene expression linked to T cell activation decreased but mitochondrial redox pathways increased in CD4 memory T cells post-COVID. However, mitochondrial flux and reactive oxygen species production were limited in a plurality of post-COVID memory T cells after stimulation with IAV, SA, and VZV. Furthermore, we found a disordered relationship between memory T cell mobilization of glycolysis, fatty acid metabolism, and oxidative phosphorylation pathways post-COVID which resulted in diminished use of catabolic pathways including glycolysis and fatty acid oxidation in antigen-specific T cells. Modulation of mitochondrial function with metformin and ubiquinol partially rescued the post-COVID decline in T cell catabolism. Collectively, these findings indicate that COVID-19 infection may have lasting effects on inhibiting T cell memory responses to commonly encountered community-acquired pathogens which can be corrected with commonly available medications. This has significant implications for the clinical care of immunologically vulnerable populations in the post-pandemic era.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/826971fe690f6be31807f55457f0b21244f3d4b9" target='_blank'>
              Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism
              </a>
            </td>
          <td>
            Daniel D. Carroll, Kamacay Cira, Jack Archer, Jason Shapiro, Ue-yu Pen, David Tieri, Lucia Leonor, Neda D. Roofchayee, Samantha S. Yee, Marc Wahab, Igor J. Koralnik, John C. Alverdy, Arjun S. Raman, L. Visvabharathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) causes a highly lethal respiratory infection for which no vaccines or antiviral therapeutics are currently available. Understanding the immune response is critical for designing effective therapeutics. Here, we comprehensively characterized the dynamics of B-cell responses in severely infected MERS-CoV patients and survivors with SARS-CoV-2 exposure history. Infected patients developed robust neutralizing antibody responses within 1 month of illness, with moderate-to-high cross-neutralization activity against SARS-CoV-2. The enhanced neutralization activity coincided with an increased abundance of specific mutated, class-switched IgG clones. Notably, one such clone was detected at moderate prevalence in both patients, and its expansion was accompanied by high neutralization activity against both viruses. Conversely, MERS-CoV survivors demonstrated higher neutralization activity against MERS-CoV after vaccination, despite minimal changes in antibody titers and limited alterations in B-cell repertoire properties. This suggests that the enhanced neutralization activity may be mediated by the reactivation and expansion of cross-reactive memory B cells targeting conserved epitopes, originally generated in response to the virus that triggered the primary immune response. These findings provide valuable insights into the B-cell repertoire landscape during natural MERS-CoV infection and highlight the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. IMPORTANCE This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1207eb36a1ae9d0a38874b4fd9dcc3679243cee7" target='_blank'>
              Dynamics of B-cell response in MERS-CoV patients and survivors with hybrid immunity
              </a>
            </td>
          <td>
            H. Al-Khatib, Fatma H. Ali, H. Zedan, M. Smatti, Peter V. Coyle, Sara Taleb, A. A. Hssain, Asmaa A Al-Thani, H. Yassine
          </td>
          <td>2025-12-16</td>
          <td>mBio</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32d744543512f7fd8cb097f605724c369cc5455a" target='_blank'>
              Single-Cell Multi-Omics Dissects Transcript Isoform and Immune Repertoire Dynamics in Human Immunosenescence
              </a>
            </td>
          <td>
            Yuhui Zheng, Ze-Hui Ren, Yafei Yang, Wenteng Liu, Fupeng Li, Yajun Zuo, Tao Zeng, Xue Wang, Xiumei Lin, Xinyue Zhu, Baibing Guan, Wenwen Zhou, Yunting Huang, Wangsheng Li, Yu Feng, Xiao Yang, Xin Liu, Xin Jin, Hanjie Li, Yuliang Dong, Xiangliang Yang, Xun Xu, Jianhua Yin, Chuanyu Liu
          </td>
          <td>2025-11-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91babd22d3b6b86432a313b4b21fca0bc39e8c82" target='_blank'>
              Single cell RNA sequencing reveals limited effects of Lrrk2 genotype in a mouse model of acute CNS inflammation
              </a>
            </td>
          <td>
            Alice Kaganovich, Liam Horan-Portelance, Natalie Landeck, Dominic J. Acri, Jinhui Ding, R. Langston, Mark R. Cookson
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Microglial cells exhibit crucial metabolic adaptations to maintain neural homeostasis. However, their dysregulated activation during infections can lead to neurotoxicity and contribute to the development of neuroinflammatory disorders. Understanding the physiological and metabolic changes of microglia during immune activation is crucial for identifying protective targets against neuroinflammation. This study investigates how the Zika virus (ZIKV) alters microglia metabolism during inflammation, highlighting cellular adaptations that sustain oxidative metabolism linked to cell survival during cellular activation and viral replication. After identifying an enriched abundance of proteins related to oxidative phosphorylation and cellular component organization in the global proteomics of mouse brains following ZIKV exposure, we investigated the relevance of these pathways during in vitro infection of human microglia. ZIKV infection led to cytoskeleton remodeling via β-tubulin reallocation, which characterized an ameboid-like phenotype. Despite the indication of a shift toward increased glycolytic activity due to decreased intracellular glucose, which suggests its consumption, and the accumulation of tricarboxylic acid cycle (TCA) intermediates, ZIKV-infected microglia exhibit enhanced respiratory capacity and an abundance of smaller-sized mitochondria in the perinuclear region. The accumulation of citrate, succinate, and malate, while maintaining mitochondrial function, suggests an important metabolic adaptation that supports biosynthetic pathways and sustains cell viability under stress. Decreased intracellular glutamate abundance supports mitochondrial oxidative metabolism. Pre-treatment with the anti-inflammatory docosahexaenoic acid (DHA) mitigates ZIKV-induced metabolic alterations by reducing pro-inflammatory markers, downregulating viral entry receptors, and lowering microglial activation and viral load. This study reveals that while ZIKV induces cell death in neuronal-like cells, the mitochondrial adaptation observed in microglial infection could be a key to maintaining cell survival throughout neuroinflammation. Our findings elucidate a novel cellular adaptation during ZIKV infection involving β-tubulin reorganization and metabolic dynamics, reflecting microglial flexibility and resistance during neuroinflammation, and demonstrating the therapeutic potential of DHA in mitigating ZIKV-induced pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d680f6e601874de149962588421e3e6c0a8d4a6" target='_blank'>
              Zika Virus Reprograms Microglial Mitochondrial Metabolism to Support Immune Activation and Viral Replication: Omega-3 DHA Counteracts Neuroinflammation and Viral Persistence
              </a>
            </td>
          <td>
            Heloísa Antoniella Braz-De-Melo, Fernanda Gomes Lago, Rafael Corrêa, I. Santos, P. Bellozi, R. Almeida, Wagner Fontes, Mariana S Castro, Aline Maria Araújo Martins, R. M. de Oliveira, Nadia Martins Serpa Rossi, Gabriel Pasquarelli-do-Nascimento, Ana Luiza Gouvea, Paulo Sousa Prado, Andreza F de Bem, Sônia Nair Báo, B. M. Ribeiro, S. Rehen, Thomas Christopher Rhys Williams, Gary P. Kobinger, Kelly Grace Magalhães
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="The innate immune response involves interferons (IFNs), antiviral cytokines that upregulate numerous IFN-stimulated genes, many of which have uncharacterized functions and mechanisms. Here we performed transcriptomic profiling of lung tissues from wild-type and IFNAR−/− mice infected with SARS-CoV-2 and single-cell RNA sequencing of bronchoalveolar lavage fluid and peripheral blood mononuclear cells from patients with COVID-19. We identified O-GalNAc transferase 2 (GALNT2), an N-acetylgalactosaminyltransferase, as an antiviral IFN-stimulated gene restricting the replication of multiple coronaviruses and influenza A viruses in vitro and in vivo, contributing to viral clearance and reducing disease severity. Mechanistically, GALNT2-dependent O-linked glycosylation may regulate viral glycoprotein proteolytic processing and impair viral growth by blocking virus–cell fusion. In addition, we found that serine residues at 810/813 in the viral spike protein undergo O-glycosylation and function as the primary genetic determinants of sensitivity or evasion towards GALNT2. Human genetic data analysis revealed that individuals with GALNT2 variants that lost antiviral function had elevated risk of hospitalization following SARS-CoV-2 infection. This study establishes GALNT2 as an antiviral factor against some respiratory virus infections. The authors find that O-GalNAc transferase 2 (GALNT2) restricts viral infection, probably through the regulation of the proteolytic processing of viral glycoproteins via its O-linked glycosylation activity, impairing virus–cell fusion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4edc78ea59897eb7bd96425cec0afc43cf52263b" target='_blank'>
              Interferon-stimulated gene GALNT2 restricts respiratory virus infections
              </a>
            </td>
          <td>
            Wei Ran, Jinghong Yang, Shi Yu, Qingtao Hu, Yuqi He, Shengjun Wang, Cheng Wei, Jing Sun, Airu Zhu, Fang Li, Lu Zhang, Pengfei Li, Huina Hu, Ruangang Pan, Yanying Yu, Yanqiu Yuan, Lingyu Sun, Yanqun Wang, Zhaoyong Zhang, Zhao Chen, Donglan Liu, Qihong Yan, Dong Wang, Kuai Yu, Yiliang Wang, Jianfen Zhuo, Zhuan Zhen, Hua Tao, Qiuhui Zeng, Kaixin Zhou, Feng Chen, Wenxuan Tang, Yuzheng Zhou, Rong Bai, Yonghao Xu, Na Li, Jun Dai, Hongyu Zhao, Jung-Eun Park, Tao Wang, Qiang Ding, Stanley Perlman, Jingxian Zhao, Yang Mao, Shaobo Wang, Jincun Zhao
          </td>
          <td>2025-12-12</td>
          <td>Nature Microbiology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/687800177db6f90a1dee9be6bba3ed7087d04c6e" target='_blank'>
              Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity
              </a>
            </td>
          <td>
            Samantha Garcia-Cardenas, Gemma Swinscoe, Amy Moran, Liam Barningham, Graham P. Cook, A. Samson, Sam J. Wilson, Michael Malim, Russell Hughes, Stephen Griffin
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="We describe RNA-Seq analyses conducted on nasopharyngeal swabs collected from 37 patients admitted to an Australian intensive care unit from October 2022 to August 2023. During this time, the dominant omicron sublineage infections broadly progressed from BA.5 to BA.2-like, to XBB-like, then XBC, consistent with global trends. Viral load and patient metadata correlations indicated this cohort was broadly representative of severe COVID-19 patients. Human gene expression analyses were complicated by the large range (>5 log) and variability in viral reads. Nevertheless, the comparison of XBC and BA.5 samples that had comparable viral read counts, revealed differentially expressed genes and a cellular deconvolution signature that indicated increased targeting of ciliated epithelial cells by XBC. To obtain more evidence for increased targeting of ciliated epithelial cells by the later omicron sublineage viruses, a series of mouse strains were infected with a BA.5 or a XBB isolate. Increased infection of the nasal turbinates and ciliated epithelial cells by XBB was demonstrated by viral titrations and immunohistochemistry, respectively. Compared with previous lineages, the omicron lineage showed increased targeting of ciliated epithelia in the upper respiratory tract, with the data presented herein suggesting this trend continued for the omicron sublineages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b2c8c06a95fec07f6805a6b9f79245ad1263a7e5" target='_blank'>
              Evidence from COVID-19 Patients and Murine Studies for a Continuing Trend Towards Targeting of Nasopharyngeal Ciliated Epithelial Cells by SARS-CoV-2 Omicron Sublineages
              </a>
            </td>
          <td>
            Agnes Carolin, Cameron R. Bishop, Kexin Yan, B. Grubor-Bauk, Mark P. Plummer, B. Tang, M. Leitner, Eamon Raith, S. C. Barry, C. M. Hope, Wilson Nguyen, D. Rawle, Andreas Suhrbier
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related sarbecoviruses encode a set of accessory proteins (3a, 3b, 6, 7a, 7b, 8, 9b, and 10) that control host responses to infection and promote virus growth. Of these accessory proteins, 7a is set apart by its intracellular localization near CoV budding sites and its incorporation into secreted virions. To investigate 7a functions during CoV infections under biosafety level 2 conditions, we constructed recombinant mouse hepatitis viruses (rMHVs) (rMHV strain A59) that express sarbecovirus 7a genes. Comparative infections revealed that 7a increased viral replication and viral output in immortalized murine cell cultures and in primary bone marrow-derived macrophages (BMDMs). This proviral effect was independent of a previously reported 7a-mediated interferon antagonizing activity. 7a is a type I transmembrane protein with a short cytoplasmic tail that operates in subcellular trafficking and signal transduction. To further elucidate tail functions, we generated a set of rA59 viruses expressing substitutions in the tail di-lysine motifs. Several substitutions reduced 7a proviral activities; notably, the K119A change in rA59-7a-KRATE eliminated 7a support of virus yield. The K119A change also reduced mouse-adapted SARS-CoV-2 virus yields in infected BALB/c mice. 7a expression was proinflammatory in BMDMs, as measured by cytokine arrays. Cytoplasmic tail substitutions tempered these proinflammatory responses, implying connections with proviral activities. SARS-CoV-2-infected macrophages have been implicated in inflammatory COVID-19, and these findings point to 7a cytoplasmic tails as potential contributors to cytokine-mediated disease. IMPORTANCE This study shows that SARS-CoV-2 accessory protein 7a promotes infection of a phylogenetically distinct embecovirus and, in doing so, elicits proinflammatory and potentially disease-relevant host responses. The proviral and proinflammatory activities were traced in part to a short 7a cytoplasmic tail. The findings localize and highlight a specific proviral component in a sarbecovirus accessory protein. This study shows that SARS-CoV-2 accessory protein 7a promotes infection of a phylogenetically distinct embecovirus and, in doing so, elicits proinflammatory and potentially disease-relevant host responses. The proviral and proinflammatory activities were traced in part to a short 7a cytoplasmic tail. The findings localize and highlight a specific proviral component in a sarbecovirus accessory protein.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5dfa631af078e38f4ca2e53db8a723825ceb2711" target='_blank'>
              A murine coronavirus infection platform identifies proviral and proinflammatory activities of SARS-CoV-2 accessory protein 7a
              </a>
            </td>
          <td>
            Grant M Hawkins, Enya Qing, Julisa Salgado, Pearl Chan, Edward M Campbell, Stanley Perlman, Thomas M. Gallagher
          </td>
          <td>2025-12-16</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="West Nile virus (WNV) is a mosquito-borne virus that causes severe neurological disease in humans. Despite substantial advances, our knowledge of the mechanisms involved in damaging the human brain is still limited. To address this gap, we developed a physiologically relevant in vitro model using human neuronal/glial cells and aimed to determine WNV tropism, assess whether the virus induces innate immune and inflammatory responses, and elucidate the resulting pathophysiological consequences. We found that WNV productively infected glial cells, whereas neurons exhibited a remarkable and unexpected resistance to infection. Despite the induction of a robust innate immune response mediated by IFN signalling and a rapid control of WNV replication in glial cells, we observed substantial death of astrocytes, oligodendrocytes, and neurons. Analysis of cytokine and chemokine expression further revealed that infection triggered an inflammatory response, potentially contributing to bystander cell death. We also showed that IFN signaling did not contribute to the resistance of neurons and identified IFI6 as an effector of the antiviral response in human glial cells. Together, our results underscore the importance of human neural models for confirming previous findings obtained in less physiologically relevant models and for unravelling novel cellular and molecular mechanisms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/435c1519049ea8d464c2e723fc442d3c3c80d655" target='_blank'>
              Role of innate immune and inflammatory signaling in West Nile virus tropism and neuronal and glial cell death
              </a>
            </td>
          <td>
            Valentine Chaillot, François Piumi, Kamila Gorna, Noémie Berry, Jennifer Richardson, Alexandra Benchoua, Muriel Coulpier
          </td>
          <td>2025-12-01</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="ABSTRACT Immunocompromised patients with prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may serve as reservoirs for viral evolution, with suboptimal immune responses facilitating the accumulation of adaptive mutations. This study aimed to characterize the drivers of SARS-CoV-2 adaptive evolution in such hosts through genomic surveillance. We retrospectively analyzed 24 patients with long-term positive nasopharyngeal reverse transcription-polymerase chain reaction results (symptom onset duration: 7–14 days on average, 1 HIV-positive patient with >20 days of infection). Most infections (April–May 2022) were caused by Omicron variants (predominantly BA.2). Phylogenetic analysis revealed accelerated viral evolution in patients with diverse underlying diseases (e.g., HIV and esophageal cancer). A total of 78 intrahost single-nucleotide variants were identified, with ORF1ab (53.8%) and the Spike protein coding region (20.5%) being hotspots. Notably, the HIV-positive patient’s virus developed unique mutations: NSP3-T779I, NSP15-A94T, and Spike double mutations N440K and I794T. Functional assays showed that the N440K/I794T double mutation significantly enhanced infectivity in Hela-hACE2 cells (P < 0.05) but reduced immune evasion (50% neutralizing titer increased ~2-fold vs BA.2, P < 0.001). The I794T mutation was later detected in the JN.1.16 strain, suggesting potential evolutionary persistence. Prolonged SARS-CoV-2 replication in immunocompromised hosts, particularly HIV-positive individuals, drives adaptive mutations with altered infectivity and immune evasion. These findings emphasize the need for monitoring such hosts to prevent the spread of potentially transmissible variants. IMPORTANCE This study reveals the characteristics of adaptive mutations and their biological functions of SARS-CoV-2 during long-term infection in immunocompromised patients, emphasizes the importance of close monitoring of the long-term replication of SARS-CoV-2, aiming to timely detect and prevent the spread of newly emerging neutralization-resistant variants in susceptible populations, and provides a key scientific basis for formulating effective public health prevention and control strategies. This study reveals the characteristics of adaptive mutations and their biological functions of SARS-CoV-2 during long-term infection in immunocompromised patients, emphasizes the importance of close monitoring of the long-term replication of SARS-CoV-2, aiming to timely detect and prevent the spread of newly emerging neutralization-resistant variants in susceptible populations, and provides a key scientific basis for formulating effective public health prevention and control strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/925a7a462ba9612099e1dfcb1d328c521716cbac" target='_blank'>
              Impact of prolonged infection on SARS-CoV-2 evolution
              </a>
            </td>
          <td>
            Fang Yan, Qiushi Jin, Yuanguo Li, Xuefeng Wang, Chunling Dong, Xianzhu Xia, Yuwei Gao, Jie Zhang, Zhijun Hou
          </td>
          <td>2025-01-06</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Parkinson`s disease (PD) is the second most prevalent neurodegenerative disorder, and increasing evidence indicates that glial activation plays a significant role in ferroptosis and the subsequent neurodegeneration. In this study, we aimed to identify ferroptosis-related astrocytes exhibiting elevated inflammation scores in PD patients. The single-cell and bulk RNA transcriptomic profiles of PD samples were collected from the Gene Expression Omnibus database. We characterized seven cell types in the substantia nigra region of PD and normal samples, and discovering that astrocytes from the PD group interacted with microglia and oligodendrocytes. Furthermore, we identified five distinct astrocyte subpopulations: Astro-C0, -C1, -C2, -C3, and -C4. The Astro-C1 subpopulation was found to be correlated with ferroptosis. Trajectory analysis revealed that the Astro-C4 subpopulation clustered at the anterior end of the differentiation trajectory, followed by a gradual transition to the Astro-C0 and Astro-C1 subpopulations. Additionally, we identified ferroptosis-related genes (NEAT1, HSPB1, HSPA5, and ATF4) within the Astro-C1 subpopulation and noting that NEAT1, HSPB1, and HSPA5 exhibited diagnostic potential for PD. Our findings indicated that lipopolysaccharide (LPS) treatment exacerbated astrocyte ferroptosis, as evidenced by elevated levels of Fe2 + , MDA, lipid ROS, and intracellular ROS, along with decreased MMP in PD. Moreover, the high expression of NEAT1 and low levels of HSPB1, ATF4, and HSPA5, might serve as a diagnostic indicator of ferroptosis in PD. Our study revealed that inflammation might exacerbate astrocyte ferroptosis. Additionally, NEAT1, HSPB1, and HSPA5 might serve as diagnostic markers for ferroptosis in PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b3a9b9c24051d90297f5237c365f49fca5a8663" target='_blank'>
              Deciphering Ferroptosis-Related Astrocyte Subpopulations and Diagnostic Biomarkers in Parkinson’s Disease through RNA Transcriptomics
              </a>
            </td>
          <td>
            Zhongying Gong, Dan Guo, Yufeng Lin, Zhiwei Liu, Mengdi Lv, Xinxin Liu, Mingshuo Sun, Linlin Wang, Tianman Zhao, Zhiyun Wang, Xue Xue
          </td>
          <td>2025-12-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Zika virus (ZIKV) poses a significant threat to neural tissue, causing substantial damage to unborn children exposed to the virus in utero, with consequences that can manifest even after birth, despite being born with a normal head circumference. Regardless of the extensive research, the interactions between ZIKV and the nervous system cells remain insufficiently understood, particularly regarding how neuronal responses influence broader inflammatory and viral dynamics especially in postnatal stages of development. This study evaluated the susceptibility to ZIKV infection, viral replication, immune response, and survival of neurons, astrocytes and microglial cells during postnatal developmental stages, using both in vivo and in vitro mice models. In vivo, a non-lethal but extensive infection of neurons and microglia was shown. The infection caused a robust but controlled immune response with elevated levels of MCP-1, TNF-α, and IL-6, that prevented severe neuronal damage. In vitro, neurons exhibited high susceptibility to ZIKV, with elevated levels of pro-inflammatory cytokines and IFN-β, indicating a strong inflammatory response. In contrast, astrocytes and microglia displayed varied responses, contributing to a pro-inflammatory feedback loop. These findings offer critical insights into the cellular dynamics of ZIKV infection, enhancing our understanding of its effects during postnatal nervous system development. By clarifying the interactions between ZIKV and neuronal cell types, this study deepens the comprehension of the virus’s pathophysiology and its broader implications for neurodevelopmental outcomes, extending beyond the well-documented association with microcephaly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80aee6bf94647ce0fef40ccbfab9270cf8289aa9" target='_blank'>
              In vivo and in vitro susceptibility and inflammatory response of postnatal mouse cortical neurons and glial cells to zika virus infection
              </a>
            </td>
          <td>
            M. Calderón-Peláez, M. Velandia-Romero, Jaime E Castellanos
          </td>
          <td>2025-12-31</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="The COVID‐19 pandemic has disproportionately affected elderly individuals, who exhibit higher risks of severe disease and mortality. Although the precise molecular mechanisms underlying this disparity remain unclear, we employed an integrative multi‐omics approach to analyze lung tissues from young, adult, and aged mice infected with the SARS‐CoV‐2 Beta variant (B.1.351). Conserved molecular signatures across age groups included the activation of antiviral immune response pathways (such as antigen processing and presentation, and cytokine‐cytokine receptor interaction), and downregulation of metabolic regulatory pathways (such as cGMP‐PKG signaling). Concurrently, we observed activation of three proinflammatory kinases‐p38 delta mitogen‐activated protein kinase (p38D), mechanistic target of rapamycin (mTOR), cytoplasmic tyrosine kinase (CTK)–along with inhibition of the antiviral kinase mammalian Ste20‐like kinase 4 (MST4) across all age groups, suggesting conserved therapeutic targets. Our results also revealed age‐dependent characteristics, with aged mice showing severe weight loss (> 15% by day 4 postinfection) and hyperactivation of complement and coagulation cascades compared to their younger counterparts. The upregulation of complement system proteins, including complement component 3 (C3), complement component 4b (C4b), and neutrophil/M1 macrophage markers S100 calcium‐binding protein A8/A9 (S100A8/A9) in aged mice, coupled with a strong positive correlation (R² = 0.89) between C3 and S100A8, suggested S100A8‐mediated complement activation. These findings elucidate how aging exacerbates SARS‐CoV‐2 pathogenesis through dysregulated immune and inflammatory responses, providing potential targets for age‐tailored therapies to mitigate severe COVID‐19 outcomes in the elderly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0fe6305dd6a280dbd86cc633d792e9ee1a3012a" target='_blank'>
              Integrative Multi‐Omics Analysis Reveals Age‐Associated Molecular Mechanisms in SARS‐CoV‐2 Infection
              </a>
            </td>
          <td>
            Xiaoyue Tang, Yan Xiao, J. Zhong, Tao Ding, Qiaochu Wang, Chunmei Shi, Zhiyi Zhang, Yehong Yang, Yue Wu, Jiangfeng Liu, Lili Ren, Juntao Yang
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by the sudden onset of obsessive-compulsive symptoms alongside a constellation of neuropsychiatric and somatic features. Disease progression typically includes flare and recovery states, with some patients exhibiting a persistent disease course (> 12 months of flare). We characterized circulating monocyte subsets during flare and recovery in pediatric patients with PANS, uncovering disease-state–dependent shifts in polarization and trafficking phenotypes. Inflammatory M1-like monocytes and monocyte-derived dendritic cells were elevated during flare, while anti-inflammatory M2-like monocytes were enriched in recovery. We also identified a circulating subset with a surface phenotype consistent with central nervous system (CNS) homing, which was reduced during flare and restored in recovery. These cells were detectable in the cerebrospinal fluid (CSF) of new-onset patients but not in persistent cases, suggesting differential compartmentalization during disease progression. Notably, monocyte phenotypes, including M2 polarization (monocytosis) and circulating CNS-homing profiles, exhibited striking sex-associated differences, particularly during recovery, with several subsets enriched in males but not females. Plasma from flare-phase patients modestly induced CNS-homing markers in monocytes from healthy donors, indicating the presence of circulating modulators. Together, these findings support a model in which distinct myeloid phenotypes—including sex-biased patterns—may contribute to both the pathogenesis and resolution of neuroinflammation in PANS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab805830c315ccc3f7c69d468623a69aa039f03c" target='_blank'>
              Sex-associated and disease state-dependent monocyte polarization and CNS-trafficking phenotypes in pediatric acute-onset neuropsychiatric syndrome (PANS)
              </a>
            </td>
          <td>
            Shamma S. Rahman, Noor Hussein, Silvia Giulia Galfrè, Fabian Gaertner, C. Macaubas, Avis L. Chan, Laurie Columbo, Jaynelle Gao, Samira Galehdari, Batuhan Bayram, Meiqian Ma, C. Manko, Kate Miles, B. Farhadian, M. Silverman, M. Thienemann, Noga Or-Geva, Keith Van Haren, Kari C Nadeau, Lu Tian, Jennifer Frankovich, Elizabeth D. Mellins
          </td>
          <td>2025-11-18</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV), a major immunosuppressive pathogen, inflicts substantial economic losses on the global swine industry. Despite extensive research into PRRSV pathogenesis, the mechanisms by which PRRSV induces immune dysfunction in vivo remain incompletely understood. Here, we performed single-cell RNA sequencing on cells isolated from the lung of PRRSV-infected piglets, generating transcriptomic profiles for 46,922 single cells encompassing 15 major cell types. We observed a significant reduction in the number of macrophages in lung tissues, which was primarily attributed to the extensive apoptosis of macrophages induced by PRRSV infection. PRRSV infection triggered aberrant differentiation of macrophage, and the SPP1high macrophage subpopulation was identified as the primary target cells for PRRSV infection. Cell-cell communication analysis revealed that PRRSV infection enhanced ligand-receptor interactions between macrophages and other cell types, associated with inflammatory responses, activation of T cells and B cells, and cell adhesion. In addition, monocytes exhibited a tendency to differentiate into macrophages, potentially compensating for the depletion of macrophages caused by PRRSV infection. Moreover, PRRSV infection caused abnormal development of B cells and incomplete activation of cytotoxic T lymphocytes in the lungs. This study provides a comprehensive characterization of how PRRSV perturbs pulmonary immune cell populations, offering valuable insights into the mechanisms underlying PRRSV-induced lung injury. IMPORTANCE Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection. Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a411b9a7f498fc257495d61e60998a9d94a15046" target='_blank'>
              Deciphering immune features and cellular heterogeneity in PRRSV infection via single-cell RNA sequencing
              </a>
            </td>
          <td>
            Jianda Li, Yue Liang, Yuyu Zhang, Yulin Xu, Fei Liu, Luogang Ding, Yu Wang, Zhihao Zhang, Zhi Chen, Wenbo Sun, Jiang Yu, Jiaqiang Wu
          </td>
          <td>2025-12-30</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Intracerebral hemorrhage (ICH) causes hematoma formation, leading to PHE, which is associated with leukocyte mobilization and increased inflammation at the site of brain injury. However, the fate of accumulated leukocytes within the hematoma and their impact on PHE expansion remain unknown. We performed single-cell immune profiling of hematoma cells from patients with acute ICH and reported a distinct phenotypic transformation of CD8+ T cells within the hematoma during the first 24 h after onset. In addition to enhanced IFN-γ production and migration capacity, these CD8+ T cells displayed remarkable glycolytic signatures. The metabolic fitness and functional reprogramming of hematomal CD8+ T cells are associated with the transcription factor FOXO1. Single-cell profiling of brain-infiltrating CD8+ T cells within the perihematomal tissues of ICH patients and cell culture assays revealed their capacity to activate microglia via the production of IFN-γ. Furthermore, the removal of hematomal CD8+ T cells reduced neuroinflammation, PHE expansion and neurological deficits in ICH mice. Thus, CD8+ T cells undergo metabolic and functional reprogramming within the hematoma during the acute phase of ICH, which contributes to PHE formation and neurological deterioration. FOXO1-driven metabolic reprogramming of hematomal CD8+ T cells drives the expansion of perihematomal edema following intracerebral hemorrhage—mechanisms and clinical implications CD8+ T cells within the hematoma are transformed during the first 24 h after ICH onset. These hematomal CD8+ T cells can possess remarkable glycolytic signatures and enhanced IFN-γ production and migration capacity, which are associated with the transcription factor FOXO1. The infiltration of CD8+ T cells in the brain augments perihematomal edema and neurological deterioration. (Figure created with BioRender). FOXO1-driven metabolic reprogramming of hematomal CD8+ T cells drives the expansion of perihematomal edema following intracerebral hemorrhage—mechanisms and clinical implications CD8+ T cells within the hematoma are transformed during the first 24 h after ICH onset. These hematomal CD8+ T cells can possess remarkable glycolytic signatures and enhanced IFN-γ production and migration capacity, which are associated with the transcription factor FOXO1. The infiltration of CD8+ T cells in the brain augments perihematomal edema and neurological deterioration. (Figure created with BioRender).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/276070da491f835ea64518208e42721a08ff69fe" target='_blank'>
              FOXO1-driven metabolic reprogramming of hematomal CD8+ T cells drives the expansion of perihematomal edema following intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jie Lin, Honglei Ren, Youliang Wang, Hanzhi Yu, Zhili Chen, Xintong Yu, Zhuyu Gao, Yan Zheng, Quanhong Wu, Yizhe Zhang, Qijian Lin, Rui Li, Decai Tian, Zhigang Cai, Qiang Liu, Ying Fu
          </td>
          <td>2025-11-14</td>
          <td>Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The integration of single-cell sequencing with spatial transcriptomics and multi-omics analyses has enabled a paradigm shift in biomedical research, thereby expanding its applicability and scientific impact. In the context of influenza virus studies, this technology has been instrumental in dissecting cellular heterogeneity, as demonstrated by its capacity to analyze differential transcriptomic profiles and reconstruct differentiation trajectories at the single-cell level following viral infection. These advances have provided mechanistic insights and a holistic understanding of influenza pathogenesis, surpassing the limitations of bulk-level analyses. This review provides a comprehensive dissection of cutting-edge applications of single-cell sequencing in elucidating influenza virus infection mechanisms, immune cell heterogeneity, and vaccine development. By highlighting the single-cell resolution of virus–host interactions and vaccine efficacy studies, this work offers novel perspectives for designing precision-targeted antiviral interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4f6de9c1519c1d75f459ef0760e41ce623109cf0" target='_blank'>
              New Insights into Influenza Virus-Host Interactions, ImmuneResponses, and Vaccine Development at Single-Cell Resolution
              </a>
            </td>
          <td>
            Xingting Li, Lingxi Gao
          </td>
          <td>2025-12-14</td>
          <td>Life Conflux</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49a5db351ada41d17475ee46b247329414cc1f0f" target='_blank'>
              Dynamics of interactions between three major respiratory pathogens in reconstituted human epithelium
              </a>
            </td>
          <td>
            Aurélien Gibeaud, Charles Terra, Émilie Portier, Pascal Lukas, Audrey Le Gouellec, Jérémie Guedj, Frederik Graw, A. Pizzorno, O. Terrier
          </td>
          <td>2025-11-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Subjects with Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), experience a wide range of symptoms, including fatigue and respiratory disturbances, affecting their quality of life. Despite the increasing prevalence of Long COVID, the underlying pathogenic mechanisms remain poorly understood. Extracellular vesicles (EVs) are known to be involved in various processes, such as tissue repair and the transmission of viral particles. However, the specific characteristics and functional roles of EVs derived- from patients with Long COVID (LC-EVs) are poorly characterized. To uncover systemic mechanisms underlying Long COVID, we performed a comprehensive characterization of patient-derived extracellular vesicles (EVs) via Nanoparticle Tracking analysis (NTA), Atomic Force Microscopy (AFM), Transmission Electron Microscope (TEM) and flow cytometry. These EVs were applied to lung cells, Mesenchymal Stem Cell (MSCs), Human Umbilical Vein Endothelial Cells (HUVECs) and Aortic Smooth Muscle Cells (ASMCs), revealing stress responses through SESN1, SESN2, and p53 activation. We further assessed mitochondrial respiration to evaluate metabolic dysfunction, and conducted targeted transfection experiments to dissect the molecular pathways involved, shedding light on EV-driven cellular reprogramming. Thus, we observed that Long COVID (LC) patients experienced breathlessness and leg discomfort during exertion. Our data highlighted that LC-EVs induce aberrant RUNX2 expression and activate the p53/p21 pathway in lung cells as well stress responses. Additionally, LC-EVs impair mitochondrial function and cellular adaptability under metabolic stress, reducing maximal respiration and ATP production at high cell densities. Protein interaction analysis showed RUNX2 involvement in key biological processes and post-transcriptional regulation by hsa-miR-204-5p was identified. Finally, LC-EVs also activated stress pathways and increased RUNX2, SESN, p53, and p21 levels in endothelial cells, aortic smooth muscle cells, and mesenchymal stem cells. In conclusions, these findings provide new insights into the role of extracellular vesicles in Long COVID, revealing their involvement in cellular stress and impaired mitochondrial function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d9f706bfa4303fba5e18198656479afdf7b243a" target='_blank'>
              Extracellular vesicles from long COVID patients promote RUNX2-mediated cellular stress via dysregulated miR-204 and p53 pathway activation
              </a>
            </td>
          <td>
            Luca Dalle Carbonare, Arianna Minoia, Sharazed Zouari, Michele Braggio, M. Cominacini, S. Gaglio, Francesca Cristiana Piritore, Pamela Lorenzi, Mirko Meneghel, Kevin Dervishi, Andrea Corsi, A. Pedrinolla, G. Giuriato, Alessandra Fiore, Adriana Celesia, Laura Guerricchio, M. Venturelli, Federico Schena, M. Donadelli, M. Mottes, Maria Grazia Romanelli, M. Perduca, Daniele Guardavaccaro, Ernesto Crisafulli, D. Zipeto, Lucio Barile, M. Valenti
          </td>
          <td>2025-11-26</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Behçet’s uveitis (BU) is a severe inflammatory ocular manifestation of Behçet’s disease, characterized by dysregulated T cell responses. However, the precise mechanisms underlying T cell dysfunction and local immune activation in BU remain poorly understood. We performed single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from BU patients and healthy controls (HCs). These data were integrated with publicly available single-cell transcriptomes of aqueous humor (AH) samples from BU patients. Key findings were validated using qPCR, flow cytometry, and functional assays. We observed a significant depletion of naive CD4⁺ T cells in BU, accompanied by their differentiation toward terminal effector states characterized by IL-32 and CXCR4 upregulation. IL-32 was identified as a central regulator promoting Th1 and Th17 polarization. Pseudotime trajectory analysis revealed a progressive differentiation process from circulating CD4⁺ T cells to Th17-like inflammatory cells within the AH, enriched for NF-κB and JAK-STAT signaling pathways. CXCR4 expression was associated with T cell chemotaxis into the ocular microenvironment. Cell-cell interaction analyses further highlighted active crosstalk between macrophages and CD4⁺ T cells via the MIF-(CD74+CXCR4/CD44) signaling axis. Our study reveals a coordinated mechanism linking systemic T cell dysregulation to localized ocular inflammation in BU. Targeting IL-32 and CXCR4 may represent promising strategies for restoring immune balance and preventing tissue damage in BU.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29f76a55277cfc7ac327aabf44366ec7aa5e2076" target='_blank'>
              Single-cell transcriptomic profiling reveals aberrant CD4⁺ naive T cell differentiation driving immune activation in Behçet’s uveitis
              </a>
            </td>
          <td>
            Lu Zhang, Yimeng Sun, Xinyu Yao, Chun Yan, Yunfei Liu, D. Qiao, Ziyu Du, Cong Hu, Fuying Guo, Ziwei Meng, Wei Chi
          </td>
          <td>2025-12-02</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23fe51bd03b4e6b215bef750c8f1bc98b4664ab0" target='_blank'>
              Mechanism of neuroinvasion and interferon response in human choroid plexus organoids during Japanese encephalitis virus infection
              </a>
            </td>
          <td>
            Y. Kumsang, Atsadang Boonmee, Chatpong Pethrak, Pisut Pongchaikul, U. Anurathapan, Chatchai Muanprasat, Phisit Khemawoot, Bunpote Siridechadilok, Natapong Jupatanakul, Nithi Asavapanumas, Nunya Chotiwan
          </td>
          <td>2025-12-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="ABSTRACT At a population level, evaluation of vaccine efficacy and of immunity in general focuses on measuring humoral immunity, especially antibody-mediated neutralization. However, antibody-dependent cell-mediated cytotoxicity (ADCC) and cellular immunity are key processes for pathogen clearance and often provide broader protection against emerging variants. More information on vaccine and infection-related determinants or markers of cell-mediated cytotoxicity is needed to inform design of standardized, high throughput tests assessing these processes. We previously showed that persons infected with SARS-CoV-2 prior to vaccination (hybrid immunity) had polyfunctional CD8+ T cells and robust ADCC against SARS-CoV-2 spike (S), while persons infected with Omicron after vaccination (breakthrough infection) had weak ADCC. In the current study, we investigated the impact of Omicron breakthrough infection on S-specific cellular immunity, including polyfunctional CD8+ T cell and cytotoxic T lymphocyte (CTL) levels of 28 previously uninfected individuals vaccinated either two or three times against SARS-CoV-2. In the group with three vaccinations, Omicron breakthrough infection significantly increased the frequency of circulating SARS-CoV-2 S-specific T cells, polyfunctional interferon-gamma and interleukin-2-producing SARS-CoV-2 S-specific CD8+ T cells and CTL after in vitro stimulation. Matrix testing with overlapping S peptides indicated recognition of one to two CTL epitopes per individual and revealed two previously unreported epitopes. Circulating S-specific cellular immune response magnitude neither correlated with, nor predicted CTL activity against SARS-CoV-2 S, but polyfunctional S-specific CD8+ T cell frequency seven days after stimulation and antibody reactivity against determinants indicating robust ADCC were both associated with day 10 CTL activity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbb2a62c4bf2c7761ccd671a47fe0b9354dc0555" target='_blank'>
              Predictive markers of SARS-CoV-2 spike-specific cytotoxic T cell activity following Omicron breakthrough infection
              </a>
            </td>
          <td>
            Kayla A. Holder, Danielle P. Ings, Keeley M. Hatfield, Kathleen E Fifield, D. A. Barnes, Keeley A Barnable, Debbie Harnum, Michael D Grant
          </td>
          <td>2025-12-09</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Abstract Objective Examine the role of T cells in shaping and sustaining humoral immunity to SARS‐CoV‐2 and identify immune factors associated with durable antibody responses. Methods Unvaccinated adults (n = 67) with SARS‐CoV‐2 infection (Wuhan) of any severity were followed longitudinally for up to 14 months. Anti‐Spike (S) binding and neutralising antibodies were measured. Bulk T cell IFNγ and IL‐2 responses were assessed by Fluorospot to multiple viral proteins. S‐specific T‐cell subsets and functions were analysed in detail by flow cytometry in a subset of participants (n = 14), combining activation‐induced markers (AIMs) and cytokines. Correlations between S‐specific T‐cell subsets, their polyfunctionality and antibody levels over time were defined. Results Over 14 months post infection, anti‐S IgG and neutralising antibodies declined significantly but remained detectable in > 85% of participants. Bulk T‐cell IFNγ and IL‐2 responses persisted without significant reduction. However, S‐specific CD4 T cells declined over time. A large proportion of these were peripheral helper T cells (Tph; CXCR5−PD‐1+), which were the main producers of IL‐21 and showed marked polyfunctionality during early convalescence, in contrast to circulating follicular helper T cells (cTfh). The early presence of polyfunctional, IL‐21‐producing Tph strongly correlated with S‐specific IgG and neutralising antibodies early post‐infection and predicted neutralising antibody maintenance a year later. Older age correlated with higher Tph and antibody levels. Conclusion Early S‐specific T‐cell responses—particularly polyfunctional, IL‐21‐producing Tph cells—play a key role in sustaining durable antibody levels post‐infection, offering insights for future vaccine strategies and understanding long‐term immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/63995037b8ae83290f6bb5ffec2deaef5580d4b2" target='_blank'>
              Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐19
              </a>
            </td>
          <td>
            Katie Tungatt, Gabriela Martins Costa Gomes, Nicole L. Fewings, Aija Stubis, C. Doyle, V. Merheb, A. Aggarwal, K. Byth, Harry Robertson, S. Dervish, Susan Maddocks, Janette Taylor, R. Bull, M. Martinello, F. Brilot, S. Turville, Anthony L. Cunningham, K. Sandgren
          </td>
          <td>2025-01-01</td>
          <td>Clinical & Translational Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Severe COVID‐19 is an immunological disorder characterized by excessive immune activation following infection with SARS‐CoV‐2, which typically occurs around the time of seroconversion. Anti‐spike IgG of critically ill COVID‐19 patients induces excessive inflammation by activation of Fc gamma receptors (FcγRs) on human alveolar macrophages, leading to tissue damage, pulmonary edema, and coagulopathy. While metabolic reprogramming of immune cells is critical for the induction of inflammatory responses, still little is known about the metabolic pathways that are involved in COVID‐19‐specific hyperinflammation. In this study, we identified that anti‐spike IgG immune complexes (ICs) induce rapid metabolic reprogramming of alveolar macrophages, which is essential for the induction of inflammation. Through functional inhibition, we identified that glycolysis, fatty acid synthesis, and pentose phosphate pathway (PPP) activation are critical for anti‐spike IgG‐induced hyperinflammation. Remarkably, while excessive proinflammatory cytokine production by macrophages is critically dependent on simultaneous stimulation with viral stimuli and anti‐spike IgG complexes, we show that the required metabolic reprogramming is specifically driven by anti‐spike IgG complexes. These findings provide new insights into the metabolic pathways driving hyperinflammation by macrophages in the context of severe COVID‐19. Targeting of these pathways may reveal new possibilities to counteract pathological inflammatory responses in severe COVID‐19 and related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7d09f7fb7e4fd28a04356b3213eb05a7c8386673" target='_blank'>
              Hyperinflammation by Human Macrophages Induced by SARS‐CoV‐2 Anti‐Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism
              </a>
            </td>
          <td>
            Chiara E. Geyer, Luís Almeida, Lynn Mes, F. Otto, W. Ashwin Mak, Graham A Heieis, Jennifer Veth, S. D. de Taeye, Tom G. Caniels, Tom P. L. Bijl, M. V. van Gils, M. D. de Winther, Jan Van den Bossche, Hung-Jen Chen, R. Houtkooper, Bart Everts, J. den Dunnen
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="ABSTRACT Mucosal immunity plays a crucial role in protection against respiratory viruses. However, the mechanisms underlying mucosal responses and their impact on COVID-19 outcomes are not well understood, as mucosal immunity is compartmentalized and not always reflected in the bloodstream. This study examined primary immune responses in 584 mucosal and blood specimens collected over a month from previously naïve adults and children with COVID-19. Various laboratory techniques were utilized to quantify and characterize viral RNA, antigens, antibodies, and cytokines in the samples, including PCR, sequencing, ELISA, and Luminex. Comprehensive system analysis uncovered distinctive characteristics associated with mild COVID-19 disease progression, including markedly early and elevated induction of mucosal IFN-α and IP-10, followed by increased levels of IL-1RA and IgG. Individuals experiencing mild COVID-19 demonstrated synchronized mucosal and systemic immune responses, with a gradual increase in antibody production that resulted in enhanced neutralization potency, potentially conferring greater protection against future infection. In contrast, individuals with moderate and severe COVID-19 exhibited diminished IFN-α and IP-10 responses and dysregulated mucosal and systemic immune responses marked by rapid and robust yet less effective humoral immunity, potentially driven by high antigen and cytokine levels in both compartments. Collectively, these findings underscore that early mucosal immune responses may play a pivotal role in attenuating COVID-19 disease severity. Additionally, they suggest that primary mucosal immune responses to novel viruses influence clinical outcomes, providing critical insights necessary for developing prognostic indicators, treatments, and mucosal vaccines that confer protection against SARS-CoV-2 and emerging respiratory pathogens. IMPORTANCE This research is crucial for understanding the intricate interplay between mucosal immunity and SARS-CoV-2 infection. By examining the distinct systemic and mucosal immune responses during COVID-19, this study addresses the critical gap in our knowledge of how the body defends itself at the primary site of infection: the respiratory mucosa. The findings shed light on the specific characteristics of the mucosal immune response, including the roles of different antibody isotypes, immune cells, and local factors in controlling viral entry and replication. Furthermore, because this study focuses on de novo immune responses, the results may have broad implications for understanding immune responses to future novel pathogens. Ultimately, this research will contribute to the development of more effective diagnostic tools, therapeutic strategies, and mucosal vaccines to prevent and control COVID-19. By focusing on the often-overlooked mucosal compartment, this work offers a new perspective on comprehending SARS-CoV-2 infection, its implications for public health, and preparedness for future pandemic threats. This research is crucial for understanding the intricate interplay between mucosal immunity and SARS-CoV-2 infection. By examining the distinct systemic and mucosal immune responses during COVID-19, this study addresses the critical gap in our knowledge of how the body defends itself at the primary site of infection: the respiratory mucosa. The findings shed light on the specific characteristics of the mucosal immune response, including the roles of different antibody isotypes, immune cells, and local factors in controlling viral entry and replication. Furthermore, because this study focuses on de novo immune responses, the results may have broad implications for understanding immune responses to future novel pathogens. Ultimately, this research will contribute to the development of more effective diagnostic tools, therapeutic strategies, and mucosal vaccines to prevent and control COVID-19. By focusing on the often-overlooked mucosal compartment, this work offers a new perspective on comprehending SARS-CoV-2 infection, its implications for public health, and preparedness for future pandemic threats.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2335005f4d41996d5dde9da49e85de154a439825" target='_blank'>
              Early mucosal IFN-α, IP-10, and IL-1RA and synchronized mucosal and systemic immune responses mediate COVID-19 disease progression
              </a>
            </td>
          <td>
            Mona Agrawal, Armando S Flores-Torres, John S Franks, Sarah Y. Lang, Thomas P. Fabrizio, Kristin E. McNair, Laura V. Boywid, Ashley J. Blair, Chloe Hundman, Nicholas D. Hysmith, Michael A Whitt, Rachael Keating, Paul G. Thomas, R. Webby, Amanda M. Green, Heather S Smallwood
          </td>
          <td>2025-11-28</td>
          <td>mBio</td>
          <td>0</td>
          <td>106</td>
        </tr>

        <tr id="The mechanisms by which Enterovirus D68 (EV-D68) infection leads to acute flaccid myelitis (AFM), a severe neurological condition characterized by sudden muscle weakness and paralysis, remain poorly understood. To investigate the cellular tropism and infection dynamics of EV-D68, we profiled naive and EV-D68-infected human spinal cord organoids (hSCOs) derived from induced pluripotent stem cells (iPSCs) using single-cell RNA sequencing (scRNA-seq). Examining the cellular composition of healthy hSCOs, we found that hSCOs include diverse cell types, including neurons, astrocytes, oligodendrocyte progenitor cells (OPCs), and multipotent glial progenitor cells (mGPCs). Upon infection with 2 EV-D68 strains, US/IL/14-18952 (a B2 strain) and US/MA/18-23089 (a B3 strain), we observed distinct viral tropism and host transcriptional responses. Notably, US/IL/14-18952 showed a significant preference for neurons, while US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes and OPCs. These findings provide novel insights into the host cell tropism of EV-D68 in the spinal cord, offering insight into the potential mechanisms underlying AFM pathogenesis. Understanding the dynamics of infection at single-cell resolution will inform future therapeutic strategies aimed at mitigating the neurological impact of enterovirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb54cf51aa995a2705a7d71cb812e43393ceb04a" target='_blank'>
              Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
              </a>
            </td>
          <td>
            Nathânia Dábilla, Sarah Maya, Colton McNinch, Taylor Eddens, Patrick T. Dolan, M. Freeman
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Microbiology</td>
          <td>1</td>
          <td>5</td>
        </tr>

        <tr id="There is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms (nLongC) 4–53 months after infection and compared them to 51 healthy pre-pandemic controls (HC). Thirty-five percent of nLongC individuals carried the apolipoprotein E4 (APOE4) gene, compared to 11% of Cov. Four plasma proteins, interleukin 1 beta (IL-1β), interleukin 8 (IL-8), glial fibrillary acidic protein (GFAP), and hemopexin, continued to be elevated in both Cov and nLongC compared to HC. Soluble CD14 was elevated in nLongC but not Cov. As a group, IL-1β decreased over time in Cov but not nLongC. Two of the elevated proteins, IL-8 and GFAP, correlated with age, with both Cov and nLongC showing higher levels than HC. Using a combination of four plasma proteins, along with age, body mass index, and APOE4 presence, we were able to achieve an area under the curve (AUC) of 0.81. These results suggest that SARS-CoV-2 infection causes a low-grade inflammatory process that, even months or years after infection, does not return to pre-COVID-19 levels, which may contribute to neurologic sequelae and accelerated aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6dc097b9097119d707ae7261b40c50b96e52a07" target='_blank'>
              Chronic Inflammation and Altered Immune Responses in LongCOVID Associate with Neurological Manifestations and Accelerated Aging
              </a>
            </td>
          <td>
            Norina Tang, Judith M. Ford, Kaitlyn Dal Bon, Lynn Pulliam
          </td>
          <td>2025-11-26</td>
          <td>Cells</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92b1464e350c468b0e960f74f8db814fa5f708d3" target='_blank'>
              Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey
              </a>
            </td>
          <td>
            Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida, Kenji Maeda, T. Hashidate-Yoshida, Hiroki Nakanishi, Takayo Ohto-Nakanishi, J. Terada-Hirashima, Yoshie Tsujimoto, Masayuki Hojo, H. Mitsuya, Takao Shimizu, Hideo Shindou
          </td>
          <td>2025-12-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) characterized by multifocal inflammation and axonal degeneration, driven by innate and adaptive immune cells. The Janus Kinase (JAK)/Signal Transducers and Activators of Transcription (STAT)/Suppressors Of Cytokine Signaling (SOCS) pathway regulates immune cell activity, with SOCS proteins functioning as negative regulators. Using the Experimental Autoimmune Encephalomyelitis (EAE) model of MS, our prior work demonstrated that mice lacking Socs3 in myeloid cells (Socs3ΔLysM) developed severe, brain-targeted EAE (btEAE), with increased cerebellar infiltration of activated neutrophils. To define neutrophil-specific roles, we generated mice with Socs3 deletion restricted to neutrophils (Socs3ΔLy6G). Following MOG-induced EAE, these mice exhibited clinical features identical to Socs3ΔLysM mice, including severe cerebellar demyelination, increased cerebellar infiltration of activated neutrophils and CD4+ T-cells, and clinical symptoms of both btEAE and classical EAE (cEAE), the latter involving the spinal cord (SC). Cerebellar neutrophils from Socs3ΔLy6G mice exhibited a primed, inflammatory phenotype with elevated reactive oxygen species, neutrophil extracellular traps (NETs) and heightened production of pro-inflammatory cytokines/chemokines. Neutrophil depletion alleviated btEAE, confirming their pathogenic role. Single-cell RNA Sequencing (scRNA-Seq) of cerebellum (CB) and SC neutrophils revealed five clusters in naïve and EAE mice, with expansion of two clusters (Neu2 and Neu4) in Socs3ΔLy6G mice with EAE. Neu2, Neu3 and Neu4 clusters showed high expression of Saa3, Il1b and Cxcl2, with Neu4 enriched in cytokine signaling pathways and inflammatory responses. Strikingly, Saa3 mRNA and protein expression were markedly increased in the CB and SC of Socs3ΔLy6G mice with EAE compared to controls. Translationally, the human orthologue SAA1 was significantly elevated in plasma from MS patients relative to healthy controls. Collectively, these findings demonstrate that Socs3 deficiency unleashes pathogenic neutrophil activity in Socs3ΔLy6G mice with EAE. They further reveal neutrophil heterogeneity within the inflamed CNS, define inflammatory transcriptional states and identify Saa3/SAA1 as potential biomarkers and therapeutic targets to attenuate autoimmune neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fe5a2480e246a352587ff976b7ff5324d95b8c9e" target='_blank'>
              Single-Cell RNA Sequencing Uncovers Neutrophil Clusters Associated with Autoimmune Neuroinflammation
              </a>
            </td>
          <td>
            Yong Wang, William Turbitt, Lianna Zhou, Zhaoqi Yan, Sweta B Patel, Wei Yang, Zhang Li, Jessica A. Buckley, R. Welner, William R. Meador, Chander Raman, H. Qin, Etty N. Benveniste
          </td>
          <td>2025-11-19</td>
          <td>Research Square</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0b1d9f79a0aea2296171fb92a1b3d1203b20d46c" target='_blank'>
              IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans
              </a>
            </td>
          <td>
            Jaime A. Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, S. Bos, Elias M. Duarte, J. V. Zambrana, Agamjot Bal, Boyeong K An, A. G. Dias, Julia A. Zhiteneva, J. Huffaker, C. Montenegro, G. Kuan, M.J. Ramos-Benitez, Á. Balmaseda, G. Alter, Eva Harris
          </td>
          <td>2026-01-01</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>67</td>
        </tr>

        <tr id="ABSTRACT Systemic lupus erythematosus (SLE), characterized by immune dysregulation, urgently requires improved diagnostic tools and mechanistic insights. The role of interferon regulatory factor-1 (IRF-1) remains unclear. We integrated single-cell transcriptomes (scRNA-seq; GSE254176), 6 bulk transcriptomic datasets (1079 SLE patients, 137 controls, GSE72326 and GSE61635 were merged as training datasets, including 256 SLE patients and 50 controls), and clinical samples (70 SLE patients and 58 controls). IRF-1 dynamics in T-cell subsets were analyzed via clustering and pseudotemporal trajectory. Diagnostic genes were identified by intersecting single-cell-derived IRF-1–associated markers with SLE differential genes, followed by feature selection. Six machine learning models were trained and validated in four independent cohorts. scRNA-seq revealed significant downregulation of IRF-1 in T-cell subsets (central memory CD8⁺, Th17) during active SLE, with compensatory overexpression in remission—validated clinically. Cross-analysis identified four IRF-1–correlated diagnostic genes: CCR7, CD274, KLRB1, and NRCAM, that are enriched in MAPK signaling and immune receptor activity. Generalized linear model (GLM) and partial least squares (PLS) models achieved superior diagnostic accuracy across validation cohorts. Immune analysis revealed decreased numbers of resting CD4⁺ memory T cells and Tregs (P < 0.01), alongside expanded proinflammatory cells (M1/M2 macrophages, neutrophils; P < 0.01). IRF-1 regulates T-cell differentiation and contributes to SLE immune imbalance. The IRF-1–associated gene–based machine learning model provides a robust, noninvasive diagnostic tool.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fee8fbcb2e712ec10437e9cabca33ae9f067a525" target='_blank'>
              The role of IRF-1 in mediating T-cell immune imbalance in systemic lupus erythematosus and the construction of a diagnostic model
              </a>
            </td>
          <td>
            Zichen Huang, Cheng Zhao, Fang Qin, Leting Zheng
          </td>
          <td>2025-11-19</td>
          <td>Autoimmunity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Hyperactivated immunity underpins severe outcomes of respiratory viral infections, yet specific immune perturbations are ill-defined. Our recent findings identified OLAH (oleoyl-ACP-hydrolase) as a driver of life-threatening viral diseases. In the same patient cohorts, we now identify the gene encoding IL-18Rα chain (IL18R1), as being highly expressed in life-threatening influenza, COVID-19, RSV and multisystem inflammatory syndrome in children (MIS-C) and demonstrate markedly elevated surface protein IL-18Rα expression on CD8 T cells in these infections. Using a mouse model of severe influenza, we further show that high IL-18Rα expression on effector T cells is associated with increased disease severity. We find that IL-18Rα expression on CD8 T cells is inversely associated with cytotoxicity-related genes, including granzyme A, granzyme B, perforin, Eomes, and KLRG-1. Our study demonstrates that IL-18Rα is associated with severe and fatal respiratory disease outcomes and proposes the use of IL-18Rα as a potential biomarker for severe respiratory viral disease. The authors previously pinpointed OLAH (oleoyl-ACP-hydrolase) as a driver of life-threatening viral diseases. Here, the authors identify increased IL-18Rα expression on CD8+ T cells, which acquire a reduced cytotoxic signature, correlates with severe respiratory viral infection of influenza A virus, RSV and COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6dcd9c2feb67dc8df25c889f6ca091e2fc94480c" target='_blank'>
              High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures
              </a>
            </td>
          <td>
            Aira F. Cabug, J. Crawford, Hayley A. McQuilten, Isabelle J. H. Foo, L. Allen, Deborah Gebregzabher, R. Mettelman, Tanya Novak, Janet Chou, L. Rowntree, Ruth R. Hagen, Abby J. Thomson, Genevieve E. Martin, Brad Gilbertson, Michael N. T. Souter, Fiona James, Emma Goodall, Simone Rizzetto, T. Flerlage, Xiaoxiao Jia, Lee-Ann Van de Velde, So Young Chang, Fabio Luciani, R. Thwaites, Jason A. Trubiano, Tom C. Kotsimbos, Allen C. Cheng, A. Randolph, P. Thomas, Jianqing Xu, Zhongfang Wang, Thi H. O. Nguyen, B. Chua, Lukasz Kedzierski, K. Kedzierska
          </td>
          <td>2025-11-24</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>72</td>
        </tr>

        <tr id="Severe fever with thrombocytopenia syndrome virus (SFTSV) infection is associated with poor clinical outcomes and defective humoral immunity yet the immunometabolic mechanisms underlying B cell dysfunction remain incompletely defined. Through integrated single‐cell RNA sequencing and B cell receptor (BCR) repertoire profiling of peripheral B cells from SFTS patients, we dissected the molecular signatures between survivors and fatal cases. Functional validation and metabolic flux analysis were further performed. Seven transcriptionally distinct B cell subsets were identified. Fatal cases exhibited a marked expansion of CXCR3+Ki‐67+CXCR5‐ extrafollicular plasmablasts, coupled with depletion of naïve and memory B cells. These plasmablasts exhibited hyperactivation of interferon‐response genes (IFI27, ISG15), upregulation of inflammatory mediators (S100A8/A9), and contraction of BCR diversity, with skewed usage of λ‐light chains. Pseudotime trajectory analysis and metabolic scoring revealed progressive upregulation of oxidative phosphorylation, glycolysis and endoplasmic reticulum stress during terminal differentiation. In fatal cases, B cells exhibited suppressed antigen presentation capacity and impaired immunoglobulin gene expression, alongside heightened oxidative stress and elevated CD39 levels. Furthermore, analysis of SFTSV‐infected versus uninfected B cells revealed that infected plasmablasts displayed enhanced inflammatory and migratory features, including upregulated CXCR3 and CCR10 expression, suggesting direct viral modulation of B cell function and trafficking. Our study reveals that dysfunctional, metabolically reprogrammed plasmablasts underlie humoral immune failure in fatal SFTS. These findings provide mechanistic insight into B cell‐mediated immunopathogenesis and highlight potential targets for prognostic evaluation and immunomodulatory intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3800a9aa69e7fadce2b5246f5ad88f00ce2eb14b" target='_blank'>
              Dysregulated B Cell Responses in Severe Fever With Thrombocytopenia Syndrome Revealed by Single‐Cell RNA Sequencing
              </a>
            </td>
          <td>
            Hongyan Hou, Siyu Zou, Teding Chang, Yun Wang, Ting Wang, Wei Wei, Rujia Chen, Renren Ouyang, Hui Hu, Shiji Wu, Feng Wang
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>1</td>
          <td>27</td>
        </tr>

        <tr id="Orthoebolavirus zairense is the species name for Zaire Ebola virus (EBOV) within Filoviridae. This group of viruses can cause severe disease in humans, characterized by hemorrhagic shock, coagulation abnormalities, and severe inflammation. While tissue macrophages are critical targets early during EBOV infection, other cell types support viral replication as disease progresses. At late stages of infection, infectious EBOV is found on the surface of the skin, which may be a critical source of infectious virus transmitted between individuals during outbreaks. Human skin contains a number of cellular targets of EBOV, including keratinocytes. Here, we demonstrate EBOV infection of telomerase-immortalized normal human skin keratinocytes (NHSK-1), as well as EBOVΔVP30 infection of NHSK-1 cells that were stably complemented with EBOV transcription factor VP30. Infection with EBOVΔVP30 did not elicit detectable endogenous interferon responses; however, exogenous pre-treatment of NHSK-1 cells with type I, II, and III interferon (IFN) inhibited EBOVΔVP30 infection and infection of an additional low-containment model of EBOV, rVSV/EBOV GP, in a dose-dependent manner. Analysis of the transcriptome of IFN-treated keratinocytes identified multiple genes unique to each IFN and a subset of ISGs upregulated by all three IFNs. Our results indicate that ISGs induced by IFN pre-treatment of keratinocytes can reduce infection, underlining that ISGs may serve as EBOV-targeting therapeutics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4c0318070bdd99dbf02defe41f969397e18f54f6" target='_blank'>
              Interferons Inhibit Ebola Virus Infection of Human Keratinocytes
              </a>
            </td>
          <td>
            Jonah Elliff, Hanora Van Ert, Kristina Sevcik, Marija Djurkovic, Danielle Rudd, Francoise Gourronc, Aloysious Klingelhutz, O. Shtanko, Wendy J Maury
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/41bbd0da732f00daf042a0654b10579ee8ea7d75" target='_blank'>
              Neutralizing XCL1 Attenuates Brain Injury and Reduces Lymphocyte and Dendritic Cell Recruitment Following Intracerebral Hemorrhage in Mice
              </a>
            </td>
          <td>
            Juyuan Shi, Shuai Chen, Junmin Wang, Yousef Rastegar-Kashkooli, P. Fu, Maosen Huang, Jiewen Zhang, Jian Wang, Chao Jiang
          </td>
          <td>2025-11-19</td>
          <td>Molecular Neurobiology</td>
          <td>1</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/679a7b822ce567d8ac2ac1c2ea01dd417c348cfe" target='_blank'>
              The SARS-CoV-2 nucleocapsid protein induces microglia senescence-mediated cognitive impairment via Glycolysis.
              </a>
            </td>
          <td>
            Nan-Shi-Yu Yang, Han-Xi Sha, Chen-Yu Zhang, Hui Chen, Yu-Biao Liu, Jian-Bing Xiong, J. Duan, Jun Zhang, Cha-Xiang Guan, Yong Zhou, Feng Su, W. Zhong
          </td>
          <td>2025-12-12</td>
          <td>Molecular medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="The upper respiratory epithelium protects the airway from microbial exposure, environmental irritants, and viral pathogens such as influenza A virus (IAV). Situated at the airway–gastrointestinal junction, the larynx must integrate this barrier function with fine neuromuscular control under constant immune stimulation. Clinical syndromes such as post-viral vagal neuropathy—marked by chronic cough, throat clearing, dysphonia, and vocal fatigue—highlight critical gaps in our understanding of how the larynx and upper airway remodel after viral injury. To address this, we employed mouse models integrating genetics, imaging, and single-cell transcriptomics to dissect IAV-induced injury and repair in the upper respiratory tract. IAV infection displayed regionally restricted tropism toward ciliated, secretory, neuroendocrine, and basal epithelial cells, eliciting rapid clearance, acute neutrophil invasion, and a sustained intraepithelial population of cytotoxic CD8+ natural killer T (NKT)-like cells. Single-cell analysis revealed injury-induced Myc expression in KRT5+ basal progenitors, which activated a proliferative repair program and an epithelial–immune communication circuit centered on a MYC-dependent CXCL10–CXCR3 axis. Basal-specific Myc deletion preserved viral replication and clearance but blunted injury-induced proliferation, skewed lineage differentiation, and impaired CD8+ NKT cell recruitment. These findings define a coordinated epithelial–immune program governing post-IAV mucosal restoration and offer mechanistic insight into persistent upper airway sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/561fc69832beac4c1e41655e3f435bfb03fefa41" target='_blank'>
              Oncogene c-Myc Regulates Upper Respiratory Epithelial Repair for Host Immunity During Acute Influenza Infection
              </a>
            </td>
          <td>
            Alexander G. Foote, Le Xu, J. Verheyden, Belle Pan, Nikita Katoch, Xin Sun
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Since the onset of the COVID-19 pandemic, obesity has been consistently associated with worse clinical outcomes. In 2020, we hypothesized that adipose tissue (AT) might serve as a viral reservoir and amplifier of immune responses in SARS-CoV-2 infection. Five years on, accumulating evidence supports this hypothesis. Recent autopsy and in vitro studies support that SARS-CoV-2 disseminates to and may replicate within human adipocytes. While several studies have detected SARS-CoV-2 RNA and proteins in AT, the recovery of infectious virus from this tissue has not yet been demonstrated. This remains a critical gap in our understanding of SARS-CoV-2 viral tropism and replication within adipocytes. Viral entry is mediated via angiotensin-converting enzyme-2 and neuropilin-1 receptors. Infected AT exhibits immune cell infiltration and cytokine activation, implicating it in systemic inflammation. Persistent viral RNA in AT correlates with prolonged metabolic dysfunction. These findings highlight the dual role of AT as a potential viral reservoir and immunometabolic organ. Understanding these mechanisms is critical to mitigating the long-term impact of COVID-19 and guiding responses to future pandemics involving metabolically active tissues.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/77a113aee7203a484ecb443a20ff11990516bad4" target='_blank'>
              Adipose Tissue in SARS-CoV-2 Viral Tropism, Viral Replication, and the Concept of a Viral Reservoir: An Update.
              </a>
            </td>
          <td>
            Liam Charles Maher, Paul M. Ryan, Noel M. Caplice
          </td>
          <td>2025-11-24</td>
          <td>Obesity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Influenza-associated bacterial super-infections in the lung lead to increased morbidity and mortality. Previous studies have investigated how preceding viral infection causes dysregulation of the innate and adaptive immune systems, leading to increased susceptibility of developing secondary bacterial pneumonia. However, these previous studies cannot account for the spatial context of immune cells in lung. In our study, we employ a spatial transcriptomics platform (10X Genomics Visium) to systematically characterize the coordination of immune cells during super-infection. We compare deconvoluted spatial transcriptomics data between super-infection and single influenza and methicillin-resistant Staphylococcus aureus infections. Consequently, we find that the recruitment of neutrophils and interstitial macrophages from lung parenchyma to the airways is inhibited in super-infection, likely impairing pathogen clearance. Additionally, by analyzing cell colocalization and signaling, we find that the interaction between CD4+ T cells, B cells, and dendritic cells is disrupted by secondary bacterial super-infection. These findings are confirmed by immunofluorescence staining. Our study constructs a spatial sequencing atlas of lung super-infection, highlighting how secondary bacterial challenge significantly impacts recruitment and signaling of immune cells. These findings provide insight into the aberrant inflammation in the super-infected lung and may aid development of therapeutics that target key immune cell recruitment pathways. The authors report a spatial transcriptomic analysis of mouse lungs following a super-infection of influenza and methicillin-resistant Staphylococcus aureus.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b9ce378b7762918ff506d637ca20c6cc75ef36ef" target='_blank'>
              Influenza virus and Staphylococcus aureus super-infection disrupts spatially coordinated cellular immunity in the mouse lung
              </a>
            </td>
          <td>
            Tianhao Liu, Leigh M Miller, B. P. Dresden, Chong Zhao, Yogesh Pillai, Angel Rangel-Garcia, ML Garcia-Hernandez, Javier Rangel-Moreno, Wei Chen, J.F. Alcorn
          </td>
          <td>2025-11-23</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="HIV-associated neurocognitive disorder (HAND) is characterized by glial activation and neuroinflammation emerging from HIV infection. Moreover, methamphetamine (METH) is a highly addictive psychostimulant whose use is linked to high HIV prevalence, significantly worsening clinical outcomes for people living with HIV and hastening onset of systemic illness. Overall, pathologies associated with HIV infection/METH use comorbidity include neuroinflammation, neurotoxicity, synaptodendritic damage, and resulting cognitive dysfunction. However, mechanisms underlying this neuropathogenesis remain elusive due to the scarcity of human brain-specific experimental model systems. Therefore, we created a next-generation three-dimensional (3D) human brain model derived from human induced pluripotent stem cells (hiPSCs). Specifically, this 3D in vitro cerebral assembloid model integrates functional microglia derived from hiPSCs with cerebral organoids. Microglia are key contributors to HAND symptoms associated with HIV/METH comorbidity. We show that the presence of microglia in this assembloid model allows productive infection with HIV, which is enhanced by METH exposure, resulting in increased glial activation, inflammatory responses (namely IL-1β and IL-6 release), and neurotoxicity marked by neuronal cell death and synaptic protein loss. Importantly, in this model, we observed markedly decreased levels of the microglial receptor TREM2, which is implicated in microglial functions including phagocytosis, apoptosis and inflammatory responses following HIV infection and METH treatment. Analysis of our model showed that decreased TREM2 function may lead to HIV- and METH-associated pathological changes. Overall, our assembloid model could be a valuable tool for future analyses of HIV/METH/CNS interactions and mechanisms underlying HAND, which could lead to novel therapeutic approaches to decreasing the CNS viral reservoir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffac3d500bac8bf3422011ef75e52fe379d437e3" target='_blank'>
              Investigation of CNS damage following HIV infection and methamphetamine exposure using human iPSC-derived microglia and 3D cerebral assembloid models
              </a>
            </td>
          <td>
            S. Tiwari, Gulshanbir Baidwan, S. Trescott, Shweta Jakhmola, N. Coufal, Tariq M. Rana
          </td>
          <td>2025-12-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="A comprehensive understanding of host-virus interactions during persistent foot-and-mouth disease virus (FMDV) infection is essential for elucidating the mechanisms that underpin disease causation by this highly contagious pathogen. This understanding necessitates the development of stable in vitro models. In this study, we established a model of persistent FMDV serotype O infection in Madin-Darby bovine kidney epithelial cells followed by integrated multiomics analyses. These analyses revealed that host cells adapt to persistent viral infection by reprogramming mitochondrial metabolism. This reprogramming is accompanied by alterations in mitochondrial structure and function, as well as the suppression of the apoptotic response in host cells. In particular, bystander cells, which are devoid of active viral replication, display enhanced proliferative capacity and possess a distinct microenvironmental signature that potentially increases viral susceptibility, facilitating sustained virus persistence within the cell population. Moreover, persistent viruses have evolved enhanced replicative fitness. Our findings elucidate the biological characteristics of FMDV-infected cell populations that persistently harbour the virus, reveal host-virus coadaptation, and highlight the critical role of bystander cells in sustaining persistent FMDV infection. These discoveries establish the foundation for further mechanistic studies of FMDV persistence maintenance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f717c7343d691b2f665717d1011e75b567875353" target='_blank'>
              Integrated multiomics reveals host-virus coadaptation in persistent foot-and-mouth disease virus infection
              </a>
            </td>
          <td>
            Shuang Wang, Zhihui Zhang, Sumin Wei, Guoliang Huang, Shuanghui Yin, Suyu Mu, Hu Dong, Shiqi Sun, Huichen Guo
          </td>
          <td>2025-11-24</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background T-cell responses are crucial in SARS-CoV-2 immune-control; however, limited data exist from African populations. We assessed interferon-gamma (IFN-γ) release by T cells among Tanzanian adults (18–70 years) previously infected with or without SARS-CoV-2 vaccination, using the ELISpot assay. We also characterized background plasma IFN-γ levels in this population. Methods Peripheral blood mononuclear cells (PBMCs) from 143 individuals, sampled 1–12 months post SARS-CoV-2 exposure, were stimulated with overlapping peptides spanning the Spike and Nucleocapsid proteins. T-cell responses were measured by ELISpot assay, and plasma IFN-γ concentrations by ELISA. Associations with participant characteristics were analyzed using gamma linear and modified Poisson regression models (p < 0.05 considered significant). Results We found high background T-cell IFN-γ release in 73.4% (105/143) of participants, leaving 38 (26.6%) with detectable responses above background; (38/38;100%) to Spike and (36/38;94.7%) to Nucleocapsid peptides. T-cell response magnitude did not differ by symptomatic/asymptomatic infection or vaccination status. However, each one-year increase in age was associated with a 1% decline in mean T-cell response (p = 0.029). Moreover, among participants with high background responses, 43/105;41% had elevated plasma IFN-γ, and 5/105; 4.8% showed cytokine storm-level concentrations. Alcohol consumption was significantly associated with elevated plasma IFN-γ (p = 0.041). Conclusion Strong and possibly cross-reactive T-cell responses to SARS-CoV-2 were detected in Tanzanian individuals following infection with/without vaccination. Moreover, high plasma IFN-γ levels were detected, especially among participants who consumed alcohol. We recommend for modifications of the ELISpot T-cell assays to optimize the evaluation of pathogen-specific T-cell responses among African residents given the high background IFN-γ release.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54f3e9b40a7457b0ee1b6ea368c711e316371b03" target='_blank'>
              T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian Population
              </a>
            </td>
          <td>
            Lilian Nkinda, Godfrey Barabona, Mark Ndubi, C. Motozono, Emmanuel Nkuwi, Doreen Kamori, F. Msafiri, Posian Kunambi, Elisha Osati, Benson Kidenya, Harrison Chuwa, F. Hassan, Juma Kisuse, S. Mfinanga, Mbazi Senkoro, Takamasa Ueno, E. Lyamuya, Emmanuel Balandya
          </td>
          <td>2025-12-01</td>
          <td>Infection and Drug Resistance</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="ABSTRACT Long-term non-progressors (LTNPs) represent a valuable model to investigate immunological features associated with non-progression in chronic HIV infection. In this study, single-cell RNA sequencing was performed on peripheral blood mononuclear cells obtained from 12 individuals, including 4 LTNPs, 4 typical progressors (TPs), and 4 healthy donors (HDs). Compared with TPs, LTNPs exhibited a higher percentage of naive T cells, whereas TPs showed a higher percentage of CD8+ Effector-GNLY cells. LTNPs also exhibited lower gene-expression scores related to T-cell activation, cytotoxicity, inflammation, and interferon-alpha response across multiple effector-state T-cell subsets. GO enrichment analysis showed that compared with HDs and TPs, LTNPs exhibited downregulation of migration, translation, and antiviral response pathways in both CD4+ and CD8+ T cells, with upregulation of stress/inflammatory response and differentiation programs in CD4+ T cells and of immune differentiation/activation pathways in CD8+ T cells. High-dimensional weighted gene co-expression network analysis (hdWGCNA) further revealed higher module eigengene expression of innate and myeloid-related modules and lower expression of B-cell and cytotoxicity-related modules in LTNPs compared with TPs. Additionally, HIV-1 RNA+ cells were detected more frequently in TPs than in LTNPs and predominantly identified within CD4+ T cells. Together, these findings reveal a transcriptionally balanced and favorable immunological profile associated with non-progressive HIV infection and inform the design of immune-based strategies toward a functional HIV cure. IMPORTANCE Understanding molecular traits associated with natural control in LTNPs is critical for advancing HIV remission and cure strategies. Using single-cell RNA sequencing, we found that LTNPs had more naive T cells and fewer CD8+ effector-GNLY cells than typical progressors, along with lower activation, cytotoxicity, inflammation, and IFN-α scores across effector-state T-cell subsets. Differential expression and GO analyses showed predominant downregulation of migration, translation, and antiviral pathways, while preserving early activation markers. Co-expression network analysis revealed higher innate/immune-regulatory module activity and lower B-cell and cytotoxicity modules in LTNPs. HIV-1 RNA+ cells were detected less frequently in LTNPs and mainly detected in CD4+ T cells. These findings highlight balanced immune programs in LTNPs, which may inform strategies toward a functional HIV cure. Understanding molecular traits associated with natural control in LTNPs is critical for advancing HIV remission and cure strategies. Using single-cell RNA sequencing, we found that LTNPs had more naive T cells and fewer CD8+ effector-GNLY cells than typical progressors, along with lower activation, cytotoxicity, inflammation, and IFN-α scores across effector-state T-cell subsets. Differential expression and GO analyses showed predominant downregulation of migration, translation, and antiviral pathways, while preserving early activation markers. Co-expression network analysis revealed higher innate/immune-regulatory module activity and lower B-cell and cytotoxicity modules in LTNPs. HIV-1 RNA+ cells were detected less frequently in LTNPs and mainly detected in CD4+ T cells. These findings highlight balanced immune programs in LTNPs, which may inform strategies toward a functional HIV cure.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6171a97ed7fcf5c1b6659f49943539558df22b4" target='_blank'>
              Single-cell transcriptome profiling reveals immunological fitness of HIV long-term non-progressors
              </a>
            </td>
          <td>
            Minjuan Shi, Rongfeng Chen, Tongjin Wu, Yu Liao, Tongxue Qin, Ziyu Wen, Junqi Liu, Xiu Chen, Beibei Lu, Chunxing Yi, Li Ye, Hao Liang, Caijun Sun, Junjun Jiang
          </td>
          <td>2025-11-24</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Severe influenza is frequently associated with bacterial or viral co-infections. Although immune-mediated mechanisms have been extensively investigated, the cell-intrinsic responses of respiratory epithelial cells prior to immune engagement remain poorly characterized. To model co-infection in vitro, we pre-activated B16 melanoma cells using the TLR9 agonist CpG ODN, followed by infection with influenza A virus (IAV) strain FM1. Key molecular events, including STING expression and activation, were assessed by Western blotting and RT-qPCR. The in vivo relevance was assessed in a mouse model of intranasal CpG ODN pre-treatment and IAV challenge. RNA-seq was performed as a supplementary approach to explore possible cell death pathways. Pre-activation significantly enhanced IAV-induced cell death within a restricted vulnerability window (≤ 24 h), independent of viral replication or TLR9 signaling. This was associated with inflammatory priming and initial STING activation. However, IAV infection subsequently suppressed STING phosphorylation and elevated inflammatory cell death. Mice pre-treated with CpG ODN exhibited increased mortality and aggravated lung injury following IAV challenge. RNA-seq analysis suggested the potential involvement of pyroptosis. These findings demonstrate that cellular pre-stimulation exacerbates influenza severity by promoting inflammatory cell death, a process mechanistically linked to the subsequent suppression of STING activation. This study reveals a novel pathogenic cell-intrinsic mechanism in co-infection pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3439ff28ee00f2494a3463487f23bdd0ebdcd631" target='_blank'>
              Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition
              </a>
            </td>
          <td>
            Tong Zhu, Mengru Zhu, Feiyu Lu, Kuo Qu, Hong Wang, Shengnan Wang, Zhengyi Sun, Yongli Yu, Liying Wang, Chaoying Yan
          </td>
          <td>2025-12-01</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29672190e5dc91629dfc6c24cbf297aca0b0fa87" target='_blank'>
              NLRC5-Mediated Epigenetic and Proteomic Regulation of Microglial Panoptosis Drives Neuroinflammation in Multiple Sclerosis
              </a>
            </td>
          <td>
            Wu Yan, Jianhong Wang, Gan Ping
          </td>
          <td>2025-11-28</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0df155cef961a4919322a6e793a6b887b5332168" target='_blank'>
              Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variants
              </a>
            </td>
          <td>
            Riaz-Ali Somji, Jonathan C. Brown, Shahid Rowles-Khalid, Tukur Abdullahi, Dongsheng Luo, Natalie Barthel, Michael Mülleder, M. Ralser, Wendy S. Barclay, C. Rallis, E. S. Giotis
          </td>
          <td>2025-11-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of COVID‐19, has caused widespread morbidity and mortality worldwide. SARS‐CoV‐2 infection triggers innate and adaptive immune responses, but excessive cytokine release can drive hyperinflammation, acute respiratory distress syndrome and poor clinical outcomes. Although serological and molecular assays, such as ELISA and RT‐qPCR, remain central to COVID‐19 diagnostics, they have limited capacity to reveal host–pathogen interactions at the tissue level. Therefore, profiling the human lung proteome offers a powerful strategy to identify molecular signatures associated with viral pathogenesis and disease severity. This review emphasises emerging technologies that advance lung proteome profiling during SARS‐CoV‐2 infection. Novel strategies include phage display for high‐throughput identification of antibody–antigen interactions, yeast two‐hybrid for mapping virus–host protein interactions and lateral flow immunoassays for rapid, point‐of‐care detection. Conversely, omics‐based technologies such as single‐cell RNA sequencing, microarrays and mass spectrometry are transforming our understanding of the lung proteome by revealing patterns of gene expression, protein abundance and immune heterogeneity. Therefore, comparing these conventional diagnostic assays with innovative approaches, we highlight their unique contributions to lung proteome research. These tools not only improve diagnostic precision but also hold the potential to uncover biomarkers for early risk stratification and therapeutic targeting. Prioritising integrative proteome‐focused strategies may ultimately guide personalised interventions and enhance preparedness for future viral outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bbbfd30116540e19ec56315bbd933a000cc82f6f" target='_blank'>
              Novel Strategies to Profile SARS‐CoV‐2 and Human Lung Proteome: Inflammatory Pathways in the Spotlight
              </a>
            </td>
          <td>
            E. Mankayi, T. E. Chiliza, N. Mvubu
          </td>
          <td>2025-01-01</td>
          <td>BioMed Research International</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Greater than a hundred genetic risk factors for Alzheimer’s disease (AD) have been identified by genome-wide association studies (GWAS), many of which are primarily expressed in microglia. However, the pathogenic role for most of them remains unclear. We sought to assess at scale how AD GWAS hits influence human microglial inflammatory responses. Thus, we conducted CRISPR inhibition (CRISPRi) screens of 119 AD GWAS hits in hiPSC-derived microglia (iMGLs), with reactive oxygen species (ROS) produced in response to the viral mimic poly(I:C) as a readout. Top hits that either decreased or increased ROS in response to poly(I:C) when knocked down were then interrogated in CROP-seq experiments, where CRISPRi was combined with single cell RNA-sequencing (scRNA-seq). These analyses identified 9 unique microglial clusters, including a poly(I:C)-driven inflammatory cluster (2). Emerging evidence supports a pathogenic role of viral infections in AD and our scRNA-seq showed significant overlap with AD-relevant microglial clusters. Knockdown (KD) of two hit genes, MS4A6A and EED, which lead to high levels of ROS in the presence of poly(I:C), increased the proportion of inflammatory cluster 2 cells and led to functionally related changes in gene expression. In addition, KD of MS4A6A reduced the proportion of iMGLs in the disease-associated microglia (DAM) cluster under all conditions, suggesting that MS4A6A may modulate the DAM response. In contrast, KD of hit genes, INPP5D or RABEP1 which led to low levels of ROS in the presence of poly(I:C), did not significantly affect the proportion of cells in inflammatory cluster 2 but rather shaped the inflammatory response. This included upregulation of a poly(I:C)-independent HLA inflammatory cluster (6) by INPP5D KD under all conditions. Despite INPP5D or RABEP1 being involved in disparate biological processes, their perturbation led to similar changes in gene expression, which included changes in genes related to metabolism such as oxidative phosphorylation, suggesting a shared conversion point by which AD GWAS hits affect cell state. Overall, our data begin to elucidate the functional roles played by various AD GWAS hits, including how they regulate and shape inflammatory responses such as those observed in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/497cdf48270eb7ac4fe84bee351f4625ecdcfd71" target='_blank'>
              High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
              </a>
            </td>
          <td>
            Christopher L. Cardona, Lai Wei, Joonwon Kim, Ellen Angeles, Gunjandeep Singh, Shiye Chen, Ronak Patel, Nkechime Ifediora, Peter Canoll, A. Teich, Gunnar Hargus, Alejandro Chavez, Andrew A. Sproul
          </td>
          <td>2025-12-01</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Viruses, like influenza and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remain major causes of upper respiratory tract infections worldwide, with symptoms ranging from asymptomatic to lethal outcomes. While antivirals and vaccines have helped ameliorate disease morbidity and mortality, these infections still pose significant challenges. Probiotics, including Lactococcus lactis strain plasma (LC-Plasma), have recently shown antiviral effects by activating plasmacytoid dendritic cells (pDCs), though their detailed mechanism remains unclear. In this study, we stimulated peripheral blood mononuclear cells (PBMCs) collected from healthy participants with LC-Plasma and conducted immunological analyses to investigate the immunomodulatory mechanisms of LC-Plasma. The supernatant derived from LC-Plasma-stimulated PBMCs (LCP Sup) exhibited dose-dependent inhibition of replication in Influenza A virus subtype H1N1 (H1N1) and SARS-CoV-2. LCP Sup significantly reduced the SARS-CoV-2 viral load in Huh-7 cells. However, in the H1N1 antiviral assay using A549 cells, LCP Sup was required at a higher concentration against H1N1 in A549 cells compared with SARS-CoV-2 in Huh-7 cells. Treatment with LCP Sup significantly upregulated interferon-stimulated genes (ISG) expression, particularly MxA, in A549 cells. While MxA showed the most notable increase, other ISGs also exhibited elevated expression levels compared with the negative control. Other cytokines, chemokines, and growth factors were also induced by LC-Plasma and CpG-DNA stimulation, and the effects of LC-Plasma were much higher than those of CpG-DNA. These results provide in vitro evidence of the antiviral mechanisms of LC-Plasma via upregulation of interferon-α (IFN-α) and related ISGs for host defense against respiratory viruses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54c1e93f06d05aceebdf2e0d94bd475aa2743cdf" target='_blank'>
              Stimulation of Peripheral Blood Mononuclear Cells with Lactococcus lactis Strain Plasma Elicits Antiviral Effects Against H1N1 and SARS-CoV-2
              </a>
            </td>
          <td>
            Zhao Xuan Low, Owen Woo, Osamu Kanauchi, P. Hassandarvish, V. Tiong, Sazaly AbuBakar
          </td>
          <td>2025-11-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Microglia are unique damage sensors of the central nervous system, and their homeostatic roles are increasingly recognized. Purinergic signaling through the P2Y12 receptor (P2Y12R) is indispensable for directed process movement of microglia in response to danger‐related ATP release. P2Y12R has also been shown to modulate microglial communication with neurovascular elements in the brain and to profoundly influence outcomes in experimental models of brain injury. However, the exact role of P2Y12R in shaping microglial phenotypes and interactions under physiological conditions remains unresolved due to disagreements between ex vivo and in vivo observations. Using in vivo 3D two‐photon imaging and high‐resolution anatomy we show that P2Y12Rs are essential regulators of microglial physiology, fundamentally shaping homeostatic microglial surveillance activity and direct contacts with other cell types. Genetic deletion or acute pharmacological blockade of P2Y12R function leads to altered surveillance activity, microglial morphology and P2Y12R nanoclustering, resulting in changes of direct microglial contacts with neuronal cell bodies, smooth muscle‐bearing blood vessels and oligodendrocyte processes in the somatosensory cortex of mice. Furthermore, molecular anatomy of P2Y12R expression shows correlation with disease severity and altered microglia–neuron interactions in human epilepsy. Thus, our results identify P2Y12Rs as major participants in microglial physiology whose dysfunction could impact defined cell–cell interactions in different neurological states.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5c367e4d1c254d3a3956accbf9f2980fe68e3660" target='_blank'>
              P2Y12 Receptor Function Governs Microglial Surveillance and Cell–Cell Interactions in the Cerebral Cortex
              </a>
            </td>
          <td>
            Balázs Pósfai, Eszter Szabadits, C. Cserép, Sára Vida, A. D. Schwarcz, Rebeka Fekete, Krisztina Tóth, Orsolya Bánkövi, C. Szekeres-Paraczky, Zsófia Maglóczky, Katinka Lakatos-Ujvári, Anna Kellermayer, Ana-Rita Bras, Péter Gombás, L. Erőss, Á. Dénes
          </td>
          <td>2025-12-02</td>
          <td>Glia</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Although most SARS-CoV-2 infections result in mild or moderate symptoms not requiring hospitalization, many patients experience persistent symptoms after their initial recovery, a condition termed Post-Acute Sequelae of SARS-CoV-2 infection (PASC). The underlying pathogenesis behind infection associated chronic illnesses, such as PASC, are poorly understood, thus critically limiting the development of therapeutics to prevent or alleviate symptoms. The current study examined the neurocognitive impact of SARS-CoV-2 induced inflammation in a nonhuman primate model. Ten adult rhesus macaques (5 female, 5 male) were monitored before, during, and after recovery from a mild COVID-19 illness (SARS-CoV-2 strain 2019-noCoV/USA-WA1/2020). Macaques exhibited persistent alterations in taste and smell, as well as decreased cognitive flexibility up to 3 months post-infection. Female macaques experienced sleep disturbances, greater stress and poorer autonomic function months after SARS-CoV-2 infection. Importantly, the development of these neurocognitive changes were associated with acute cytokine response to infection and increased microglia activation in brain tissue at 4 months post-infection. These findings suggest a causative link between the inflammatory response to mild COVID-19 symptoms and persistent neurocognitive changes associated with PASC and provide rationale for therapeutic strategies aimed at reducing acute inflammatory responses to the virus.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e39b66a62b804a305ef8c1e9f417b8c7fa8e3e19" target='_blank'>
              Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaques
              </a>
            </td>
          <td>
            Tomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, Winni Weng, Muskan Ali, Alex van Schoor, Elise G. Viox, Kevin Nguyen, James Auger, Richard Ketan, M. Gagne, Breanna Picou, Nadia A Golden, Monica Vaccari, Sherri Jean, Jennifer S Wood, Joyce Cohen, R. P. Johnson, Daniel C Douek, Benoit A Niclou, Rebecca D. Levit, Ian N. Moore, Mirko Paiardini, J. Raper
          </td>
          <td>2025-12-02</td>
          <td>Research Square</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f06caba0f4cc503c8b0aa1aadbc7d5f878826110" target='_blank'>
              GPR34 regulation of disease-associated microglial states and responses to physiological stimuli
              </a>
            </td>
          <td>
            Ana Geller, Min Jee Kwon, Sean K Simmons, Qihong Xu, William E. Martenis, Jordan L. Doman, Sahana Natarajan, Katherine J. Stalnaker, Jixiang Zhang, Xian Adiconis, Trang Nguyen, Matthew Demers, Donovan L. Batzli, Antia Valle-Tojeiro, Christy Biji, Sameer Aryal, Horia Pribiag, Constanze Depp, Nader Morshed, Deeksha Misri, Diana Bohannon, Elena Longhi, Hasmik Keshishian, Steven A. Carr, David McKinney, Alexandra E.Gould, Evan P Lebois, M. Weïwer, Matthew Johnson, Joshua Z. Levin, Yan-Ling Zhang, Morgan Sheng, Prabhat S. Kunwar
          </td>
          <td>2025-12-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially infects airway epithelial cells. This infection is mediated by the binding of SARS-CoV-2 spike (S) protein to ACE2 expressed on target cells. Patients with allergic (type-2) asthma have been reported to be less susceptible to coronavirus disease 2019 (COVID-19), but these effects are controversial and mechanistically unclear. We previously showed lower expression of ACE2 mRNA in airway epithelial cells from type-2 asthmatics compared to healthy donors. Moreover, we and others demonstrated that the type-2 cytokine interleukin 13 (IL-13) suppresses ACE2 expression and SARS-CoV-2 infection in human epithelial cells. To better understand the relationship between type-2 inflammation, ACE2 expression, and SARS-CoV-2 infection, we investigated the effects of IL-13 on critical steps of epithelial cell infection by SARS-CoV-2: S protein-mediated binding to ACE2 on epithelial cells, and ACE2-mediated SARS-CoV-2 entry into these cells. Recombinant IL-13 significantly inhibited both these processes. This inhibition appeared to be mediated by IL-13-induced suppression of ACE2 transcription because IL-13 failed to affect S protein-mediated viral entry into cells that express ACE2 under the control of an IL-13 unresponsive heterologous promoter. We propose that IL-13 protects epithelial cells from SARS-CoV-2 infection largely by inhibiting ACE2 expression and ACE2-mediated downstream events that allow the virus to access its cellular targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df8083f73ae8478fb1031798b020e6d2348e4b62" target='_blank'>
              IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting ACE2-mediated virus binding and cell entry
              </a>
            </td>
          <td>
            Vadim Pivniouk, Oksana Pivniouk, J. Uhrlaub, Seongmin Hahn, Allyson Molzahn, Hiroki Kimura, Mari Numata, H. Chu, J. Ledford, Monica Kraft, J. Nikolich, Donata Vercelli
          </td>
          <td>2025-11-24</td>
          <td>ImmunoHorizons</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Introduction The long-term dynamics of T-cell immunity following SARS-CoV-2 vaccination, essential for durable protection, remain incompletely understood. This study, therefore, aimed to investigate the kinetics and persistence of spike-specific T-cell responses in vaccinated healthcare workers. Methods Within the framework of the ORCHESTRA Project, we conducted a longitudinal study on the kinetics and persistence of CD4+ and CD8+ T cell immunity in healthcare workers (n=305) from four hospitals and public health centers across two European countries who received either 2 or 3 doses of an mRNA vaccine, with or without prior SARS-CoV-2 infection. Specifically, the anti-spike adaptive immune cellular response was evaluated, focusing on its crosstalk with the B cell response as measured by serology. Circulating cellular adaptive immune cells were extensively analyzed using flow cytometry to assess pro-inflammatory cytokine production (TNF-α, IFN-γ, IL-2), functional activation (CD154), and memory differentiation (CD45RO). Results Our findings show that anti-spike T cell reactivity is not influenced by age, with the only exception of a weak positive correlation with spike-specific CD8+CD45RO+ T lymphocytes (Spearman’s rho = 0.34, p<0.001), and an equally weak negative correlation with CD8+TNF+ (Spearman’s rho = -0.23, p<0.01). Other variables, such as gender and job category, did not significantly impact the vaccine-induced, anti-spike T cell immune response. Discussion No distinct relationship between CD4+ and CD8+ T cell subsets was observed post-vaccination. However, specific dynamic changes in vaccine-induced T cells were identified showing clear dose- and time-dependence. Finally, the median level of CD8+CD154+ lymphocytes, indicative of activated T cells, was significantly associated with infection incidence and may represent a reliable predictive biomarker. This study provides evidence that the vaccine-induced anti-spike cellular immune response should be considered when making vaccination decisions, as it has predictive value for infection risk.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07ae26ae5551412fdb1a4df495b2f7c4fe3ee344" target='_blank'>
              A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project
              </a>
            </td>
          <td>
            S. Ugel, Akshita Gupta, Gianluca Spiteri, P. Marchetti, F. De Sanctis, Shari Wouters, Angelina Konnova, M. Monaco, A. Carta, M. Pezzani, F. Liviero, S. Pavanello, M. dell’Omo, Eleonóra Fabiánová, Jana Bérešová, F. Larese Filon, Marcella Mauro, Giuseppe Verlato, Vincenzo Bronte, Samir Kumar-Singh, S. Porru
          </td>
          <td>2025-11-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, L. Tian, B. Jones, R. Lu, G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, J. P. Wood, J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="ABSTRACT The recently identified alphacoronavirus swine acute diarrhea syndrome coronavirus (SADS-CoV) has a high fatality rate in neonatal piglets. Currently, no vaccines or treatment strategies for SADS-CoV infection are available. The stimulator of interferon genes (STING) pathway plays a critical role in initiating innate immune responses against RNA viral infections; however, its role in host defense against SADS-CoV infection remains unexplored. We assessed the pathogenicity of SADS-CoV in 3-day-old, 7-day-old, and 3-week-old mice, revealing striking age-dependent susceptibility—a pattern mirroring clinical observations in piglets. Additionally, SADS-CoV infection activated the STING-dependent pathway, which resulted in significant interferon responses in infected mice. In vitro experimental findings confirmed that STING pathway activation inhibited SADS-CoV replication by modulating the NF-κB and IRF3 signaling pathways and mediating the production of inflammatory cytokines, which underscores the importance of the STING pathway in antiviral defense mechanisms. In vivo studies revealed that the STING inhibitor C176 significantly promoted viral replication, whereas activation of the STING pathway using the STING agonist diABZI increased antiviral immune responses and reduced viral replication. Notably, diABZI protected mice from SADS-CoV infection by reducing viral replication through mechanisms involving both type I interferon-dependent and -independent pathways. These results represent the first demonstration of the in vivo therapeutic efficacy of pharmacological STING activation against SADS-CoV. These findings demonstrate that the STING pathway serves as a critical regulator of host defense against SADS-CoV and suggest that STING-targeted intervention has therapeutic potential. IMPORTANCE Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging zoonotic pathogen with significant implications for veterinary and public health; it has a high mortality rate in piglets and the potential for cross-species transmission. Currently, there are no approved vaccines or specific antiviral agents available for this pathogen. In this study, we demonstrated that the stimulator of interferon genes (STING) pathway serves as a critical mediator of host defense against SADS-CoV infection. STING activation inhibits viral replication by coordinating interferon responses and modulating NF-κB/IRF3 signaling, and its inhibition exacerbates infection. Importantly, pharmacological activation of the STING pathway using the agonist diABZI significantly inhibited viral replication in vivo in a STING-dependent manner, with contributions from both type I interferon-dependent and -independent antiviral mechanisms, highlighting its therapeutic potential. These results advance our understanding of antiviral defense strategies against SADS-CoV and identify STING pathway regulation as a viable therapeutic approach for this emerging pathogen. Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging zoonotic pathogen with significant implications for veterinary and public health; it has a high mortality rate in piglets and the potential for cross-species transmission. Currently, there are no approved vaccines or specific antiviral agents available for this pathogen. In this study, we demonstrated that the stimulator of interferon genes (STING) pathway serves as a critical mediator of host defense against SADS-CoV infection. STING activation inhibits viral replication by coordinating interferon responses and modulating NF-κB/IRF3 signaling, and its inhibition exacerbates infection. Importantly, pharmacological activation of the STING pathway using the agonist diABZI significantly inhibited viral replication in vivo in a STING-dependent manner, with contributions from both type I interferon-dependent and -independent antiviral mechanisms, highlighting its therapeutic potential. These results advance our understanding of antiviral defense strategies against SADS-CoV and identify STING pathway regulation as a viable therapeutic approach for this emerging pathogen.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a05a2e5279a634fa785ee9b0dff3bb87703a347f" target='_blank'>
              STING agonist diABZI confers protection against swine acute diarrhea syndrome coronavirus in neonatal mice by activating antiviral immunity
              </a>
            </td>
          <td>
            Yuying Li, Wei Chen, Xinyu Zhang, Jiyong Zhou, Yanqing Hu, Yi-min Zhou, Tian Lan, Haixin Huang, Lu-lu Xie, Yan Qin, Lin Zhou, Wen-chao Sun, HuiJun Lu
          </td>
          <td>2025-12-29</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a28b81ea6fc6b707e55712e8827fecaac853add4" target='_blank'>
              Developing Topics.
              </a>
            </td>
          <td>
            N. C. Silva, Ryan G. Stein, Yi Gu, Chun Liang Hsu, Roger C. Tam, M. Salluzzi, C. McCreary, W. Alkeridy, Kevin Lam, Alex L. MacKay, S. Kolind, Benoît Cossette, Lauren E Griffith, David B. Hogan, Jacqueline M. McMillan, Parminder Raina, E. E. Smith, Teresa Liu-Ambrose
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & dementia : the journal of the Alzheimer's Association</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Organ transplant recipients are at high risk of developing chronic infection when exposed to hepatitis E virus (HEV), which can rapidly progress to liver fibrosis and cirrhosis. Macrophages play a key role in the response to the infection and disease progression. However, the interactions amongst immunosuppressants, macrophages, the course of HEV infection and activation of inflammatory response remain unclear. In this study, we generated M0, M1 and M2 macrophages from the human THP‐1 cell line. These macrophages were then infected with HEV and treated with different immunosuppressants. We visualised viral infection using laser confocal microscopy, and quantitatively analysed viral replication and inflammatory responses by bulk sequencing, RT‐qPCR, ELISA and Western blotting. We found that the M1 inflammatory macrophages exhibited the highest, while M2 macrophages had the lowest levels of viral RNA. Genome‐wide transcriptome analysis indicated that viral, inflammation and immunity‐related pathways were predominantly upregulated by HEV infection. Dexamethasone exerted potent inhibitory effects on inflammatory response in macrophages. Mycophenolic acid (MPA) demonstrated inhibitory effects on viral replication, IL‐1β and TNF‐α expression, whereas mTOR inhibitors had the opposite effects, and tacrolimus showed no clear effect. In conclusion, immunosuppressants can differentially affect HEV replication and the subsequent inflammatory responses in macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eac70274038702e260d9f4da11346625f1871599" target='_blank'>
              The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages
              </a>
            </td>
          <td>
            Jiahua Zhou, Kuan Liu, P. Boor, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-12-16</td>
          <td>Journal of Viral Hepatitis</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Inflammatory responses including glial activation, and upregulated inflammatory factors occurred after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected central nervous system. Blood-brain barrier (BBB) disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the long-lasting neurological damage even after the epidemic ends. The BBB is a highly selective dynamic interface to protects the brain from neurotoxins and the elimination of byproducts of brain metabolism via efflux transporters. The COVID-19 pandemic has introduced new challenges in managing neurological conditions, and understanding SARS-CoV-2 journey through BBB and the interconnections between the members of BBB is crucial. This review aims to summarize and elucidate the damage to the main constituent cells of BBB, including brain microvascular endothelial cells, astrocytes, and microglia and its contribution to COVID-19. Further understanding of these interactions may facilitate the development of improved treatment options and preventative measures of central nervous system injury due to COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/85e1f8e6db59f325d648f88b5923eb205b1a3a64" target='_blank'>
              Exploring SARS-CoV-2 impact on blood-brain barrier and its composition: A review
              </a>
            </td>
          <td>
            Jin Li, Shangfu Xu, Sixu Guo
          </td>
          <td>2025-11-21</td>
          <td>Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33a034aeaf82d86cd18ab74f1a0b8c466df7ff53" target='_blank'>
              Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
              </a>
            </td>
          <td>
            Jill M. Lawrence, W. Dampier, J. Mell, Diehl R. De Souza, Kayla Schardien, Kyle Yeakle, R. J. Barnett, Bhaswati Sen, Azad Ahmed, Michael Bouchard, Brian Wigdahl, Micheal Nonnemacher
          </td>
          <td>2025-12-04</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The placenta possesses several structural and immunological barriers against viral infections, the SARS-CoV-2 detection in placental tissues has raised concerns regarding possible alternative viral entry mechanisms beyond the canonical ACE2/TMPRSS2-mediated pathway. In this context, the present study evaluated the immunohistochemical expression patterns of ADAM17, Cathepsin L, Clathrin, ACE-2, Furin, NRP-1, and TMPRSS2-molecules involved in SARS-CoV-2 placental entry pathways - as well as the detection of viral RNA by RT-qPCR in paraffin-embedded samples. The study included 75 paraffin-embedded placental samples (decidua and villi) collected after spontaneous placental delivery at birth from patients who tested positive for COVID-19 (COVID-19 Group), and 19 paraffin-embedded control placental samples collected prior to the COVID-19 pandemic (NON-COVID-19 Group). A statistically significant reduction in NRP-1 expression was observed in the COVID-19 group decidua (p < 0.001), including in RT-qPCR - positive samples (p = 0.001), regardless of comorbidities or underlying conditions. A statistically significant reduction in Clathrin expression was also found in the decidual samples of the COVID-19 group and in RT-qPCR - positive samples (p = 0.05and 0.013, respectively), while Cathepsin L expression was significantly increased in the placental villi of the COVID-19 group (p < 0.001) and in RT-qPCR - positive samples (p = 0.005). These findings may contribute to a better understanding of the mechanisms underlying SARS-CoV-2 interaction with the placenta, possibly through auxiliary and/or endocytic entry pathways, and may support future investigations into the impact of these alterations in the context of maternal SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bf129d03af40a7a9e20aecd51a08fd5d6af1eee7" target='_blank'>
              Placental infection by SARS-CoV-2: exploring alternative entry pathways.
              </a>
            </td>
          <td>
            Carolina Lumi Tanaka Dino, Barbara Maria Cavalli, Carolline Konzen Klein, Felipe Paes Gomes da Silva, Nicolas Henrique Borges, Ana Catharina Joaquim, Thiago Rodrigues Dos Santos, Natan de Araújo, Lucas Baena Cartens, Ana Clara Simões Flórido Almeida, Seigo Nagashima, Caroline Busatta Vaz de Paula, Cleber Machado-Souza, Lúcia de Noronha, Meri Bordignon Nogueira
          </td>
          <td>2025-11-30</td>
          <td>Tissue barriers</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71b827598caa3b92c66b1747f1e4d291bdfd16d5" target='_blank'>
              Multi-omics Analysis of Human Blood Cells Reveals Unique Features of Age-associated Type2 CD8 Memory T cells
              </a>
            </td>
          <td>
            Hiroyuki Matsui, Marlene Cervantes, Mir M. Khalid, Alan Tomusiak, Varun B. Dwaraka, Jorge Landgrave-Gomez, Prasanna Vadhana Ashok Kumaar, Qingwen Chen, Jesica Lasky-Su, Jake Stone, Ritesh Tiwari, Ryan Kwok, Shuntaro Ichikawa, Benjamin D. Ambrose, Rebeccah Riley, G. Hormazabal, Ariel Floro, Andreea Cristina Alexandru, Ryan Smith, B. Schilling, Herbert Kasler, Eric Verdin
          </td>
          <td>2026-01-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="There are multiple reports of elevated inflammation in patients with major depression. It is, however, unclear whether these reported perturbations in immune functions in depression affect the general functionality of the peripheral immune system. Here, using single-cell RNAsequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) extracted from blood samples collected prior to a flu vaccination administration/immunization (at baseline), we found downregulated T cell and B-cell-associated gene expression repertoire coupled with a selectively upregulated plasmablast, CD14 classical monocytes, and natural killer (NK) proliferating cell-associated gene expression in 9 depressed patients (6 females) compared to 5 healthy controls (5 females), as well as in association with depression ratings. Our cell type proportion analysis revealed shifts in immune cell populations, specifically reduced numbers of CD4+ T and CD8+ T proliferating cells, plasmablasts, and NK cells in individuals with depression compared with controls. In contrast, we found increased numbers of CD14 classical and CD16 monocytes as well as doublet cells in depressed individuals compared with controls. Although our baseline and flu vaccine challenge did not show marked differences in peripheral immune markers measured by a multiplex cytokine assay, our results suggest impaired innate and adaptive immune responses at the transcriptomic and cellular population levels in depressed patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2cf073f7c3882ea32b466937ec788669b0a8b86" target='_blank'>
              Immune System Alterations in Depression across Baseline and Flu Vaccine Challenge
              </a>
            </td>
          <td>
            D. Arasappan, Alyssa Marron, Sina Sanei, Mbemba Jabbi
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d58d659e01646033f54b4d5e7e8ed88c2867fb7" target='_blank'>
              Microglia Mitochondrial Metabolism in Neurological Diseases
              </a>
            </td>
          <td>
            Jin Wang, Yikun Gao, Qing Chen, Xiaoxing Xiong, Sen Miao, Xuemei Chen, Youjia Tang, Lijuan Gu
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c515ee3e9e86703752ec072206a806bfdf0f76b3" target='_blank'>
              SLAMF1-peptide mediated epigenetic priming reprograms innate immune responses in sepsis
              </a>
            </td>
          <td>
            Sindre Ullmann, Birgitta Ehrnström, Jørgen Stenvik, S. Pinto, Yashwanth Subbannayya, Victor Boyartchuk, I. Mestvedt, Mahamaya Dhaware, Siddhesh S. Kamat, L. Ryan, Hilde Vagle, T. Dahl, B. Halvorsen, J. K. Damås, T. Espevik, Maria Yurchenko
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>71</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/39c6149cb08e1045d409bebe7df152823b6d7c93" target='_blank'>
              Nasopharyngeal colonisation by Streptococcus pneumoniae enhances host anti-viral responses to respiratory virus infection
              </a>
            </td>
          <td>
            Hanwen Hou, Julie McAuley, Ana Maluenda, Kim Mulholland, Simon Phipps, O. Wijburg, C. Satzke, Sam Manna
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5897a60d341e7e87d77fe14a00583999f5220e9" target='_blank'>
              Single nuclear RNA sequencing shows altered microglial and astrocytic functions in post-mortem Parkinson’s disease tissue
              </a>
            </td>
          <td>
            Indra Roy, R. Thomas, Georgina Jiménez Ambriz, S. Farhan, V. Piscopo, T. Durcan
          </td>
          <td>2025-11-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="The immune system is increasingly recognized as playing an important role in the pathogenesis of the neurodegenerative movement disorder Parkinson’s disease (PD). In particular, key PD risk genes LRRK2 (which encodes leucine-rich repeat kinase 2) and GBA1 (which encodes glucocerebrosidase) are highly expressed in monocytes and implicated in the regulation of immune inflammatory pathways and lysosomal function. While preclinical studies demonstrate that missense mutations in LRRK2 and GBA1 can modulate the response to inflammatory stimuli, studies in primary immune cells from PD patients harboring these mutations are few. Therefore, peripheral blood mononuclear cells were obtained from idiopathic PD patients, (n = 42), as well as PD patients with GBA1 (n = 15) and LRRK2 (n = 13) mutations, and neurologically normal controls (n = 36). Cells were stimulated with interferon gamma, which strongly induces expression of the LRRK2 protein, and treated with and without the LRRK2 kinase inhibitor MLi-2. Live and fixed cell flow cytometry panels were used to measure the activities of LRRK2 and glucocerebrosidase, as well as cathepsin activity and the expression of the human leukocyte antigen receptor (HLA-DR) in classical, intermediate, and non-classical monocytes. Interferon gamma stimulation had marked effects on LRRK2 levels and phosphorylation of the LRRK2 substrate Rab10, as well as effects on the expression of HLA-DR and cathepsin activity, with some mutation-specific and monocyte-type-specific outcomes. These results help to advance understanding of how risk genes may interact with immune stimuli in the context of PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1cce2d38ec41917e59ddb9a0ffb1ba7dc8595f" target='_blank'>
              Interferon gamma stimulates coordinated changes in LRRK2, GCase, and cathepsin activities in idiopathic and genetic Parkinson’s disease monocytes
              </a>
            </td>
          <td>
            Laura P. Hughes, R. Wallings, Julian Agin-Liebes, R. N. Alcalay, Alicia Garrido, M. Tansey, Nicolas Dzamko
          </td>
          <td>2025-11-26</td>
          <td>NPJ Parkinson's Disease</td>
          <td>0</td>
          <td>65</td>
        </tr>

        <tr id="ABSTRACT In the context of COVID-19, macrophages are primarily responsible for sensing and responding to the virus, significantly influencing disease outcomes. They are involved in early pathogen recognition, immune activation, and tissue repair. Heterogeneity and phenotypic plasticity of macrophages are dynamically shaped by microenvironmental cues, including metabolites, hypoxia, and pathogen-derived signals. Notably, emerging evidence underscores that cellular metabolism, particularly in macrophages, dictates immune responses to viral infection. This metabolic-immune crosstalk critically determines COVID-19 severity, ranging from viral clearance to hyperinflammation or fibrosis. In this review, we systematically dissect how cell-intrinsic metabolic nodes and extrinsic factors modulate macrophage effector functions, while illustrating the complications associated with macrophage metabolic dysregulation in SARS-CoV-2 infection. These mechanistic insights provide a rational foundation for therapeutic strategies targeting macrophage metabolism to rebalance immune responses and mitigate COVID-19 complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a2e1bb8d0dab5824b185f810e0cd5ef78deac45" target='_blank'>
              Metabolic control of macrophages in coronavirus disease 2019
              </a>
            </td>
          <td>
            Li An, Houxi Xu, Qiaoling Fan, MengJiang Lu, Dongdong Sun
          </td>
          <td>2025-12-23</td>
          <td>Virulence</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="A hallmark of COVID-19 patients is the reduction of the lymphocyte population accompanied by activation, senescence, and exhaustion markers. We investigated patients admitted to hospital wards who either recovered after a short hospitalization or progressed to critical illness. Patients (n=48) were recruited between May and September 2020; 19 healthy volunteers were enrolled as controls. Blood samples were collected on days 0, 3, and 7 of hospitalization and around 30 days after discharge (convalescence sample, CS30). Lymphocyte counts and extended immunophenotyping were performed by flow cytometry and analyzed using conventional and stochastic methods. At D0 and D7, total lymphocytes, natural killer cells, T cells, TCD4 cells, and TCD8 cells were lower in patients than in volunteers but were restored at CS30. The stochastic analysis identified 11 distinct clusters of lymphocytes, nine of them with significant differences between patients and healthy controls. Clusters of TCD8+ memory cells showing activation, senescence, and exhaustion were increased in patients during hospitalization and in the convalescence samples. In contrast, clusters 5 (TCD4+ Central Memory exhausted activated) and 7 (TCD4+ Central Memory exhausted) were decreased in patients during the disease compared to healthy controls. Overall, the conventional flow cytometry analyses corroborated the findings from the stochastic analysis, showing that effector memory (EM) and TEMRA subsets exhibited sustained markers of exhaustion and senescence, particularly in TCD8+ cells. Our findings reinforce lymphopenia, T cell activation, senescence, and exhaustion as essential immunological features of COVID-19; while cell counts fully recovered, lymphocytes remained dysfunctional in convalescent samples.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccf36a0bfe213bfeb842f9d7a3a65163a5e63e4c" target='_blank'>
              Tracking immune dysregulation in COVID-19: lymphocyte dynamics from hospitalization to recovery
              </a>
            </td>
          <td>
            G.S. Eburneo, M.B. Sousa, M. Brunialti, S. Santos, J.G.D. Silva, P. Ferreira, N.C.J. Bellei, J.S.O. Arakaki, Giuseppe G F Leite, R. Salomão
          </td>
          <td>2025-11-14</td>
          <td>Brazilian Journal of Medical and Biological Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d88f1d062847fce5f75c6558cc3546479b70f4a7" target='_blank'>
              A myeloid trisomy 21-associated gene variant is protective from Alzheimer’s disease
              </a>
            </td>
          <td>
            Mengmeng Jin, Ziyuan Ma, Rui Dang, Haiwei Zhang, Rachael Kim, Haipeng Xue, Jesse Pascual, Hanwen Yu, Ava V. Papetti, Yan Liu, Steven Finkbeiner, Elizabeth Head, Ying Liu, Peng Jiang
          </td>
          <td>2025-11-24</td>
          <td>Nature Neuroscience</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Long- and post-COVID-19 syndromes have emerged as a significant global health challenge, with millions of individuals experiencing persistent or the development of new symptoms after a long period of an initial SARS-CoV-2 infection. These symptoms are multisystemic and may indicate changes in the respiratory, neurological, cardiovascular and gastrointestinal systems, in addition to prolonged fatigue. Vaccination has played a crucial role in reducing severe disease and mortality, but the impact of the different vaccine combinations on the development and resolution of Long COVID remains a topic of debate. This review synthesizes current evidence on how different vaccine platforms, dosing strategies and booster doses influence the immunological response, protection, incidence, severity, and persistence of Long COVID symptoms. We discuss key immunological mechanisms by which vaccination may modulate and protect post-COVID syndrome outcomes, including its effects on viral clearance, immune response reprogramming, inflammation, and autoimmunity, seeking to combat misinformation and concepts spread by fake news. The review also highlights controversies and research gaps, such as variability in vaccine response among different populations and the role in the selection of more transmissible and virulent SARS-CoV-2 variants, as well as the potential differences between vaccine-induced and infection-induced immunity, and the role of pre-existing immune conditions in this scenario.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1877f162e92139adf77d3156392d030444bf043" target='_blank'>
              Vaccination and COVID-19: impact on long-COVID
              </a>
            </td>
          <td>
            Gustavo N. Guimarães, N. S. Brunetti, D. G. de Lima, J. Proença-Módena, Alessandro S Farias
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="AIMS
Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that cardiovascular disease predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with preexisting atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.


METHODS AND RESULTS
Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in-vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA-sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.


CONCLUSIONS
This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.


TRANSLATIONAL PERSPECTIVE
This study evaluates the underlying molecular mechanisms of worse outcomes of patients with atherosclerotic cardiovascular disease during respiratory infections, specifically COVID-19. Patients with atherosclerotic cardiovascular disease present with a dysregulated hyperinflammatory, type I interferon-driven immune response already during moderate COVID-19. This not only explains a major risk factor for severe COVID-19 but might also enable targeted therapies for this specific risk group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417901a925ab6ef7f438ab3c6409b92a5127c60d" target='_blank'>
              Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
              </a>
            </td>
          <td>
            J. Leberzammer, W. Abplanalp, Katharina Grikscheit, Emmanouil G. Solomonidis, S. Glaser, B. Schuhmacher, Maximilian Merten, Gligorije Jeremijev, A. Wilken-Schmitz, Lara Korth, David John, S. Günther, C. Kuenne, Mario Looso, C. Valasarajan, V. Beneš, Ferris Jung, Vivianne Niehaus, Gabriele Anton, Christoph Stellbrink, C. Römmele, S. Göpel, Soni S Pullamsetti, J. Vehreschild, M. Vehreschild, S. Ciesek, David M. Leistner, A. Zeiher, S. Dimmeler, S. Cremer
          </td>
          <td>2025-12-13</td>
          <td>Cardiovascular research</td>
          <td>0</td>
          <td>159</td>
        </tr>

        <tr id="ABSTRACT After antigen encounter, long‐lived antibody‐secreting cells (ASC) secrete high‐affinity circulating antibodies. In addition, memory B cells (MBC) are quickly reactivated upon antigen re‐exposure and predominantly generate shorter‐lived ASCs. Studies have suggested that MBC can differentiate into ASCs without recognizing their cognate antigen, a process known as “bystander activation”. This antigen‐independent reactivation of MBC could help maintain circulating antibody levels, thereby protecting against future infections. To elucidate whether SARS‐CoV‐2 mRNA vaccination leads to bystander activation of B cells, the dynamics of antibody concentrations against six pathogen‐specific antigens not encountered during the sampling period were analyzed over time. Deep profiling of antigen‐specific B cell responses was simultaneously performed using multiparameter high‐dimensional spectral flow cytometry. Antibody concentrations against tetanus toxoid (TT), respiratory syncytial virus (RSV), and influenza hemagglutinin (HA) unexpectedly increased 6 weeks after the first SARS‐CoV‐2 vaccination. Deep profiling of B cell differentiation stages demonstrated a short‐term increase in influenza‐specific IgG+ DN3 B cells, RSV‐specific IgG+ CD11c+ activated B cells, and TT‐specific IgG+ MBC following vaccination. In this study, we demonstrated at both the antibody and cellular levels that SARS‐CoV‐2 mRNA vaccination transiently activates distinct early activated B cell compartments directed against influenza HA, RSV, and TT.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f900c073d1085623f61904044b055568f8e6e7fd" target='_blank'>
              SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults
              </a>
            </td>
          <td>
            Lisan H Kuijper, L. Kummer, Laura Fernandez Blanco, K. van der Straten, M. Claireaux, A. Bos, Miranda C Dieker-Meijer, T. Jorritsma, M. Duurland, M. Steenhuis, Juan J Garcia Vallejo, K. V. van Dam, E. Stalman, L. Wieske, S. Tas, L. Boekel, Gert-Jan Wolbink, T. Rispens, T. Kuijpers, F. Eftimov, M. van Gils, A. ten Brinke, S. V. van Ham
          </td>
          <td>2026-01-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Background Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (Mtb) co-infection remains a major cause of mortality in AIDS patients, yet the mechanisms of pathogen interplay and host immune remodeling remain poorly understood. Methods To capture early untreated states, we applied single-cell RNA sequencing (scRNA-seq) to peripheral blood mononuclear cells from healthy controls, and from participants newly diagnosed with HIV mono-infection or HIV-Mtb co-infection, before therapy initiation. Integration guided by a Directed Acyclic Graph (DAG) inferred a pseudo-temporal trajectory from health to HIV infection to co-infection. Results Along this continuum, TNF-α and TGF-β signaling progressively declined in CD8+ T cells and monocytes. Th1 cells emerged as the dominant anti-tuberculosis effectors, whereas Th17 cells exhibited transcriptional exhaustion and ribosomal stress signatures consistent with a non-responsive state. Cell communication analysis revealed fewer overall interactions but increased signaling strength within pathways during co-infection. Notably, we observed a transition in T cell from MHC class II to class I, a shift that was most pronounced in the CD4+ effector memory subset. These rewired interactions featured selective upregulation of inhibitory checkpoint molecules (PGE2–PTGES3–PTGER2/4, PPIA-BSG, PECAM1) and loss of stimulatory signals (CD6-ALCAM, CLEC2B/C/D-KLRB1). Discussion Our study provides a single-cell roadmap of HIV-Mtb co-infection and identifies Th1/Th17 imbalance and MHC-I-biased T-cell signaling reconfiguration as candidate targets for restoring immune homeostasis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3079e80670107d8df959c9a9373c58fb84ac742d" target='_blank'>
              Single‐cell transcriptomics reveals pathogen interactions and T cell reprogramming in HIV and Mycobacterium tuberculosis co‐infection
              </a>
            </td>
          <td>
            Zihui Zhao, Suyue Huang, Wei Huang, Wei Song, Li Liu, Jun Chen, Ren-fang Zhang, Yinzhong Shen
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e66ca3285aa3fb2f5b1301f35111f35086a256eb" target='_blank'>
              Zika virus inhibits mitophagy to facilitate its replication
              </a>
            </td>
          <td>
            Qi Li, Xiaoxue Ding, Yong Yin, Xingchi Nie, Shengbo Cao, Jing Ye
          </td>
          <td>2025-11-28</td>
          <td>Animal Diseases</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="African swine fever (ASF) is a highly contagious hemorrhagic disease caused by African swine fever virus (ASFV), which has inflicted devastating impacts on the global swine industry. Currently, no commercially available vaccines exist. A major obstacle in ASF research of mechanistic exploration and vaccine studies is the virus’s strict tropism for primary cells like porcine alveolar macrophages (PAMs), while exhibiting poor susceptibility to most immortalized cell lines. This study compared the replication and host response of the ASFV SY-1 strain in PAMs versus immortalized porcine macrophage cell lines (iPAMs) using qPCR, western blot, and early infection transcriptome data. Results revealed that the SY-1 strain replicates only minimally in iPAMs, with significantly lower replication capacity than in PAMs. Transcriptomic data demonstrated divergent host responses: iPAMs predominantly involved in in the regulation of lipid metabolism and response to oxidative stress, whereas PAMs preferentially activate cytokine signaling and immune responses. Furthermore, Functional validation indicated JPH4 and CYP1A1 (selected from differentially expressed genes list) as potential host factors influencing viral replication. This study delineates early host–virus dynamics in ASFV susceptible cells (PAMs) and restricted replicating cells (iPAMs), which not only provides an insight into the replication of ASFV but also improved rational design of antiviral strategies in ASF research.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43327ef974ead7f5fb634f703f8e597b4b8095fa" target='_blank'>
              Transcriptome analysis of differences in the infection of African swine fever virus (SY-1 strain) in iPAMs and PAMs
              </a>
            </td>
          <td>
            Haiying Mao, Chuxing Cheng, Yong Wang, Wenhui Zhou, Ke Zhang, Yongqi Wang, Lihao Wang, Zhenrui Song, Xiaomei Sun, Yuanfeng Zhang, Xiaotong Hu, Yumei Zhang, Zong Zou, Ya Zhao, Qiang Zhang, Meilin Jin
          </td>
          <td>2025-12-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Viruses critically depend on host lipid metabolism to drive replication, assembly and immune evasion during infection and pathogenesis. While previous studies have demonstrated that certain viruses induce lipid droplet accumulation in infected host cells, lipid droplets have been reported to exert either proviral or antiviral effects across different research contexts. The present study investigates how porcine deltacoronavirus (PDCoV) regulates lipid droplet biogenesis and fatty acid synthesis in LLC-PK1 cells, with the aim of elucidating the potential molecular mechanisms and regulatory gene targets that govern lipid droplet homeostasis during infection. First, we characterized PDCoV’s impact on lipid droplet homeostasis in LLC-PK1 cells using immunofluorescence staining, lipidomic profiling and gene expression analysis. Subsequently, we investigated the molecular mechanisms governing lipid droplets’ antiviral effects against PDCoV, focusing on interferon (IFN) response pathway and endoplasmic reticulum (ER) stress signaling. Finally, we employed gene knockout (KO) strategy to study the regulatory gene of lipid metabolism that modulate the efficiency of PDCoV infection. PDCoV infection caused significant accumulation of lipid droplets in LLC-PK1 cells. Transcriptional and lipidomic analyses revealed a disruption in lipid metabolism, characterized by altered gene expression and elevated cellular triacylglycerol (TAG) levels. Lipid droplets exhibited co-localization with actively replicating virus, suggesting a potential proviral role of lipid droplets in PDCoV infection. However, excessive lipid droplets accumulation strongly suppressed PDCoV infection. This antiviral effect was linked to enhanced type I/III IFN responses and ER stress. We further identified the pan-coronavirus host factor TMEM41B as a key regulator of lipid droplet homeostasis. TMEM41B KO induced aberrantly enlarged lipid droplets and potently inhibited PDCoV infection. Re-expression of TMEM41B restored both lipid droplet morphology and PDCoV infection, underscoring its role in modulating infection through lipid metabolic regulation. This work delineates host factors and mechanisms governing the lipid droplet-PDCoV interplay, revealing an antiviral strategy via chemical or genetic modulation of lipid droplet homeostasis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb997a6629e0d4f9b9acbc8d0af66ffaafcce8b0" target='_blank'>
              Porcine deltacoronavirus infection promotes intracellular lipid droplet accumulation
              </a>
            </td>
          <td>
            Xiaohui Yang, Haiwen Zhong, Chuanzhao Yu, Jie Cheng, Huijie Jiang, Cuizhen Wang, Changxu Song, Huaqiang Yang
          </td>
          <td>2025-11-17</td>
          <td>Virology Journal</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1babe6054c4059128d610e6cfbc8906c8e8c1b18" target='_blank'>
              IFNγ-Driven Inflammatory Responses in the Nasal Mucosa Drive Influenza Virus Shedding and Transmission
              </a>
            </td>
          <td>
            Stacey Bartlett, Hedy L. Rocha, Leon L. Hsieh, Stephen T. Yeung, Chan Wang, Grace O. Ciabattoni, Cynthia A. Loomis, Huilin Li, B. tenOever, M. Ortigoza
          </td>
          <td>2026-01-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/077d61a2f5398bd9d9325e4f8f0c44e0a25878aa" target='_blank'>
              Flu Virus Infection in Juvenile Mice Leads to Lifelong Multi-Organ Damage and Parkinsonian Pathological Changes in Aging
              </a>
            </td>
          <td>
            Ruina You, Cuicui Liu, Xun Liu, Xinglian Wang, Zhuoya Xu, Qian Huang, Guolin Dong, Chaoqun Liang, Na Wang, Zhichao Miao, Taijiao Jiang, Dayan Wang, Lei Deng, Yousong Peng
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="


 Airborne particulate matter (PM), particularly fine (PM
 2.5
 ) and coarse (PM
 10
 ) particles, is a major environmental health concern linked to increased respiratory morbidity and mortality. During the COVID-19 pandemic, epidemiological studies suggested that PM exposure may worsen SARS-CoV-2 infection outcomes; however, cellular mechanisms underlying this association remain incompletely understood. Here, we investigated how pre-exposure to PM
 2.5
 and PM
 10
 impacts SARS-CoV-2 infection dynamics in Calu-3 human epithelial cells.




 Calu-3 cells were pre-exposed to PM for 72 h prior to infection with either the wild-type Wuhan strain or the more virulent Delta variant for additional 48 h. Viral infection, receptor expression, apoptosis and cytokine responses were assessed.




 PM
 10
 , but not PM
 2.5
 , enhanced Delta variant infection, increasing the proportion of infected cells by 13.7% and viral titers by 2.6-fold compared with controls. This enhancement was not attributable to changes in ACE2 receptor expression or viral entry efficiency but instead impaired antiviral defenses. PM10 pre-exposure suppressed apoptosis and reduced the expression of pro-inflammatory cytokines including IFN-γ, IP-10, and TNF-α during Delta infection.





 These findings suggest that PM
 10
 compromise epithelial antiviral response by dampening apoptotic cell clearance and inflammatory responses, thereby creating a cellular condition more permissive to viral replication. Our study provides a mechanistic basis by which particulate air pollution may amplify SARS-CoV-2 pathogenicity in a variant-specific manner. These results underscore further validation in physiologically relevant systems and highlight the potential public health implications of air pollution during viral pandemics.

">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac9a796dc8ff736d95d72734234fedf3e2cf1ff5" target='_blank'>
              Particulate matter exposure potentiates SARS-CoV-2 delta variant infection by suppressing epithelial antiviral responses
              </a>
            </td>
          <td>
            Supasek Kongsomros, Jiraporn Paha, Phayungsap Prasara-a, Sopita Visamol, Pinnakarn Techapichetvanich, Apisada Jiso, Kwanchanok Uppakara, Ardythe L. Morrow, Alexander W. Thorman, S. Chutipongtanate, Phisit Khemawoot, A. Thitithanyanont
          </td>
          <td>2026-01-05</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Post-COVID cardiac complications have emerged as a significant and persistent clinical concern, yet their underlying mechanisms remain poorly understood. Animal models can act as proxies to investigate the pathophysiology of the human, post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this experimental study was to evaluate the expression of inflammatory biomarkers in cardiac tissue 28 days after SARS-CoV-2 infection in a female hACE2 mouse model, with a focus on chemokine-mediated immune activation. Twelve female C57BL/6 hACE2 mice were infected with the Omicron variant (BA.1.17 lineage) of SARS-CoV-2, and eleven non-infected mice served as controls. Cardiac tissue was analyzed via Western blot for markers of innate immune activation (TLR4, MyD88, NF-κB) and pro-inflammatory cytokines (IL-6, IL-18, IL-1β, TNF-α, CD11d). Cardiac tissue injury markers (iNOS, PAI-1 and Connexin43) were also analyzed. Compared to non-infected mice, cardiac tissue from infected mice showed significantly higher expression of IL-6 (p = 0.028), indicating an inflammatory state, and CD11d (p = 0.016), suggesting an inflammatory stage accompanied by sustained activation of chemokine-mediated inflammatory signaling. No significant differences in TLR4 (p = 0.340), MyD88 (p = 0.410), NF-κB p65 (p = 0.780), IL-18 (p = 0.548), IL-1β (p = 0.455), and TNF-α (p = 0.125) expressions were observed Similarly, no changes in cardiac damage markers (iNOS: p = 0.4684; PAI-1: p = 0.5345; Connexin 43: p = 0.2879) were found. The results of this experimental study would support the hypothesis of persistent low-grade inflammation as a contributor to post-COVID cardiac sequelae in females that is not accompanied by severe tissue damage, as also observed in clinical studies. This study also reinforces the need for studies evaluating the functional and structural evolution of the myocardium after an acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8c71f525771ab829c5b8bbcdcdb88fac1b05cc46" target='_blank'>
              Cardiac Tissue Damage in a Female Animal Post-COVID Model: Relevance of Chemokine-Mediated Inflammation
              </a>
            </td>
          <td>
            Silvia Flaj-Prados, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Eva M. Sánchez-Robles, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="Persistent, unresolved inflammatory processes disrupt the complex homeostatic state and lead to severe disease, ultimately resulting in organ failure, shock, and death. The mediators that monitor and control the programmed mechanisms in tissue homeostasis and repair remain elusive. A recently discovered group of endogenous proteins, termed neuronal guidance proteins (NGPs), has gained attention as important mediators of immunoregulation and tissue homeostasis through their role in the complex interplay between metabolic reprogramming and immunity. In murine peritonitis, the deficiency of the NGP Plexin C1 (PLXC1−/−) led to an increase in neutrophil and Ly6Chi monocyte recruitment to the injury site and a decrease in the phagocytosis rate. This was accompanied by a decrease in the endogenous biosynthesis of specialized proresolving lipid mediators (SPMs) such as Maresin-1 and Protectin DX and finally by a lengthening of the resolution interval. Peritoneal macrophages (MΦs)PLXC1−/− followed specific strategies to adapt their metabolism to catabolic conditions, by reducing fatty acid oxidation and oxidative phosphorylation, increasing aerobic glycolysis and activation of the pentose phosphate pathway, and disrupting the tricarboxylic acid cycle. The decreased MΦsPLXC1−/− citrate levels corresponded with a lipid mediator profile in which PGD2 and PGE2 were greatly decreased in murine PLXC1−/− peritoneal exudates, indicating a lesser effect on lipid mediator class switching and ultimately the formation of SPMs. Analysis of the related signaling networks indicated mTOR and AKT2 phosphorylation pathways are critical determinants of metabolic reprogramming in activated MΦsPLXC1−/−. These findings highlight a novel role for PLXC1 in regulating the crosstalk between immunometabolism and inflammation resolution programs in severe inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142901da389dc4e201c184a92df6289f59bd6377" target='_blank'>
              Plexin C1 modulates metabolic programming for resolution of severe inflammation
              </a>
            </td>
          <td>
            Andreas Körner, Michael Koeppen, Jasvir Kaur, Julia C Fitzgerald, S. Kostidis, Torsten Kaussen, Christoph Trautwein, M. Giera, Tamam Bakchoul, Alice Bernard, V. Mirakaj
          </td>
          <td>2025-11-25</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="ABSTRACT Chikungunya virus (CHIKV) is an emerging, mosquito-borne alphavirus responsible for debilitating, long-lasting arthralgia and myalgia. In light of recent findings of prolonged CHIKV RNA shedding in human semen and testicular tropism in animals infected with related alphaviruses, it is imperative to investigate CHIKV's capacity to infect the human testis, an established reservoir for arboviruses like Zika, and to delineate its implications for testicular function. Using an ex vivo human testicular tissue model, we demonstrate that CHIKV rapidly infects peritubular myoid cells (PMCs) and a range of interstitial cells, with robust viral production peaking at day 3 before declining. Importantly, seminiferous tubule cells and isolated testicular germ cells proved nonpermissive to CHIKV infection, indicating a potential limitation for seminal shedding of virions. Infected testicular explants exhibited a broad antiviral response but limited pro-inflammatory cytokines upregulation. CHIKV replication in the testis induced apoptosis and cell death, with a marked impact on PMC markers including decreased transcriptional expression of genes crucial for PMC contractile properties and extracellular matrix production. In summary, our study highlights the susceptibility of human testicular tissue to CHIKV infection, marked by robust viral replication that primarily compromises PMC function. The observed cellular impairment and damage suggest that CHIKV infection might negatively affect key testicular functions, such as tubular contractility and sperm release. These findings warrant further investigation into semen parameters and viral shedding in CHIKV-infected men.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/db2223232e271cfdf9d6135d60998d17a29caaad" target='_blank'>
              Chikungunya virus replicates in the human testis ex vivo and impacts peritubular myoid cells functional markers
              </a>
            </td>
          <td>
            Matéo Cartron, Vincent Ciesielski, Laurent Houzet, Krishani Dinali Perera, Hervé Abiven, María José Lista Brotos, Ingrid Plotton, Romain Mathieu, Julien Branchereau, Laurent Martin-Lefevre, Pierre Roques, Dominique Mahé, Nathalie Dejucq-Rainsford
          </td>
          <td>2025-12-01</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/374e623a09a6fc538a56807d5d61bb92b1f9f1a3" target='_blank'>
              Cellular Distribution of Pyruvate Kinase M2 After Spinal Cord Injury in Adult Rats
              </a>
            </td>
          <td>
            Alejandro Arriero-Cabañero, Natalia Díaz-Rubio, Cristina Talabán-Rocha, Lorenzo Romero-Ramírez, V. Buzoianu-Anguiano, Jörg Mey
          </td>
          <td>2025-11-29</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Toxoplasma gondii is a globally prevalent intracellular parasite that infects ~40 million Americans. The murine immune response to Toxoplasma relies on both toll-like receptor (TLR) 11/12 and immunity related GTPase-mediated (IRGs) responses, which humans lack, making it unclear how the human immune response detects and responds to the parasite. We investigated whether human Vγ9Vδ2 T cells, which detect phosphoantigens through the BTN3A1 receptor, shape the early immune response to the parasite. Using primary human peripheral blood mononuclear cells (PBMCs), we show that Vγ9Vδ2 T cells are activated by Toxoplasma-infected cells in a BTN3A1-dependent manner leading to secretion of interferon gamma (IFNγ) and tumor necrosis factor-alpha (TNFα). Additionally, these T cells potentiate IFNγ production by natural killer (NK) cells, via TNFα and interleukin (IL)-12 produced during infection. Active parasite invasion is required to stimulate the IFNγ response, and inhibition of the host mevalonate pathway, which limits the synthesis of the phosphoantigen isopentenyl pyrophosphate (IPP), attenuates the cytokine response, indicating Toxoplasma infection increases host phosphoantigens leading to Vγ9Vδ2 T cell activation. Our findings identify Vγ9Vδ2 T cells as key effectors that potentiate NK cells in the early human immune response to Toxoplasma, bridging innate and adaptive immunity in the absence of TLR11/12 signaling.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6baec0197c59f767ac2b9af6c48776dd5b07acfc" target='_blank'>
              The early human interferon gamma response to Toxoplasma gondii is driven by Vγ9Vδ2 T-cell sensing of host phosphoantigens and subsequent NK-cell activation
              </a>
            </td>
          <td>
            Felipe Rodriguez, Jeroen P. J. Saeij
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="

 Multisystem inflammatory syndrome in children (MIS-C) is a severe condition that arises 4–6 weeks after SARS-CoV-2 exposure, marked by persistent fever, mucocutaneous symptoms, cardiac involvement, and shock. Natural killer (NK) cells are thought to contribute during the acute phase due to their antiviral and immunoregulatory roles, but their phenotype during recovery is not well defined. An expansion of TCR Vβ21.3+ T cells has been observed during acute MIS-C, though their long-term presence and significance remain unclear.



 Peripheral blood mononuclear cells (PBMCs) were collected from 4 healthy pediatric controls, 4 febrile (non-COVID) controls, 4 children with acute COVID-19, 9 with acute MIS-C, 8 MIS-C convalescents (6–12 months), and 6 long-term MIS-C convalescents (4 years). TCR Vβ21.3 expression was analyzed using a T cell panel (CD3, CD4, CD8, CD27, CD45RA, TCR Vβ21.3). NK cell phenotype was assessed after co-culture with K562 cells using markers including CD56, CD3, CD16, CXCR6, Ki67, NKG2D, NKG2C, and CD158.



 NK cells from acute MIS-C patients showed decreased CD57, CD158, and CD107a, along with increased NKG2D expression. Clustering analysis revealed a unique NK cell population exclusive to acute MIS-C, defined by absent CD107a and elevated CXCR6 and Ki67. Most alterations resolved within 6–12 months, except CD158, which remained low even after 4 years. TCR Vβ21.3+ T cells persisted for up to a year but were undetectable at 4 years.



 MIS-C triggers a transient NK phenotype marked by reduced cytotoxicity and increased activation, suggesting a hyperactivated or dysregulated immune profile. Persistent downregulation of the inhibitory receptor CD158 may indicate prolonged NK activation. TCR Vβ21.3+ T cells appear to be short lived. Further long-term studies with larger cohorts are needed to validate these findings.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c63e6c5c161a67863c64ce2aea0e118e09c3073" target='_blank'>
              Tracking NK and Memory T Cell Dynamics in Children Affected by Multisystem Inflammatory Syndrome (MIS-C)
              </a>
            </td>
          <td>
            Natalia González, Camila Astudillo, Yazmin Espinosa, Paz Cerda-Castro, Juan Pablo Araya, Grace Ayleen Silva, Martín Felipe Hernández, M. C. Poli, Emma Rey-Jurado
          </td>
          <td>2025-12-22</td>
          <td>Journal of Human Immunity</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/275812dc3294ac678dbefad1e9f5e6d112d20c5e" target='_blank'>
              SP140 limits type I interferon–driven pathology, preserving T cell motility and promoting resistance in tuberculosis
              </a>
            </td>
          <td>
            Maxime Caouaille, Léa Fromont, Tomoyo Shinkawa, Marion Faucher, Aizat Iman Abdul Hamid, Serge Mazères, Yaël Duvergé, Yohan Lorreyte, Emmanuelle Näser, S. Behar, Emma Lefrançais, O. Neyrolles, Denis Hudrisier
          </td>
          <td>2025-12-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Long COVID has emerged as a major global health concern, yet the long-term trajectory of immune recovery and its contribution to persistent symptoms remain to be elucidated. Here, we conducted a three-year longitudinal follow-up of the 47 COVID-19 patients and applied single-cell RNA sequencing (scRNA-seq) and multiplex cytokine profiling to comprehensively characterize the peripheral immune landscape during convalescence. We observed persistent immune dysregulation up to three years post-infection, characterized by chronic inflammation and impaired restoration of naïve CD4⁺ T cells, naïve CD8⁺ T cells, and SLC4A10⁺ MAIT cells—features reminiscent of immunosenescence. Notably, Th17 cells, rather than monocytes, emerged as key drivers of chronic inflammation beyond one year. We identified two distinct Th17 subsets: RORC⁺ Th17 cells and LTB⁺ Th17 cells. While RORC⁺ Th17 cells were negatively correlated with inflammatory cytokine levels, LTB⁺ Th17 cells showed proinflammatory features and were positively associated with long COVID symptoms. Sustained elevation of S100A8 and IL-16 in follow-up patients may contribute to the persistent presence of LTB⁺ Th17 cells. Together, our study provides an in-depth longitudinal map of immune remodeling in COVID-19 convalescents, revealing key cellular and molecular drivers of sustained inflammation up to three years post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f682ef5df5972e318b0093c3cf2459508e92d089" target='_blank'>
              T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19
              </a>
            </td>
          <td>
            Tian Zheng, Ru Gao, Yiwei Liu, Ye-ming Wang, Chao Wu, Li Guo, Lan Chen, Xinming Wang, Yan Xiao, J. Zhong, Rongling Zhang, Ying Wang, Xianwen Ren, Bin Cao, Lili Ren, Jianwei Wang
          </td>
          <td>2025-11-20</td>
          <td>Immunity & Inflammation</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Background Little information is available on the immune signaling pathway that drives severe coronavirus disease 2019 (COVID-19) in asthma. Our study uses single-cell RNA sequencing (scRNA-seq) to evaluate the association between immune dysfunction and progression to severe COVID-19 in asthma. Methods Four patients with asthma and eight patients without asthma from three centers in South Korea were analyzed. Samples were collected from each patient over three-time points: at the time of COVID-19 infection, 1 week later, and 2 weeks later. Results Patients were classified into four groups according to the presence or absence of asthma and COVID-19 severity: non-asthma/mild COVID-19 (n=5), non-asthma/severe COVID-19 (n=3), asthma/mild COVID-19 (n=3), and asthma/severe COVID-19 (n=1) groups. A high-quality scRNA-seq dataset composed of 155,565 cells was generated that characterized peripheral immune cells. Analysis of the proportion of cell type by time points showed a decrease in T-cells at the second time point in the asthma/severe COVID-19 group, compared to the others. When the proportion of T-cell subtype was analyzed by time point, an increase in the proportion of CD8+ T-cell was shown at the second time point in the asthma/severe COVID-19 group compared to the other groups: in differentially expressed genes analysis, notably, we observed relatively higher levels of cytotoxicity-related genes in the asthma/severe COVID-19 group compared to the others. Conclusion Our study provides new insights into the mechanisms underlying the progression of COVID-19 infection in patients with asthma. A reduction in the proportion of T-cells while expanding cytotoxic CD8+ T-cell proportion was associated with severe COVID-19 presentation in asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/024d563473f02b1257c1b2dc0e7510521f7669e6" target='_blank'>
              T-Cell Immune Dysfunction and Progression to Severe COVID-19 in Asthma Revealed by Single-Cell RNA Sequencing
              </a>
            </td>
          <td>
            B. Kim, Youlim Kim, Sang Hoon Lee, Siyoung Lee, Minjun Choi, Byeongchan Lee, Jae Seok Jeong, Sang-Heon Kim, Hyun Lee, Kwang Ha Yoo
          </td>
          <td>2025-11-18</td>
          <td>Tuberculosis and Respiratory Diseases</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="ABSTRACT Chronic persistent viral infections can lead to significant spleen damage, thus disrupting the host humoral immune response; however, the underlying mechanisms remain unclear. In this study, we employed a Lymphocytic choriomeningitis virus (LCMV) chronic infection model to investigate the effects of virus infection on spleen damage. Mice infected with Lymphocytic choriomeningitis virus clone 13 (LCMV-CL13) presented a series of pathological features, such as white pulp atrophy and reduced germinal center diameter, length, and area in the spleen. More importantly, we observed a diminished GC response alongside a weak antibody response in the chronic infection model. Single-cell RNA sequencing (scRNA-seq) further revealed the dysregulation of gene expression, including Bbc3, Atf3, and Ptpn6, which inhibit B-cell differentiation during chronic viral infection. We verify that the upregulation of Bbc3 or Atf3, respectively, can promote apoptosis in BaF3 cells. Immune repertoire (IR) analysis revealed that the molecular diversity of the BCR repertoire after LCMV-CL13 infection, specifically manifested in BCR clonal diversity, IGHV gene segment usage preference, and CDR3 sequence changes. In conclusion, this study demonstrated that chronic LCMV-CL13 infection interrupted the development of splenic B cells by increasing the expression of apoptosis genes, thus enhancing our understanding of the underlying mechanisms of B-cell development interruption during chronic viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b7874d18fa09f3125fcaf4e38c682df442d0201" target='_blank'>
              Chronic viral infections impaired the growth process of splenic B cells by upregulating Bbc3 and Atf3 in LCMV-CL13 infected mouse model
              </a>
            </td>
          <td>
            Zhe Li, Wei Yang, Fangzhou Cai, Dan-ping Li, Qian Chen, Yiteng Zhang, Jiarui Cui, Wei Wang
          </td>
          <td>2025-12-02</td>
          <td>Virulence</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Introduction A global outbreak of Mycoplasma pneumoniae pneumonia (MPP) emerged following the Corona Virus Disease 2019 (COVID-19) pandemic. Different altitudes significantly impact community-acquired pneumonia (CAP). Whether there are differences in the immune responses of children with MPP at different altitudes is unknown. Methods This study collected bronchoalveolar lavage fluid (BALF) from children with MPP in Nanjing (altitude, 20 m) or Qinghai (altitude, 4,058.40 m) for transcriptome sequencing analysis to investigate pulmonary immune responses in children with MPP at different altitudes. Results Children with refractory Mycoplasma pneumoniae pneumonia (RMPP) in the plateau group showed milder clinical manifestations, with shorter duration of fever before admission, lower levels of serum tissue injury markers, and lower incidences of atelectasis. Neutrophils and T cells in the lungs of the plain group were activated, along with the activation of the NOD-like receptor signaling pathway or the inhibition of the PI3K–Akt signaling pathway. The immune cells of children with MPP in the plateau group showed adaptive changes, which manifested as increased M2 polarization of macrophages, CD8+ T cells, and B cells, and decreased neutrophils and CD4+ T cells. Conclusion Excessive activation of the pulmonary immune response in children with MPP of the plain region may be related to the NOD-like receptor signaling pathway and PI3K–Akt signaling pathway. Adaptive changes in immune cells occurred in children with MPP of the plateau region.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/41f9c6a1f207f00de91201f2412fa8ce260fcf9e" target='_blank'>
              High-altitude immune remodeling in children with Mycoplasma pneumoniae pneumonia: a multi-center transcriptome study
              </a>
            </td>
          <td>
            Yingying Luo, Jing Hou, Weifen Lu, Haixia Cao, Erwa Hao, YaoGang Zhang, Feng Liu, Yifan Zhu, Yanyan Ma
          </td>
          <td>2025-12-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Salivary gland dysfunction and inflammation are common following SARS-CoV-2 infection. This study aimed to investigate the effects of SARS-CoV-2 spike and envelope proteins on glandular function in healthy C57BL/6 mice through direct intra-glandular injection into the submandibular glands. Local administration of spike protein significantly reduced salivary secretion, while the envelope protein had no measurable impact. Histological analysis revealed the presence of leukocyte foci in two-thirds of spike protein-treated mice, while none were detected in the vehicle- or envelope protein-treated groups. Furthermore, spike protein treatment led to a significant increase in total immune cells and B cells, and an expansion of the CD44high CD62Llow effector/effector memory subsets within CD4 T cells and B cells in the submandibular glands. Notably, serum antinuclear antibodies developed in one-third of spike-treated mice, consistent with the reported salivary gland pathology in COVID-19 patients that resemble autoimmune Sjögren’s disease. Moreover, spike protein treatment increased phospho-STAT3 levels and induced transcriptomic changes indicating impaired acinar compartment, heightened adaptive immune responses, and altered tissue remodeling activity. These findings show that SARS-CoV-2 spike protein alone is sufficient to initiate significant salivary gland pathology in the absence of intact virus or ACE2 interaction, providing evidence for a novel mechanism by which SARS-CoV-2 induces salivary gland dysfunction and pathology with autoimmune features.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0ed181b81ada91ccc763c713a424a697626f932b" target='_blank'>
              SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice
              </a>
            </td>
          <td>
            Fernanda Aragão Felix, Yuqiao Jiang, Jing Zhou, Dongfang Li, Victoria Zhou, Sílvia Ferreira de Sousa, Kevin Matthew Byrd, Qing Yu
          </td>
          <td>2025-11-21</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d70a7f410d7273941b555f5d38eb406c7358fb4" target='_blank'>
              Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus
              </a>
            </td>
          <td>
            D. Marín-Moraleda, A. Tort-Miró, E. Ezcurra, S. Montaner-Tarbes, J. Muñoz-Basagoiti, E. Coatu, M. J. Navas, M. Muñoz, P. Monleón, J. González-Oliver, L. Pailler-García, S. Pina-Pedrero, F. Accensi, F. Rodríguez, J. Argilaguet
          </td>
          <td>2025-12-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b584d18974b0aa971de59c6e27544a571d208d19" target='_blank'>
              Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            A. Verma, Lu Tan, Noah Schuster, Skyler L Moye, Li-Chun Lin, Shearon A. Lowery, Eazhisaivallabi Duraisami, Juan E Abrahante Lloréns, Qiang Qiu, Marco Hefti, D. K. Meyerholz, Mitchell C Coleman, C. R. Yu, Mark W Albers, Stanley Perlman
          </td>
          <td>2026-01-13</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Besides its robust antiviral activity, type I interferon (IFN-I) also exerts immunomodulatory effects and can even drive pathology during chronic viral infections. Mechanisms that regulate IFN-I induction during virus infection, thus strongly affecting the outcome of disease, remain to be defined. Here, using the lymphocytic choriomeningitis virus (LCMV) Docile strain, we identified acid ceramidase (aCDase, Asah1) as a critical lipid-metabolic regulator of endosomal, nucleic acid-driven IFN-I responses and disease outcome during chronic virus infection. aCDase is highly expressed in plasmacytoid dendritic cells (pDCs) and required for robust early IFN-I production. aCDase deficiency resulted in ceramide accumulation, blunting IFN-α/β induction, impairing IFN-I-dependent upregulation of programmed death-ligand 1 (PD-L1) on antigen-presenting cells and preventing the exhaustion of virus-specific CD8+ T cells, leading to severe immunopathology. This pathology is abrogated by CD8+ T-cell depletion or by adoptive transfer of IFN-I-induced PD-L1-expressing macrophages. Conversely, limiting ceramide production in acid sphingomyelinase (Asm)-deficient mice prevented ceramide accumulation, and pDCs showed accelerated IFN-I induction. Mechanistically, ceramide abundance regulated IFN-I production by altering endosomal signaling microdomains. Collectively, our findings reveal ceramide homeostasis as a key determinant of IFN-I-driven CD8+ T-cell exhaustion and immunopathology during chronic viral infection and highlight aCDase as a potential therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3347a83451be199ba4cf611d6ba58e4cec09e11d" target='_blank'>
              Acid ceramidase regulates CD8+ T-cell exhaustion via type I interferon-mediated upregulation of PD-L1
              </a>
            </td>
          <td>
            Zhongwen Hu, Hossam Abdelrahman, Abdelrahman Elwy, F. Kuang, Swati Dhiman, Shafaqat Ali, Marcel Marson, Lisa Holnsteiner, Thamer A Hamdan, J. Friebus-Kardash, Elisa Wiebeck, W. Hansen, S. Scheu, Erich Gulbins, P. Lang, K. Lang, Judith Lang
          </td>
          <td>2025-12-09</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="This review article attempts to provide a unifying hypothesis to explain the myriad of symptoms and predispositions underlying the development of PASC (Postacute Sequelae of COVID), often referred to as Long COVID. The hypothesis described here proposes that Long COVID is best understood as a disorder of persistent immune dysregulation, with chronic macrophage activation representing the fundamental underlying pathophysiology. Unlike transient post-viral syndromes, Long COVID involves a sustained innate immune response, particularly within monocyte-derived macrophages, driven by persistent spike protein (peripherally in MAIT cells and centrally in Microglial cells), epigenetic imprinting, and gut-related viral reservoirs. These macrophages are not merely activated temporarily but also become epigenetically “trained” into a prolonged inflammatory state, as demonstrated by enduring histone acetylation markers such as H3K27acDNA Reprogramming. It is proposed that recognizing macrophage activation as the central axis of Long COVID pathology offers a framework for personalized risk assessment, targeted intervention, and therapeutic recalibration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b5f2903ed6d3bcbf8e560a451808bb27c9205bb" target='_blank'>
              The Central Role of Macrophages in Long COVID Pathophysiology
              </a>
            </td>
          <td>
            Philip Mcmillan, Anthony J Turner, B. Uhal
          </td>
          <td>2025-12-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Considerable attention has been recently devoted to the involvement of immune cells in the central nervous system (CNS) during infections with neurotropic viruses, such as SARS-CoV-2, HIV-1, and ZIKV. These viruses are capable of infecting astrocytes and microglia, the main glial cells in the CNS, responsible for regulating neuronal activity. Here, we discuss how viral infections lead to metabolic reprogramming toward aerobic glycolysis in these cells, enhancing pro-inflammatory pathways, such as inflammasome activation, resulting in the secretion of inflammatory cytokines that favor the development of neuroinflammation. In this mini review, we discuss the pivotal interplay between metabolism and immunity towards viral pathogenesis in the CNS, pointing out the relevance of therapeutic strategies targeting both metabolic and immunological pathways to enhance antiviral and neuroprotective responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c603076d92448698be2b3b34d399b974e9d4c131" target='_blank'>
              Viral reprogramming of glial metabolism as a driver of neuroinflammation
              </a>
            </td>
          <td>
            Tamara Rodrigues, Gabriel Salles Beltrão, Heloísa Girardi, Aguinaldo R. Pinto
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Cardiac arrhythmias increase during acute SARS-CoV-2 infection and in long COVID syndrome, by unknown mechanisms. This study explored the acute and long-term effects of COVID-19 on cardiac electrophysiology and the cardiac conduction system (CCS) in a hamster model. Electrocardiograms and subpleural pressures were recorded by telemetry for 4 weeks after SARS-CoV-2 infection, and interferon-stimulated gene expression and macrophage infiltration of the CCS were assessed at 4 days and 4 weeks postinfection. COVID-19 induced pronounced tachypnea and cardiac arrhythmias, including bradycardia and persistent atrioventricular block, though no viral protein expression was detected in the heart. Arrhythmias developed rapidly, partially reversed, and then redeveloped, indicating persistent CCS injury. COVID-19 induced cardiac cytokine expression, connexin mislocalization, and CCS macrophage remodeling. Interestingly, sterile innate immune activation by direct cardiac injection of polyinosinic:polycytidylic acid (PIC) induced arrhythmias similar to those of COVID-19. PIC strongly induced cytokine secretion and interferon signaling in hearts, human induced pluripotent stem cell-derived cardiomyocytes, and engineered heart tissues, accompanied by alterations in excitation-contraction coupling. Importantly, the pulmonary and cardiac effects of COVID-19 were blunted by JAK/STAT inhibition or a mitochondrially targeted antioxidant, indicating that SARS-CoV-2 infection indirectly leads to arrhythmias by innate immune activation and redox stress, which could have implications for long COVID syndrome.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a92f76b73d2e82fbe68eed03e9d787580f7a5e73" target='_blank'>
              Innate immune activation and mitochondrial ROS induce acute and persistent cardiac conduction system dysfunction after COVID-19.
              </a>
            </td>
          <td>
            D. Ashok, Ting Liu, Misato Nakanishi-Koakutsu, Joseph Criscione, Meghana Prakash, Alexis Tensfeldt, Byunggik Kim, Bryan Ho, Julian Chow, Morgan Craney, M. Ranek, Brian L. Lin, Kyriakos N. Papanicolaou, Agnieszka Sidor, D. Foster, Hee Cheol Cho, Andrew Pekosz, J. Villano, Deok-Ho Kim, Brian O'rourke
          </td>
          <td>2025-12-22</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is increasingly recognized as a multisystem disorder involving pathological α-synuclein (α-syn) accumulation and widespread neuroimmune dysregulation. Microglia, the resident immune cells in the central nervous system (CNS), are pivotal mediators of the bidirectional communication between the CNS and peripheral systems. In addition to sensing neuronal injury and α-syn pathology, microglia dynamically respond to peripheral immune signals, including circulating cytokines, immune cell infiltration, and microbial metabolites, through pattern recognition receptors such as Toll-like and NOD-like receptors. Furthermore, microglia regulate blood–brain barrier integrity, modulate peripheral immune cell recruitment, interact with meningeal lymphatic vessels, and contribute to the propagation of α-syn within the CNS and along the gut–brain axis. However, a comprehensive framework encompassing their diverse roles in peripheral–central immune crosstalk remains underdeveloped. This review synthesizes recent advances elucidating how microglia link the CNS to peripheral immune and metabolic signals in PD. We further highlight microglial contributions to α-syn propagation along the gut–brain axis and discuss how their functional states influence disease progression. A deeper understanding of microglial involvement in this complex neuroimmune interface may inform the development of effective and system-level therapeutic strategies for PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b4787f9c236f2822ea4097343456b74122cbca" target='_blank'>
              Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
              </a>
            </td>
          <td>
            Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le
          </td>
          <td>2025-12-01</td>
          <td>Translational Neurodegeneration</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Phage therapy (PT) is a promising alternative for antibiotic-resistant infections, but its immunomodulatory effects in clinical settings remain poorly understood. This exploratory observational study aimed to characterize pro- and anti-inflammatory gene response patterns in ten patients undergoing personalized PT at the Phage Therapy Unit in Wrocław. Peripheral blood mononuclear cells (PBMCs) and granulocytes were analyzed to assess changes in the expression of 22 selected immune-related genes associated with innate and adaptive immune signaling pathways. While no uniform pattern of immune gene expression was observed across the cohort, individual cases exhibited significant up- or downregulation of specific genes. Interestingly, we identified biological age as a potential determinant of the host response. Specifically, older patients showed higher activation of the innate sensing machinery in PBMCs, characterized by a higher TLR4 fold change which may reflect the “inflammaging” phenomenon. These findings suggest that chronic exposure to bacterial viruses (bacteriophages), unlike many viral infections, does not trigger a predictable, significant systemic immune activation and that immune responses to PT are highly individualized by host- and phage-related biological factors. By documenting this spectrum of real-world responses, our work provides baseline data and hypotheses to guide the rational design of future preclinical and clinical investigations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ab2b289866cbc1eb0a98219b4968f109c16e453" target='_blank'>
              Analysis of Pro- and Anti-Inflammatory Gene Response Patterns in Patients Receiving Phage Therapy
              </a>
            </td>
          <td>
            Hubert Kasprzak, Maciej Przybylski, W. Fortuna, Sławomir Letkiewicz, Paweł Rogóż, B. Bubak, Andrzej Górski, R. Międzybrodzki
          </td>
          <td>2025-12-23</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Background Severe COVID-19 is frequently associated with acute respiratory distress syndrome (ARDS) and prolonged pulmonary sequelae. Persistent immune activation, including dysregulated B cell responses and increased proinflammatory chemokines, has been linked to the post-acute sequelae of SARS-CoV-2 infection. However, the mechanisms linking these factors remain poorly defined. Methods Sixty patients were studied four months after acute COVID-19, including 34 who developed ARDS, 26 who did not develop ARDS, and 12 healthy controls. Clinical, computed tomography scan (CT), and diffusion capacity of the lungs for carbon monoxide (DLCOc) assessments were performed. Anti-SARS-CoV-2 IgM/IgG levels were quantified, circulating B cell subsets were characterized, and circulating cytokines and chemokines were measured. CXCR3 expression on B cells was analyzed by spectral flow cytometry. In vitro assays were performed to evaluate the effects of CXCL9 and CXCL10 on B cell activation, plasma cell differentiation, IgG production, and CD40L expression on CD4+ T cells. Associations between immunological markers and pulmonary sequelae were assessed. Results IgG, but not IgM, levels were significantly higher in patients with ARDS than in patients without ARDS. Both COVID-19 groups showed a reduction in CD19+CD20+ B cells and an increase in plasmablasts compared to controls. Serum levels of CXCL9 and CXCL10, but not other cytokines, positively correlated with IgG levels. In vitro, CXCL9 increased CD86 expression on B cells, while both chemokines promoted plasma cell differentiation (CD27+CD38+, CD138+) and increased total IgG secretion. CXCL9 also increased the expression of CXCR3 and CD40L on activated CD4+ T cells. Clinically, patients with combined CT abnormalities and reduced DLCO had the highest levels of IgG, CXCL9, and CXCL10. Conclusion Four months after COVID-19, patients with prior ARDS and persistent pulmonary sequelae exhibit sustained elevations of anti-SARS-CoV-2 IgG and chemokines CXCL9 and CXCL10. Both chemokines directly enhance B cell differentiation into IgG-secreting plasma cells in vitro, while CXCL9 also increases CD4+ T cell help, suggesting a mechanistic link between chronic inflammation, increased humoral responses, and long-term lung impairment. Targeting CXCL9/CXCL10–CXCR3 signaling could offer therapeutic potential to mitigate post-COVID pulmonary complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f87e4a08188abb1875547220225dd7d5712072b" target='_blank'>
              CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
              </a>
            </td>
          <td>
            R. Quiroga, Sergio Sanhueza, Catalina Sepúlveda, Bárbara Antilef, C. Munoz, Camilo Cabrera, M. Fraga, Faryd Llerena, L. Lamperti, M. I. Barria, Alicia Colombo, Gonzalo Labarca, Mario Henriquez-beltran, Luciano Ferrada, Estefanía Nova-Lamperti
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Introduction Long COVID (LC), a clinical condition marked by persistent and new symptoms after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects up to 10-20% of infected individuals. Although autoimmunity has been proposed as a key mechanism, the specific role of circulating autoantibodies in LC remains unclear. We characterized the autoantibody profiles in individuals with LC and assessed their association with persistent post-COVID symptoms, in comparison to recovered patients and pre-pandemic healthy controls (PPHC). Methods We analyzed 17 autoantibodies in a cohort of 220 pre-pandemic controls and 291 COVID-19 patients, targeting self-antigens. Of those, 237 patients presented symptoms for a month or more after the onset of SARS-CoV-2 infection (long COVID patients), and 54 individuals recovered from the initial infection without chronic symptoms. Autoantibody frequencies and associations with clinical variables were assessed using logistic regression and subgroup analyses. Results Autoantibody prevalence was higher in recovered individuals (37%) than in LC patients (24%) or PPHC (19%). While certain autoantibodies such as a-cardiolipin (a-CL) IgM, a-AML IgG, a-SSA IgG and a-SSB IgG were elevated in some COVID-19 patients, they were not significantly different in LC. The most frequently detected autoantibody was a-CL IgM, found across all groups and especially in individuals that fully recovered from COVID-19. However, a-CL did not differentiate individuals with long COVID or correlate with symptom persistence but was associated with the occurrence of dysphagia and anorexia as symptoms. No correlation was observed between autoantibody presence and disease severity. Discussion These findings do not support a primary pathogenic role for the evaluated autoantibodies in LC and emphasize the need for longitudinal studies to explore their temporal dynamics and interaction with other immunological or clinical factors involved in post-COVID-19 conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3eda56950809fc6d0fbb43c3e1d9ce4d782eb02d" target='_blank'>
              Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls
              </a>
            </td>
          <td>
            Jéssica de Jesus Silva, Laila Sampaio Horta, Sayonara Melo Viana, A. B. Cazé, I. S. Oliveira, Mariana M. Pereira, Natalie Antas Nascimento, Blenda de Jesus Pereira, Ícaro Bonyek-Silva, Sara Nunes de Oliveira Araújo, Ananda Isis Lima de Marinho, Juqueline Rocha Cristal, Vishal Rao, Camila Coelho, T. Cerqueira-Silva, K. Malmegrim, A. Camelier, C. R. Cardoso, N. Tavares, Manoel Barral-Netto, Aldina Barral, C. Barbosa, V. Boaventura
          </td>
          <td>2025-12-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/436bf9880456701390ff5d79fb01556ece3f12f3" target='_blank'>
              Single-cell characterization of skin response to a bite by West Nile virus-infected mosquito reveals fibroblast-mediated barrier to transmission
              </a>
            </td>
          <td>
            Hacène Medkour, Federico Bocci, Norman Schneider, Idalba M Serrato-Pomar, Félix Rey-Cadilhac, Elliott F. Miot, Wilfried A. A. Saron, A. S. St. John, G. Maarifi, Yingzi Liu, D. Missé, Qing Nie, Duncan R. Smith, Sébastien Nisole, M. Plikus, J. Pompon
          </td>
          <td>2026-01-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="In a recent study published in Nature, Grippin and colleagues showed that SARS-CoV-2 mRNA vaccines can transiently reset the tumor – immune interface, converting immunologically “ cold ” tumors into those that respond to PD-1/PD-L1 blockade. This work supports COVID-19 mRNA vaccines as systemic immune modulators that, when timed appropriately around immune checkpoint inhibitors (ICIs), can sensitize tumors and improve survival across diverse cancer types. 1 In mouse tumors, spike mRNA lipid nanoparticles (RNA-LNPs) elicited IFNAR1-dependent innate activation that drove dendritic-cell priming and the expansion of cytotoxic CD8 ⁺ T-cell clones, accompanied by PD-L1 upregulation in tumor and myeloid compartments. Blocking type I interferon signaling abrogated both PD-L1 induction and synergy with anti-PD-1/PD-L1, pinpointing IFN-I as the mechanistic lynchpin and de ﬁ ning a short “ interferon window ” during which checkpoint blockade is maximally effective. To probe antigen speci ﬁ city, the authors replaced spike with the human cytomegalovirus antigen pp65, which is overexpressed in human glioma but not in the B16F0 model, and observed comparable antitumour activity, indicating that the checkpoint-sensitive state is largely driven by antigen-agnostic sensing of the mRNA – LNP platform rather than spike-speci ﬁ c priming. They further modi ﬁ ed the mRNA backbone, showing that replacing N1-methyl-pseudouridine with uridine in pp65 mRNA strengthened synergy with ICI, whereas the same change in spike mRNA conferred only modest numerical bene ﬁ t — evidence that RNA chemistry and structure, independent of the encoded antigen, can tune the magnitude of IFN-I – mediated tumor sensitization">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/774fa9aca5d2a2345b4788f1b81988c717440d52" target='_blank'>
              When vaccines reset tumors: SARS-CoV-2 mRNA shots create a transient checkpoint-sensitive state
              </a>
            </td>
          <td>
            Hao Chi, Michele Carbone, Youping Deng
          </td>
          <td>2025-12-01</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Mycobacterium tuberculosis (Mtb) persists within macrophages, yet how different host species shape bacterial state remains poorly understood. Here, we directly compared the intracellular transcriptome of Mtb during infection of human and mouse macrophages, revealing distinct host-imposed microenvironments that drive the pathogen into separable metabolic states. Lipid metabolism and regulatory circuits were prominently remodeled, with mouse macrophages inducing iron- and oxidative-stress responses while human macrophages promoted fatty acid import programs. Using fluorescent fatty acid tracing, we uncovered a striking species-specific phenotype: Mtb forms intracellular lipid inclusions (ILIs) in murine macrophages but not in human macrophages. This phenotype was independent of culture media, macrophage ontogeny, or host antimicrobial factors such as nitric oxide and itaconate. Access of Mtb to host-derived lipids required the ESX-1 secretion system and was inversely correlated with host triacylglycerol (TAG) synthesis. Inhibition of TAG formation in human macrophages partially restored Mtb ILI formation, revealing a metabolic gate that governs lipid flow between host lipid droplets and intracellular Mtb. Together, these findings establish a cross-species framework for decoding host-driven bacterial metabolic states and identify a key barrier limiting Mtb’s access to host lipid stores in human macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8455ca23c679ae25863ebe15850f9b46faecf1b3" target='_blank'>
              Systems analysis reveals alternate metabolic states adopted by Mycobacterium tuberculosis across species
              </a>
            </td>
          <td>
            Jonathan Padilla-Gomez, Rachel McGinn, Yisha Liang, Kendra Libby, Alison E Ringel, Charles Evavold, Bryan D. Bryson
          </td>
          <td>2025-11-15</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Tumor-specific CD8+ T lymphocytes play a critical role in anticancer immunity but frequently become dysfunctional and exhausted within the immunosuppressive tumor microenvironment. Although immune checkpoint inhibitors can restore T-cell activity, resistance to these treatments remains a significant challenge. Therefore, understanding the transcriptional and regulatory mechanisms underlying CD8+ T-cell exhaustion is crucial for the development of effective therapies. We developed two murine models of acquired immune checkpoint inhibitor resistance through prolonged anti-PD1 treatment. To gain insight into CD8+ T-cell exhaustion, we performed single-cell multiomics analysis, including both scRNA-seq and scATAC-seq, to capture gene expression profiles and chromatin accessibility. Moreover, we collected three external datasets to validate the results in silico. We further assessed the therapeutic potential of Runx2 through marker expression and cytotoxicity assays. Our single-cell analysis revealed distinct T-cell subsets, including early and terminally exhausted populations, along with their exhaustion trajectories. Runx2 was identified as a key transcription factor associated with CD8+ T-cell exhaustion in both models and correlated with immunotherapy response in clinical data. Additionally, functional marker expression and cytotoxicity assays demonstrated that inhibiting Runx2 improved CD8+ T-cell cytotoxicity. These findings highlight the role of Runx2 as a crucial regulator of CD8+ T-cell exhaustion in the context of prolonged immune checkpoint inhibitor treatment. Targeting Runx2 may provide a novel strategy to overcome immune checkpoint inhibitor resistance and enhance therapeutic efficacy, offering promising avenues for combination therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4efed637bde0b584b5806d223ee2a3f6b51d5e91" target='_blank'>
              Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution
              </a>
            </td>
          <td>
            Tzu-Yang Tseng, Ching-Hung Hsieh, Hsuan-Cheng Huang, Yu-Ching Wu, Chiun Hsu, Chia-Lang Hsu, D. Ou, Hsueh‐Fen Juan
          </td>
          <td>2025-12-01</td>
          <td>Molecular Cancer</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="Alcohol use disorder (AUD) is associated with significant neuroimmune dysregulation, with microglia emerging as a potential pathological driver of neurotoxicity. However, the molecular landscape driving this alcohol-induced reactivity has yet to be uncovered, especially in the context of human microglia. Here, we comprehensively characterized global-scale molecular changes of human stem cell-derived microglia (iMGLs) after exposure to ethanol and inflammatory mediators lipopolysaccharide (LPS) and TNFα using mass spectrometry-based proteomics. KOLF2.1J hiPSCs were differentiated to iMGLs utilizing commercially available kits and treated with multiple ethanol exposure paradigms, LPS, and TNFα. Proteomic profiles were assessed by data-independent acquisition (DIA) mass spectrometry, followed by a Luminex cytokine assay and a functional phagocytosis assay. Ethanol produced distinct, temporally dependent proteomic changes that differed markedly from the robust proinflammatory responses induced by LPS and TNFα. Cytokine measurement confirmed an overall lack of proinflammatory responses of iMGLs treated with ethanol in contrast to the elevated levels in LPS- and TNFα-treated cells. However, Ingenuity Pathway Analysis and flow cytometry revealed an increase in phagocytosis of iMGLs treated with ethanol for 48 hours. Our findings demonstrate that ethanol exposure induces distinct and temporally dependent molecular phenotypes in human iMGLs, which differ markedly from the robust proinflammatory responses elicited by LPS and TNFα. The novel pathways identified in this study will provide new insights into the human-specific response to ethanol and emphasizes the importance of utilizing human-specific models for neuroimmune interactions in AUD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/243231cde6c0b823c9ec42396c1fb1a29f3ae249" target='_blank'>
              Deep Proteomic Profiling of Human Stem Cell-Derived Microglia: Insights Into Inflammatory and Alcohol-Induced Reactivity
              </a>
            </td>
          <td>
            Tiara Wolf, Jessica Wohlfahrt, Jennifer Guergues, Stanley M. Stevens
          </td>
          <td>2025-11-17</td>
          <td>Research Square</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a6e844afd2f8abcaae1eb543c8265bbf026b4bd" target='_blank'>
              SARS-CoV-2 Spike Peptides Trigger Nociceptive Responses Through Spinal TLR4 Pathways
              </a>
            </td>
          <td>
            Bruno Eduardo Silva, R. D. dos Santos, F. P. Veras, E. Cilli, Danilo da Silva Olivier, Marco Antonio de Andrade Belo, I. Charlie-Silva, Ester Siqueira Caixeta, A. Barchuk, Albená Nunes-Silva, Thiago Roberto Lima Romero, G. Galdino
          </td>
          <td>2025-12-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Introduction Zika virus (ZIKV) infection has been associated with neurological syndromes, particularly during outbreaks caused by Asian lineage strains. However, experimental models suggest that African strains may exhibit an equal or more virulent profile. Neuroinvasion by systemic viruses often requires crossing the blood–brain barrier (BBB), which disruption amplifies viral dissemination and neuropathology. Type I interferons (IFNs) are key to restricting ZIKV replication, but their specific role in preserving BBB integrity remains poorly defined. Methods Here, we used human brain microvascular endothelial cells (HBMECs) as a simplified BBB model to compare transcriptional responses and IFN modulation following infection with either the African prototype strain ZIKVMR766 or the Asian epidemic strain ZIKVPE243. The role of endothelial cell–mediated IFN responses was further assessed in vivo by intravascular inoculation of mice with endothelial-specific IFNAR depletion using ZIKVMR766. Results and discussion Infection of HBMEC with ZIKVMR766 triggered a greater number and broader range of differentially expressed genes, especially ones associated with interferon signaling and translational pathways, whereas ZIKVPE243-infected samples clustered closer to non-infected ones. ZIKVMR766 infection also resulted in higher viral titers and faster dissemination across endothelial monolayers. Both strains induced IFN-β expression but suppressed downstream IFN signaling by reducing STAT1 phosphorylation and promoting STAT2 degradation, with these effects being more pronounced for ZIKVMR766. Despite these evasion mechanisms, neutralization assays revealed that endothelial cells-derived IFNs production and response partially restricted viral replication, preserved HBMEC viability, and protected against barrier disruption, with ZIKVPE243 showing greater sensitivity to IFN-β. Importantly, in vivo infection of mice lacking endothelial IFNAR signaling resulted in elevated CNS viral load and increased lethality following ZIKVMR766 infection, underscoring the pivotal role of endothelial IFN responses in viral control, maintenance of BBB integrity, and protection against neuroinvasion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/56674b5024c412f991e7ef83dca244fa427476f0" target='_blank'>
              Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo
              </a>
            </td>
          <td>
            Luan Rocha Lima, Y. M. Mustafá, Paula Luize Camargos Fonseca, S. V. A. Coelho, Pierina Lorencini Parisi, C. Simeoni, L. M. Meuren, Bruno Braz Bezerra, N. C. Mebus-Antunes, F. Matassoli, J. Proença-Módena, Renato Santana Aguiar, L. B. de Arruda
          </td>
          <td>2025-12-03</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a progressive neurodegenerative disorder defined by amyloid-β (Aβ) plaques, tau hyperphosphorylation, and neuroinflammation. Although earlier work emphasized brain-resident glia (microglia and astrocytes), recent studies highlight adaptive immune cells, particularly T and B lymphocytes, as modulators of AD pathology. This review synthesizes animal and human findings from 2022–2025 to provide updated insights into the multifaceted roles and therapeutic potential of adaptive immunity in AD. Infiltration of peripheral T and B cells into the brain parenchyma links peripheral immunity to central nervous system (CNS) pathology. Both infiltrating lymphocytes and resident glia show context-dependent dual effects, either exacerbating neurodegeneration or promoting neuroprotection. Therapeutic strategies under active investigation include modulation of CD4+ T cell differentiation, adoptive transfer of regulatory T cells, and next-generation active vaccines for AD. Overall, selective modulation of discrete immune subsets may enable adaptive-immunity-based treatments, a complex yet promising avenue for AD therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3b57de078f4e9067551a7f587763ddb6ea70cdf6" target='_blank'>
              Adaptive Immunity and Alzheimer’s Disease: Dual Roles in Neurodegeneration and Neuroprotection with Therapeutic Implications
              </a>
            </td>
          <td>
            You Min Ahn, Min-Kyoo Shin
          </td>
          <td>2025-12-31</td>
          <td>Biomolecules & Therapeutics</td>
          <td>1</td>
          <td>0</td>
        </tr>

        <tr id="The effects of antiretroviral therapy (ART) and treatment interruption on myeloid cell egress from the central nervous system (CNS) during human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection remain poorly defined. We hypothesized that CNS macrophages normally traffic out of the CNS, accumulate during viral infection and inflammation, and are released as inflammation resolves. To test this, we administered intracisternal (i.c.) injections of two different colored fluorescent superparamagnetic iron oxide nanoparticles (SPION) to SIV-infected macaques either early in infection (12–14 dpi) or 30 days before necropsy. SPION are preferentially taken up by perivascular, meningeal, and choroid plexus macrophages, enabling us to track macrophage turnover, infection, and migration. In non-infected macaques, SPION+ macrophages trafficked from the CNS to peripheral sites including the deep cervical lymph node (dCLN), lumbar lymph nodes, spleen, and dorsal root ganglia (DRG). With SIV infection, these cells accumulated in the CNS and showed reduced peripheral trafficking. ART decreased the number of SPION+ perivascular macrophages, and to a lesser extent, meningeal or choroid plexus macrophages. After ART interruption, SPION+ perivascular and choroid plexus macrophage numbers remained stable, whereas SPION+ meningeal macrophages increased. ART eliminated SIV-RNA+ perivascular macrophages, leaving few- scattered SIV-RNA+ cells in the meninges and choroid plexus. Following ART interruption, perivascular macrophages remained virus-negative, but scattered viral RNA+ meningeal macrophages persisted. In non-infected macaques, SPION+ macrophages trafficked to the dCLN, spleen, and DRG, but this trafficking diminished with SIV infection and AIDS with SIVE. Importantly, SIV-RNA+ SPION+ macrophages that exited the CNS were cleared by ART and did not reappear after treatment interruption. Using two differently colored SPION to assess establishment of CNS viral reservoirs, we observed higher numbers of early-labeled macrophages within and outside the CNS in animals with AIDS and SIVE, ART treatment, and ART interruption. These findings support a model in which SIV-infected perivascular macrophages seed an early CNS viral reservoir, while the meninges and choroid plexus undergo continual viral seeding during infection. ART reduces trafficking of infected macrophages out of the CNS and clears the perivascular macrophage reservoir, but SIV-RNA+ meningeal macrophages can persist, in low numbers, and can rebound after ART interruption.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/978817c1cd51902524161c071846dc82c1a681a8" target='_blank'>
              Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS
              </a>
            </td>
          <td>
            Zoey K. Wallis, C. Midkiff, Miaoyun Zhao, P. Autissier, Soon Ok Kim, Addison Q. Amadeck, Yiwei Wang, M. Jakubowski, Tricia H. Burdo, Andrew D. Miller, Qingsheng Li, Xavier Alvarez, Robert V. Blair, Kenneth C. Williams
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Introduction Variability in antibody responses among individuals following vaccination is a common phenomenon. This study employs single-cell transcriptome sequencing to characterize the transcriptomic features underlying these variations during the antibody decline phase after inactivated COVID-19 vaccination. Methods Sixty-five healthy volunteers received two doses of BBIBP-CorV. Antibody levels were measured 109–140 days post-vaccination. From these, 15 samples representing low, median, and high antibody titers were selected for PBMC single-cell RNA sequencing. Results Re-analysis of antibody kinetics revealed that titers during the decline phase are most strongly associated with long-term persistence. Differentially expressed genes were enriched in immune pathways including lymphocyte activation, antigen presentation (MHC-I and MHC-II), and interferon signaling. Significant variation in HLA genes, particularly HLA-B, was observed across PBMC cell types. Cell-cell communication analysis further identified enhanced MHC-I signaling in high-titer groups, dominated by HLA-B interactions with CD8+ T cells. Discussion These findings reveal a state of balanced immune alertness during the decline phase, providing insights into the cellular and molecular determinants of long-term humoral immunity and informing future vaccine design.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e4610a113f57e05290eb85d8cd24d003e8a69792" target='_blank'>
              Single-cell transcriptome profile during the antibody decline phase following inactivated COVID-19 vaccination
              </a>
            </td>
          <td>
            Zhongyi Zhu, Yaling Huang, Jiatong Sun, Meirong Li, Yong Chen, Fubaoqian Huang, Chuanyu Liu, Weijun Chen, Jinmin Ma
          </td>
          <td>2025-12-02</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/730bda77c6f77da1330b66ac6126520d39d7c77d" target='_blank'>
              Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients.
              </a>
            </td>
          <td>
            Andy An, Arjun Baghela, Peter Zhang, Travis M. Blimkie, Jeff Gauthier, Daniel E Kaufmann, E. Acton, Amy H. Lee, Roger C. Levesque, Robert E. W. Hancock
          </td>
          <td>2025-12-19</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Five years after the onset of the SARS-CoV-2 pandemic, post-COVID-19 condition continues to affect millions of subjects with persistent symptoms that significantly impair quality of life. Post-COVID-19 pain, particularly in women, has emerged as a frequent yet underestimated symptom. The validation and identification of animal models that reproduce persistent symptoms after an acute SARS-CoV-2 infection is crucial for a better understanding of the underlying mechanisms. The aim of the current study was to evaluate thermal nociception, biomarkers of inflammation, and nerve tissue damage in a female animal model of post-COVID-19 condition. A SARS-CoV-2 infection model was established by intranasal administration of the Omicron variant (BA.1.17 lineage) in transgenic female C57BL/6 mice expressing the human ACE2 receptor (hACE2). Nociception was assessed using the hot-plate test for 28 days post-infection. Afterwards, animals were sacrificed to analyze plasma inflammatory biomarkers by multiplex analysis. In addition, IL-6, IL-18, and IL-1β expression were evaluated by immunohistochemistry to analyze neural inflammation in the saphenous nerve. The results revealed that heat nociceptive thresholds in infected mice did not significantly differ from those of non-infected, but a trend toward lower thresholds was observed in the infected group (days 14 and 28 post-infection). In addition, a slight modification in pro- and anti-inflammatory cytokines/chemokines in plasma was detected, but no changes in the expression of IL-6, IL-1β, or IL-18 were observed in the saphenous nerve. Based on all the analyses conducted, infection with the Omicron variant of SARS-CoV-2 did not induce thermal sensitization in animals nor alterations in the expression of inflammatory biomarkers in the saphenous nerve. Finally, a slight state of systemic inflammation was present in the infected animals. The absence of detectable changes in this animal model underscores the need for further research to clarify the discrepancies observed in human patients and to explore alternative pathways potentially involved in post-COVID-19 pain syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c5891963e60492cf50fdb97401736f4c20927eb7" target='_blank'>
              Assessment of Nociception and Inflammatory/Tissue Damage Biomarkers in a Post-COVID-19 Animal Model
              </a>
            </td>
          <td>
            Eva M. Sánchez-Robles, C. Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-29</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29fe25ea72e27bc7febd50ceacab0f0b8d2a1098" target='_blank'>
              SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.
              </a>
            </td>
          <td>
            T. N. Almanaa, H. Al-kuraishy, A. Al-Gareeb, Maii A. Abdelnaby, A. Alexiou, M. Papadakis, Islam E Abo-ElFetoh, G. Batiha
          </td>
          <td>2025-12-18</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3fc8ff2573897e0ada53acc75e2ba0024f6203b5" target='_blank'>
              Natural killer cells mediated antibody dependent cellular cytotoxicity response in acute and recovery phases of chikungunya
              </a>
            </td>
          <td>
            Diptee Trimbake, M. Ganu, A. Ganu, Anuradha S. Tripathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV), a filamentous, enveloped, negative-sense, single-stranded RNA virus, is a common cause of respiratory infections in pediatric and elderly populations, often leading to severe inflammation and lung damage. To date, there is no effective treatment for RSV infection. Therefore, elucidating the antiviral mechanism in RSV infection is critical for identifying potential effective therapeutic targets. Type I interferons (IFN-Is), especially IFN-β, play a key role in the immediate immune response against viral infection by inhibiting viral load and spread. Current studies have shown that ARCN1 (archain 1), the δ subunit of the coat protein complex I complex, is involved in intra-Golgi trafficking and protein transport from the Golgi apparatus back to the endoplasmic reticulum. In this study, we demonstrate that ARCN1 suppresses the anti-RSV innate immune response by promoting E3 ubiquitin ligase STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation of IKKε. Mechanistically, ARCN1 recognizes and binds to the δL motif of STUB1 via its flexible MHD domain while interacting with IKKε. This finding provides a theoretical basis for the development of new antiviral treatment strategies targeting ARCN1.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32c87ced4d49da7da6a4806fe632d757e2e9e8ee" target='_blank'>
              ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation
              </a>
            </td>
          <td>
            Jiamin Cai, Yunfei Ye, Zhengrong Chen, Fei Xu, Xiaoping Li, Mengyun Wu, Ji Zhou, Yuanyuan Shao, Peijie Zhu, Jing Zhao, Jingjing Hu, Yufeng Wang, Cancheng Li, Xiaoyu Tian, Beibei Huang, Tian Xia, Wenjun Wang, Chuangli Hao, Yi Yang, Jinping Zhang
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="In nature, animals encounter diverse pathogens that trigger specific peripheral defense programs and elicit sickness behavior, a set of stereotyped physiological and behavioral changes thought to promote host fitness. Most studies to date have relied on one or a few mouse models of infection, limiting insights into pathogen-specific neuroimmune interactions that generate sickness. We hypothesized that different pathogens might elicit distinct sickness states by engaging different cell types and brain circuits. Using inflammatory models representing bacterial, viral, allergic, parasitic or colitis conditions, we assessed sickness across scales: organismal – behavior and physiology; cellular – brain-wide neural activity; and molecular – single-cell in situ transcriptomics in hypothalamus areas associated with social and homeostatic functions affected during sickness. Remarkably, immune challenges elicited unique repertoires of changes across all scales. Our findings reveal pathogen-specific sickness states encoded by the brain across scales, thereby broadening our understanding of how infections make us sick.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a973ce07eaa0ba52a5d26dc1ae4c7f5dadb199db" target='_blank'>
              Brain-immune interactions generate pathogen-specific sickness states
              </a>
            </td>
          <td>
            Zuri A. Sullivan, Bertrand J. Wong, Vikrant Kapoor, Paula Kathleen Vincze, Harris S. Kaplan, Pia Giraudet, Brianna R. Watson, Adel Misherghi, Sebastian Lourido, Jeffrey R. Moffitt, Catherine Dulac
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Urea, traditionally recognized as the final product of protein metabolism and a regulator of urine concentration, has recently emerged as a potential contributor to central nervous system (CNS) pathologies. However, its role in ischemic stroke remains largely unexplored. In this study, we identify urea as a previously unrecognized risk signal, whose levels rapidly increase in the brain following ischemic stroke. Elevated urea triggers the induction of neurotoxic A1-type astrocytes and promotes neuronal pyroptosis. Mechanistically, this process is mediated by the astrocytic urea transporter UT-B, which facilitates urea influx and initiates a cascade of neuroinflammatory responses. Through quantitative proteomics and gene silencing, we further demonstrate that urea exacerbates DNA damage via activation of the transcriptional coactivator Wwtr1, thereby amplifying the generation of A1 astrocytes. Collectively, our findings reveal a novel pathophysiological role for urea in ischemic brain injury and underscore the critical involvement of astrocytes in modulating neuroinflammation and neuronal death.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/474d5b7de05b53f8d874de6c5bf15b5559646a43" target='_blank'>
              Urea functions as a risk signal driving astrocyte-mediated neuroinflammation following stroke
              </a>
            </td>
          <td>
            Yang Han, Tongshuai Zhang, Dandan Wang, Shanshan Yang, Yixiang Jiang, Yao Zhang, Fan Zhu, Haiquan Tao, Liwei Zhao, Xianfeng Li, Haicheng Yang, Jing Lan, Jiachen He, Changyong Tang, Baoxue Yang, Guangzhi Wang, Xuan Li, Guangyou Wang
          </td>
          <td>2025-11-24</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d503b9da216c3e9533c8e7c5f25f5ef7851a1e3" target='_blank'>
              Potential Mechanisms and Hypotheses for Pathogenic Microorganisms Triggering Kawasaki Disease
              </a>
            </td>
          <td>
            Jinhan Yu, Linlin Cheng, H. Zhan, Yuan Huang, Siyu Wang, Haolong Li, Yongmei Liu, Yingchun Xu, Ye Guo, Yongzhe Li
          </td>
          <td>2025-12-01</td>
          <td>Clinical Reviews in Allergy & Immunology</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="This review aims to discuss the apparent reduction in pulmonary cancer incidence in the general population during and shortly after the COVID-19 pandemic from a biological and pathophysiological mechanistic point of view. While the epidemiological evidence points to a disruption in the early- and mid-stage diagnostic process, which causes a shift to late-stage lung cancer discovery with no impact on its actual prevalence, an alternative hypothesis based on the intersection of viral and cancer biology could have a real effect on lung carcinogenesis as an independent phenomenon. By weaving together population-level trends, mechanistic insights, and translational oncology, we discuss whether the pandemic-associated decline in lung cancer diagnoses reflects primarily a temporary diagnostic artifact or whether it also reveals biologically relevant intersections between SARS-CoV-2 and pulmonary oncogenesis. The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has exerted profound and multifaceted effects on global healthcare systems, altering patterns of disease detection, management, and outcomes across nearly all medical disciplines. These disruptions generated what has been termed a “diagnostic deficit”, producing a backlog of undetected cancers that have only partially been recovered in subsequent years. This phenomenon, sometimes described as a “COVID-19 debt” in oncology, is thought to contribute to excess late-stage diagnoses and potentially worse medium-term survival outcomes. Beyond the disruption of medical systems, the pandemic also raised a more speculative but biologically intriguing question: could SARS-CoV-2 infection itself, through direct or indirect mechanisms, influence lung cancer biology? Our review aims to critically synthesize the evidence across seven domains to address this dual hypothesis. (1) We examine the observed effects of the pandemic on cancer incidence, highlighting global registry and health-system data; (2) we review SARS-CoV-2 infection biology, including viral entry, replication, protein functions, and treatment implications; (3) we summarize the pathogenesis of lung cancer; (4) we explore the role of immune checkpoints in tumor immune evasion, followed by (5) analyses of immune dysregulation in acute infection and (6) in long COVID; and (7) finally, we evaluate proposed oncogenic mechanisms of SARS-CoV-2, integrating molecular virology with cancer immunology. We conclude that the “diagnostic deficit” phenomenon was a reality during and immediately post-pandemic. However, a definitive answer to the questions related to the impact of the infection as an independent phenomenon would require advanced research information covering the biology of the viral infection and lung cancer oncogenesis: processes that are not currently implemented in routine clinical laboratory investigations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d0bf5466dfce0bf8184f1ba8da30a22761eadbf2" target='_blank'>
              COVID-19 and Lung Cancer Interactions: A Literature Review
              </a>
            </td>
          <td>
            S. László, E. Ianoși, A. Văsieșiu, Mioara Szathmáry, M. Ianoși, Delia-Liana Rachiș, Gabriel Nistor, G. Jimborean
          </td>
          <td>2025-11-30</td>
          <td>Medical Sciences</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/067b711dad1b01bf4fc346e14734d26bf59c2c8a" target='_blank'>
              Differential regulation of p62-ubiquitin conjugates in neurons versus astrocytes during cellular stress
              </a>
            </td>
          <td>
            D. Sidibe, Erin M. Smith, Maeve L. Spivey, Maria C. Vogel, Sandra Maday
          </td>
          <td>2025-11-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1486b2a0665ed52ccf9a17b86e0809646ad8755a" target='_blank'>
              Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
              </a>
            </td>
          <td>
            A. Popa, Elena Popa, Tatiana Dramba, Elena-Adorata Coman, Mihaela Poroch, M. Ungureanu, A. Bacușcă, Ana-Maria Slanina, Gema Bacoanu, V. Poroch
          </td>
          <td>2025-11-25</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa3ea2bba5477695ec904d1360c6f71b6b797a04" target='_blank'>
              Single-Cell RNA Sequencing Reveals Impaired Regulatory T Cell Function and a Pro-inflammatory Th17 Profile in Systemic Sclerosis
              </a>
            </td>
          <td>
            G. Villanueva-Martin, G. Borrego-Yaniz, M. Acosta-Herrera, J. Callejas-Rubio, Norberto Ortego, N. Mages, S. Börno, María Gutiérrez-Arcelus, Javier Martin, L. Bossini-Castillo
          </td>
          <td>2026-01-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Introduction The role of Regulatory T cells (Tregs) in severe COVID-19 remains unclear. Some authors reported that Tregs increased in peripheral circulation, while other investigators reported that these cells decreased in severe COVID-19 patients. The expression of FoxP3 in Tregs remains inconsistent and controversial. These observations have been made using immune phenotyping via flow cytometry and T-cell sequencing; however, none of these data provide a clear indication of what Tregs are doing in this chaotic hyperactivated immune response. Methods We conducted a comprehensive characterization of the Treg compartment in a longitudinal cohort of patients with acute COVID-19, including individuals with mild or severe disease. Using RNA-seq, we analyzed gene expression across the cohort, while flow cytometry enabled us to determine Treg phenotype and observe changes during disease progression. Furthermore, we assessed Treg activity through a suppression assay. Results Gene expression analysis revealed significant downregulation of genes involved in regulatory pathways supporting T regs' functional activities, consistent across the severe patients analyzed. In contrast, we found increased expression of these genes in patients with mild disease. This finding was further confirmed by phenotyping analysis, which showed significant differences in CD25+CD127- Treg cells between mild and severe patients, positively associated with CTLA-4 and PD-1 inhibitory markers. Surprisingly, these results did not correlate with FoxP3 expression. Furthermore, a high frequency of CD25+CD127- Treg cells was associated with young, mild patients. In contrast, a lower frequency of CD25+CD127- cells and a higher frequency of FoxP3+ cells were associated with elderly patients. Finally, a Treg functional assay showed a lower capacity for suppression in Tregs obtained from severe patients compared to those from mild patients in the acute phase of the disease. Discussion Our findings offer critical insights into the role of Tregs in SARS-CoV-2, with implications that extend beyond this viral infection. Understanding how Tregs contribute to immune responses in COVID-19 could inform therapeutic strategies to modulate immune regulation in infectious diseases more broadly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/375e622ef27c7342cf0c8ff5baa1cafe0077df24" target='_blank'>
              Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19
              </a>
            </td>
          <td>
            Camila Kossack, Felipe Bravo, Francisco Fuentes-Villalobos, Claudio Quevedo, Matias A. Medina, Raúl Riquelme, M. Rioseco, Mario Calvo, Karina Pino-Lagos, Felipe Aguilera, M. I. Barria, J. Garrido
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Brain border-associated macrophages (BAMs) are resident immune cells at the border of the central nervous system (CNS), and their physiological functions and roles in neurological diseases have been widely reported. However, the specific mechanisms by which BAMs contribute to vascular cognitive impairment and dementia (VCID) remain unclear. This article systematically reviews the subsets, origin and differentiation, molecular markers of BAMs, and their research progress in various brain diseases such as hypertension, Alzheimer's disease (AD), and stroke. On this basis, this article deeply analyzes the potential hypotheses of BAMs' involvement in the pathogenesis of VCID, including their regulation of neurovascular unit (NVU) homeostasis, their core role in neuroimmune inflammation, their impact on the lipid metabolism pathways in the CNS, and their involvement in the pathogenesis of vascular risk factor-related cognitive impairment (VRFCI). The mechanistic hypotheses proposed in this article aim to provide new perspectives for understanding the pathophysiology of VCID and may open up new directions for the development of early intervention and targeted treatment strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32e6891eacdfd18b6e3225a16512daaa1f69d7f7" target='_blank'>
              Border-associated macrophages: an emerging perspective from physiological basis and multi-disease roles to the mechanism of vascular cognitive impairment and dementia
              </a>
            </td>
          <td>
            Tian Li, Jing Zhang, Hao Song, Ran Zhang, Fan Fan, Zhiwei Huang, Mengliu Zeng, Biwen Peng, Junjian Zhang
          </td>
          <td>2025-12-01</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Joint inflammation is a hallmark of post-traumatic osteoarthritis (PTOA) progression and a recognized driver of articular destruction and symptoms. Despite its known pathological role, inflammation has not been successfully targeted to treat PTOA. With the hypothesis that blocking the acute influx of systemically-derived immune cells can mitigate injury-induced inflammation and downstream PTOA disease severity, we targeted immune cell recruitment via systemically-administered poly salicylic acid (PolySA) particles. This formulation targets immune cells in circulation, namely neutrophils and monocytes, to inhibit their vascular extravasation into injured tissue. Employing a murine joint injury model, we show that PolySA particles reduced neutrophil and monocyte recruitment to the synovium by >50% when administered acutely after injury. Sex-specific therapeutic effects of PolySA emerged 7d post-ACLR, whereby female knee joints exhibited increased cathepsin activity and alleviation of knee hyperalgesia. Despite also observing reduced immune cell recruitment in male mice treated with PolySA, therapeutic effects were entirely absent in males. RNAseq of female synovium revealed a transcriptomic signature indicative of accelerated immune resolution and matrix remodeling in PolySA-treated female mice. Analyses at a timepoint of established disease showed that PolySA-treated female mice exhibited sustained pain alleviation, reduced osteophyte formation, and decreased histopathological PTOA and synovitis severity scores. Together, these findings indicate that blocking acutely-recruited immune cells to the local joint microenvironment via systemic PolySA particle treatment is a promising therapeutic for PTOA prevention by reprogramming early injury-induced inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/51457e1233724ae5b8f78a7dd131e88e871ddba3" target='_blank'>
              Acute immune modulation with poly-salicylic acid particles ameliorates pain and structural damage in post-traumatic osteoarthritis
              </a>
            </td>
          <td>
            Michael L. Felder, L. Lammlin, Adrienne A. Giannone, M. V. Guevara, Scarlet C. Howser, Isabelle Smith, O. Eniola-Adefeso, Tristan Maerz
          </td>
          <td>2025-11-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/97aa2343cc3f40eb7c452dc50f451e6fac835427" target='_blank'>
              The role of pyroptosis during HIV infection
              </a>
            </td>
          <td>
            M. Yaseen, Nizar M. Abuharfeil, H. Darmani, Mohammed N. Shatnawi
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated not only with respiratory illness but also with profound vascular and coagulation disturbances. Long COVID (LC) is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and palpitations. Mechanistically, SARS-CoV-2 induces direct endothelial injury, promotes a pro-inflammatory cytokine milieu, and activates platelets, leading to immunothrombosis and impaired fibrinolysis. Consequently, patients exhibit microthrombosis, elevated plasma D-dimer, fibrinogen dysregulation, and persistent hypercoagulability. Clinically, this translates into an increased risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as arterial thrombotic events such as myocardial infarction and stroke, which may persist months after acute infection. Understanding the interplay between endothelial injury, inflammation, and coagulation is crucial for risk stratification and the development of preventive and therapeutic strategies. We conducted a systematic narrative review of the literature, including human clinical and mechanistic studies identified through PubMed, Scopus and Web of Science up to 30 September 2025. This review synthesizes current evidence on vascular complications in LC, highlighting endothelial dysfunction as a central pathophysiological nexus linking the acute phase of SARS-CoV-2 infection with chronic LC manifestations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f14dffbb63f077cbdc46f26a8295d84afd04c13d" target='_blank'>
              Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review
              </a>
            </td>
          <td>
            Maja Stojanović, Marko D Djuric, Irina B Nenadic, Suzana C. Bojic, Ana Andrijevic, Aleksa Popovic, Slobodan Pešić
          </td>
          <td>2025-12-31</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6f9c933a473e49313c32514553adbf6d9c17d2eb" target='_blank'>
              IFNγ-associated immune–metabolic remodeling drives serotonin–kynurenine imbalance with cortical vulnerability in lupus-prone mice
              </a>
            </td>
          <td>
            Karim Matmat, R. Guéant-Rodriguez, Emmanuel Darcq, Okan Baspinar, J. Alberto, J. Guéant, A. Mensah-Nyagan, Hélène Jeltsch-David
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1908b3b3226f8c7878c6e6b6c337b73f90a53429" target='_blank'>
              Dual-function cytokines as modulators of autophagy: reprogramming inflammatory resolution in severe COVID-19
              </a>
            </td>
          <td>
            Sohrab Khan, Ping Tang, Pingchang Yang, Jing Li, Haiqiang Wu
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, has had a profound global impact. Diabetes mellitus is a major comorbidity associated with higher infection risk, severe disease, and mortality in COVID-19 patients. This review examines the bidirectional relationship between COVID-19 and diabetes, focussing on immunometabolic mechanisms, post-COVID metabolic effects, and therapeutic implications. A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science for articles published until May 2025 using the terms "COVID-19," "SARS-CoV-2," "diabetes," and "immunometabolism." Peer-reviewed studies addressing clinical, molecular, or therapeutic interactions between the two diseases were included. Evidence shows that SARS-CoV-2 infection aggravates metabolic dysfunction through immune dysregulation, cytokine-mediated inflammation, and β-cell injury. Hyperglycemia promotes viral replication and inflammatory damage, creating a vicious cycle that worsens outcomes. Reports also indicate an increased risk of new-onset and post-COVID diabetes. Certain antidiabetic agents, such as metformin and GLP-1 receptor agonists, may improve prognosis via anti-inflammatory and metabolic effects. Diabetes significantly amplifies the severity of COVID-19 through intertwined metabolic and immune mechanisms. Understanding these interactions provides new insights into disease management and supports the development of targeted immunometabolic therapies for improving outcomes in diabetic patients affected by COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80e954bc39ab4c596e3acc382fff9dbe2db6d37d" target='_blank'>
              COVID-19 in Diabetic Patients: Mechanisms, Risks, and Therapeutic Considerations.
              </a>
            </td>
          <td>
            Rania Hamdy, Amal Z Barakat, Eman J Abuzaid, Tasneem Elsayed, M. Husseiny
          </td>
          <td>2025-12-04</td>
          <td>Reviews in medical virology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Long COVID (LC) is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated chronic condition and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems, including cardiovascular. Extensive literature supports an association between SARS-CoV-2 infection and cardiovascular complications and increased cardiovascular risk after infection. The cardiovascular sequelae after SARS-CoV-2 infection have not yet been comprehensively characterized. A growing body of evidence suggests that endothelial dysfunction is a central mechanism in COVID-19 and has also been identified as a key pathogenic mechanism in LC. Although considerable progress has been made in characterizing the epidemiology, clinical course, and biology of LC, many questions remain unanswered. The incomplete understanding of the pathomechanisms of LC has hampered the development of targeted therapies to date. Further research and data are needed to develop effective therapeutic and preventive tools. Based on current literature this review aims to provide an up-to-date overview of the pathomechanisms affecting the cardiovascular system and the potential role of selected micronutrients, vitamins and minerals, and flavonoids as preventive and therapeutic strategies in LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fecb1ed06a4859e6569f30b68493347d474b7177" target='_blank'>
              Cardiovascular damage and comorbidities related to long COVID: pathomechanisms, prevention, and therapy
              </a>
            </td>
          <td>
            M. Kvandová, P. Balis, B. Kaločayová, Jana Vlkovicova, Silvia Dobrodenkova, A. Puzserova
          </td>
          <td>2025-12-03</td>
          <td>Frontiers in Cardiovascular Medicine</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a860b1f890cd6919e6ed4f49c16018a6906fcd8a" target='_blank'>
              Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics.
              </a>
            </td>
          <td>
            Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen, L. Bek, Maaike de Bie, Tobias M Defesche, Chantal A Boly, Manon Drost, M. Hellemons, W. Dik, M. Versnel
          </td>
          <td>2025-12-10</td>
          <td>Journal of clinical immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="SARS-CoV-2, the virus responsible for COVID-19, disrupts human cellular pathways through complex protein–protein interaction, contributing to disease progression. As the virus has evolved, emerging variants have exhibited differences in transmissibility, immune evasion, and pathogenicity, underscoring the need to investigate their distinct molecular interactions with host proteins. In this study, we constructed a comprehensive SARS–CoV–2–human protein–protein interaction network and analyzed the temporal evolution of pathway perturbations across different variants. We employed computational approaches, including network-based clustering and functional enrichment analysis, using our custom-developed Python (v3.13) pipeline, BioEnrichPy, to identify key host pathways perturbed by each SARS-CoV-2 variant. Our analyses revealed that while the early variants predominantly targeted respiratory and inflammatory pathways, later variants such as Delta and Omicron exerted more extensive systemic effects, notably impacting neurological and cardiovascular systems. Comparative analyses uncovered distinct, variant-specific molecular adaptations, underscoring the dynamic and evolving nature of SARS-CoV-2–host interactions. Furthermore, we identified host proteins and pathways that represent potential therapeutic vulnerabilities, which appear to have co-evolved with viral mutations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69099fff2803ece73e94ac8189f87993409fb26a" target='_blank'>
              Temporal Profiling of SARS-CoV-2 Variants Using BioEnrichPy: A Network-Based Insight into Host Disruption and Neurodegeneration
              </a>
            </td>
          <td>
            Sreelakshmi Kalayakkattil, Ananthakrishnan Anil Indu, Punya Sunil, Haritha Nekkanti, Smitha Shet, Ranajit Das
          </td>
          <td>2025-12-05</td>
          <td>COVID</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Sepsis is a life-threatening condition marked by dysregulated immune responses and organ dysfunction, with macrophages playing central roles in both hyperinflammation and immunosuppression. Recent advances highlight mitochondrial metabolism as a key regulator of macrophage polarization and function. Pro-inflammatory M1 macrophages rely on glycolysis and produce high levels of reactive oxygen species (ROS) and cytokines, while reparative M2 macrophages depend on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO). Mitochondrial dysfunction—characterized by excessive mitochondrial ROS (mtROS), impaired mitophagy, and disrupted fission/fusion dynamics—exacerbates immune dysregulation and tissue injury. Organ-specific macrophage metabolic reprogramming further influences sepsis pathology, particularly in the kidney, lung, and heart. Therapeutic strategies targeting mitochondrial pathways—such as small-molecule modulators, stem cell-derived extracellular vesicles, and RNA-based gene therapies—have shown promise in restoring macrophage homeostasis and improving outcomes. This review underscores the importance of immunometabolic regulation in sepsis and advocates for mitochondria-targeted interventions as a novel precision approach to immune modulation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/28a95befdb160cdec7982590929761d8997fba7a" target='_blank'>
              Mitochondrial immunometabolism in sepsis: orchestrating macrophage polarization and dysfunction
              </a>
            </td>
          <td>
            Ke Yang, Qiang Zhao, Youhan Sun, Li Lin, Xiao Han
          </td>
          <td>2025-12-02</td>
          <td>European Journal of Medical Research</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Severe Coronavirus disease 2019 (COVID-19) is associated with abnormal innate and adaptive immune responses, as well as systemic alterations, including a shift in lipid network. A case–control study was conducted to describe the systemic lipidomic profile in COVID-19 according to disease severity. Selected polyunsaturated fatty acids (PUFAs), oxylipins, and endocannabinoids were analysed using a targeted liquid chromatography coupled to mass spectrometry in tandem method. Multivariate receiver operating characteristic curve-based model evaluation was performed to define a lipidomic signature for the disease. A total of 135 hospitalized COVID-19 patients, of whom 85 had severe form, and 134 healthy individuals were included. Patients exhibited increased levels of free PUFAs, proinflammatory and pro-resolving oxylipins, and endocannabinoids compared to controls. A combination of five lipid mediators, i.e., prostaglandin D2, prostaglandin E2, thromboxane B2, lipoxin B4, and 2-archidonylglycerol, discriminates patients from control individuals with excellent accuracy [AUC, 0.977 (0.950–0.995)]. The severe form is characterized by an imbalance between proinflammatory and pro-resolving oxylipins and increased endocannabinoids. COVID-19 is associated with a lipid storm that conditions disease severity. Targeting lipid mediators-related metabolic and signalling pathways could be an interesting therapeutic option in severe forms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a5fb8bf52683c50e4277c9e8f4f3b1e200f52531" target='_blank'>
              COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
              </a>
            </td>
          <td>
            A. Bouabdallah, M. K. Ben-Fradj, Mohamed Bessem Hammami, Rim Abdelmalek, H. Sanhaji, T. Klopfenstein, Moncef Feki
          </td>
          <td>2025-11-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="ABSTRACT Enterovirus 71 (EV71) is a viral pathogen responsible for causing hand, foot, and mouth disease, which can lead to severe neurological complications. This study aims to elucidate the pyroptosis mechanism underlying brain injury induced by EV71 infection. EV71-infected BALB/c suckling mice exhibited characteristic symptoms, including weight loss, lethargy, and limb weakness. Notably, elevated levels of the inflammatory proteins IL-1β and IL-18 were detected in the brain tissue of the infected mice. Research findings indicate that EV71 infection activates the NLRP3 inflammasome, resulting in an increased release of IL-1β and IL-18. Furthermore, upregulation of the expression of Caspase-1, Caspase-11, and the pyroptosis-related protein GSDMD was observed in the context of EV71 infection. Importantly, the administration of inhibitors targeting Caspase-1 and Caspase-11 led to the downregulation of these protein expression levels and simultaneously reduced the severity of the inflammatory response in the brain tissue. These results highlight the critical regulatory role and cross-talk between Caspase-1 and Caspase-11 in EV71-induced brain injury, which involves inflammatory responses and pyroptosis. The significance of these findings enhances our understanding of the pathogenic mechanisms associated with EV71 infection and offers valuable insights for the development of new therapeutic strategies. IMPORTANCE This study elucidated the molecular mechanism underlying pyroptosis-mediated brain injury during EV71 infection in hand, foot, and mouth disease (HFMD), addressing a critical knowledge gap in neuroinflammatory pathogenesis. Using a BALB/c suckling mouse model, we demonstrated that EV71 infection induced a significant upregulation of the pro-inflammatory cytokines IL-1β and IL-18 in brain tissues. Mechanistically, the activation of the caspase-1/11-GSDMD axis was confirmed via Western blot analysis, which revealed an increase in cleaved GSDMD levels in the presence of EV71, indicating a definitive link between the virus and pyroptotic cell death, as supported by studies on GSDME’s role in EV71-induced cell pyroptosis. Specific inhibitors targeting caspase-1/11 have been shown to effectively suppress protein expression, reduce neuroinflammatory markers, and improve survival rates, as demonstrated in studies involving acute pancreatitis, EAE, and non-canonical cell death. These findings not only advance the understanding of EV71 neuropathogenesis but also identify caspase-1/11 as promising therapeutic targets for mitigating HFMD-associated brain injury. This study elucidated the molecular mechanism underlying pyroptosis-mediated brain injury during EV71 infection in hand, foot, and mouth disease (HFMD), addressing a critical knowledge gap in neuroinflammatory pathogenesis. Using a BALB/c suckling mouse model, we demonstrated that EV71 infection induced a significant upregulation of the pro-inflammatory cytokines IL-1β and IL-18 in brain tissues. Mechanistically, the activation of the caspase-1/11-GSDMD axis was confirmed via Western blot analysis, which revealed an increase in cleaved GSDMD levels in the presence of EV71, indicating a definitive link between the virus and pyroptotic cell death, as supported by studies on GSDME’s role in EV71-induced cell pyroptosis. Specific inhibitors targeting caspase-1/11 have been shown to effectively suppress protein expression, reduce neuroinflammatory markers, and improve survival rates, as demonstrated in studies involving acute pancreatitis, EAE, and non-canonical cell death. These findings not only advance the understanding of EV71 neuropathogenesis but also identify caspase-1/11 as promising therapeutic targets for mitigating HFMD-associated brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c322c9f621ed76545357fb58c7ef5e681afa5b13" target='_blank'>
              Enterovirus 71 infection induces pyroptotic brain injury via synergistic activation of classical inflammasome and viral gasdermin D cleavage
              </a>
            </td>
          <td>
            Tianrun Liu, Baixin Wang, Yingyu Li, Shuming Tian, Xinlong Gao, Yuhan Fan, Xiaomeng Zhang, Limin Yang, Rui Wu, Lei Liu
          </td>
          <td>2025-11-25</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The devastating clinical, psychological, and economic impact of the COVID‐19 pandemic, caused by global spread of the second Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has engendered a massive response from the scientific community to rapidly understand the biology of SARS‐CoV‐2 and to develop interventions to prevent infection or progression to life‐threatening disease. Angiotensin converting enzyme‐2 (ACE2) and its interaction with the SARS‐CoV‐2 Spike glycoprotein, which mediates fusion of the virion envelope with the target cell membrane, have emerged as a major pharmacological target, as disruption of the Spike‐ACE2 interaction prevents cells from becoming infected and hence from producing viral progeny. Moreover, the dysregulation of ACE2 that occurs in the context of SARS‐CoV‐2 infection may have broader implications for COVID‐19 pathogenesis. Here we summarize the role of ACE2 as a physiologic regulator of human health, as a facilitator of SARS‐CoV‐2 infection, as a factor in COVID‐19 disease, and as a target for pharmacological interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2e59f0d9c946db9a9c160b8605a6c2ca92d39a0" target='_blank'>
              The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions
              </a>
            </td>
          <td>
            M. McVoy, A. Kummarapurugu
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Background The host response to SARS-CoV-2 depends on multiple factors including age, gender, underlying diseases and genetic background. Viral sensing and activation of the interferon signaling pathway in the early antiviral response could affect disease outcome. This study evaluated gene expression of Toll-like receptor 7 (TLR7), tyrosine kinase 2 (TYK2) and 2’-5’ oligoadenylate synthetase 1 (OAS1) in two early longitudinal samples from mild, moderate and severe cases. Methods Demographic and clinical variables were obtained from 157 COVID-19 patients. Peripheral blood mononuclear cells were used for genotyping and gene expression determination, and plasma for viremia detection, by qPCR and digital PCR, respectively. Gene expression was analyzed using Generalized Linear Mixed Models nested by patient. First, univariate analyses determined which variables were significantly associated with gene expression. Next, multivariate models were built with these variables, following the backward method. Results TLR7 levels were higher in patients with mild disease compared to those with moderate disease and decreased over time. In contrast, patients with severe disease had lower TLR7 expression, which remained stable. OAS1 behavior was similar, whereas TYK2 remained unchanged. Multivariate analysis confirmed the relation of low TLR7 expression with severity and viremia. OAS1 levels directly correlated with higher viremia. TYK2 was associated with OAS1 expression, and OAS1 with both TLR7 and TYK2 levels. Conclusions Low TLR7 levels were associated with severe COVID-19, and together with OAS1 expression were modulated over time according to severity. While TLR7 expression decreased across all severity groups as the disease resolved, OAS1 expression persisted in severe cases with higher viremia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa069123cd3aa2607cda4c137a1e8f7972b1b186" target='_blank'>
              Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Estíbaliz Alegría-Carrasco, Marta Jaén-Castaño, Pablo Delgado-Wicke, Nelly D. Zurita-Cruz, Nuria Montes, Emilia Roy-Vallejo, Sara Fernández de Córdoba-Oñate, Ana Nicolao-Gómez, Rosa Carracedo-Rodríguez, A. Marcos-Jiménez, Laura Cardeñoso-Domingo, Isidoro González-Álvaro, Elena Fernández-Ruiz
          </td>
          <td>2025-12-09</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Rift Valley fever virus (RVFV) is a Phlebovirus causing febrile and haemorrhagic illness in ruminants and humans. The viral protein NSs is a major virulence factor that suppresses the IFN-β response in various hosts. Hence RVFV variants lacking functional NSs such as Clone 13 are highly attenuated. It is speculated that from the sites of infection, the virus disseminates to the target organs via the bloodstream. We hypothesized that primary infection of circulating immune cells, and their response to infection are critical factors determining systemic RVFV spread and pathogenesis. Human PBMC from healthy blood donors were exposed to both wild-type (WT) RVFV and Clone 13 strains. Flow cytometric analysis revealed that monocytes expressing LRP1, a known RVFV receptor, are target cells for RVFV. RNA-seq analysis of monocytes exposed to WT and Clone 13 strains showed a large number of differentially expressed genes compared to mock exposed cells. Various genes involved in antiviral immune mechanisms were specifically modulated in monocytes either in response to WT or Clone 13 infection. Expression of genes encoding key inflammatory mediators such as CCL2, CD40, CD83 were only upregulated in Clone 13-infected monocytes whereas IFNB1 and NFKB1 were downregulated specifically in WT-infected monocytes. Taken together, our findings suggest that RVFV NSs dampens the innate immune responses in monocytes which may be critical not only in RVFV pathogenesis but also in the induction of virus specific immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9bbf32c5fcf87eba5101e9e1046f41aebb58c18c" target='_blank'>
              Differential innate immune activation by wild-type and NSs-deficient RVFV strains in human blood monocytes.
              </a>
            </td>
          <td>
            Niranjana Nair, Julia Friese, P. J. Wichgers Schreur, A. Osterhaus, G. Rimmelzwaan, C. K. Prajeeth
          </td>
          <td>2025-12-29</td>
          <td>Emerging microbes & infections</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bce54efd110fde03077139b1afa9c1f4e6856c6b" target='_blank'>
              Single-cell analysis of B cell dysregulation in pediatric sepsis stratified by disease severity.
              </a>
            </td>
          <td>
            Fahd Alhamdan, Stefano Gianoli, Koichi Yuki, S. Koutsogiannaki
          </td>
          <td>2025-12-31</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Simple Summary Between 2021 and 2024, large segments of the population—including cancer patients—experienced multiple COVID-19 infections and received repeated doses of mRNA vaccines. The concomitant increase in newly diagnosed cancers or fast progression of cancers under treatment raised concerns about whether SARS-CoV-2 or the vaccines might play a role in these outcomes. While it appears extremely unlikely that SARS-CoV-2 and anti-COVID-19 mRNA vaccines can elicit genotoxic events causing neo-cancerogenesis in a short time, they could still cause non-genotoxic pro-carcinogenic effects. Indeed, multiple molecular, cellular, and systemic mechanisms, including disruption of the immunosurveillance and induction of inflammation in the tumor microenvironment, disruption of autophagy and of tumor suppressor pathways, and activation of signaling involved in cell proliferation and cell migration, could synergistically lead to the awakening and fast growth of dormant microtumors, particularly in vulnerable individuals exposed to both repeated infections and vaccinations over a short time frame.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de3cfcddce3551466023c757b442fae429468eda" target='_blank'>
              SARS-CoV2 and Anti-COVID-19 mRNA Vaccines: Is There a Plausible Mechanistic Link with Cancer?
              </a>
            </td>
          <td>
            C. Isidoro
          </td>
          <td>2025-12-01</td>
          <td>Cancers</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="Neurodegenerative diseases are a multifactorial problem for modern neurology, due to their unknown etiology, difficult diagnostics, and, consequently, the lack of causal methods of treatment. Rising life expectancy exacerbates the problem by increasing the number of patients, as most of them fall ill in older age. Recent research shows that inflammation, both peripheral and neuroinflammation, may take part in the pathogenetic pathways of disease development. Some studies suggest that the initiation of the process occurs outside of the nervous system and is causally related to the immune system. This review focuses on the role of basic peripheral immune cells, including lymphocytes and neutrophils, in the course of selected central nervous system pathologies and their potential use as a biomarker. Both types of leukocytes not only change their quantity, but, more importantly, their function. Furthermore, they interact with microglial cells that constantly surveil the central nervous system and respond to pathological factors. Their joint action, however, can be either neuroprotective or neurotoxic. This review highlights that the development of neurodegeneration is associated with a dysregulation of the balance between immune cell phenotypes and their interactions. The disturbed immune response does not allow for the organism to correctly control the disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ef5e62d571874de2ebc2fe74c74f57d6af4d6b8" target='_blank'>
              White Blood Cells in Neurodegenerative Diseases in the Context of Neuroinflammation
              </a>
            </td>
          <td>
            Agnieszka Wełnicka-Wesołowska, Monika Gołąb-Janowska
          </td>
          <td>2025-11-24</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Background/objectives The complex interplay between sarcoidosis and COVID-19 remains an important area of research, since COVID-19 leads to long-term changes in the immune system. However, COVID-19 is often followed by autoimmune diseases, including newly manifesting sarcoidosis. The goal of this study is to characterize CD4+ T cell subsets, playing a pivotal role in the regulation of innate and adaptive immunity, in the peripheral blood of patients with sarcoidosis after COVID-19. Methods The peripheral blood samples from patients with sarcoidosis (n = 61) were studied. We divided patients into two distinct groups: sarcoidosis patients with no history of COVID-19 (n= 30) and COVID-19 convalescent patients with sarcoidosis within 12–24 weeks after recovery (n = 31). Healthy controls (n = 40) were similar in terms of age and sex to patients with sarcoidosis. Immunophenotyping of peripheral blood cells was performed using a ten-color flow cytometry. Results Sarcoidosis patients with COVID-19 history had higher levels of T-helper cells (Th) when compared to COVID-19 naïve patients with sarcoidosis, but lower levels when compared to healthy controls. In COVID-19 convalescent patients with sarcoidosis, we noted higher absolute numbers and percentages of CD45RA–CCR7– and CD45RA+CCR7– cells within Th subset. Among COVID-19 convalescent patients with sarcoidosis we also found higher levels of T helper 1 cells and T helper 2 cells (with CXCR5–CCR6–CXCR3+CCR4– and CXCR5–CCR6–CXCR3–CCR4+ phenotypes, respectively) when compared to other groups. We also noted a statistically significant increase in central memory CXCR5+CCR6–CXCR3– follicular Th cells, as wells as effector memory CXCR5+CCR6–CXCR3– and CXCR5+CCR6+CXCR3– follicular Th cells in both groups of patients with sarcoidosis vs. healthy controls. Conclusions Our study demonstrated Th cells imbalance in patients with sarcoidosis and COVID-19 history. These findings suggest possible clinical and visual progression of chronic lung sarcoidosis in COVID-19 convalescent patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/532c2a46c2caa9fb95b8e3141b2c680f9a900d65" target='_blank'>
              Immune responses in pulmonary sarcoidosis following COVID-19
              </a>
            </td>
          <td>
            A. Starshinova, Igor Kudryavtsev, Artem Rubinstein, T. Akisheva, A. Golovkin, Z. Korobova, Anastasia Kulpina, D. Kudlay
          </td>
          <td>2025-11-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction Viruses, particularly Epstein–Barr virus (EBV), are strongly implicated in multiple sclerosis (MS) pathogenesis, yet reliable biomarkers of active viral replication remain limited. Double-stranded RNA (dsRNA) represents a hallmark of viral replication and may serve as a measurable indicator of viral infection. Methods We developed a sandwich ELISA to quantify dsRNA levels in matched plasma and cerebrospinal fluid (CSF) samples from 70 treatment-naïve MS patients at first clinical onset and in plasma from 26 sex- and age-matched healthy controls. We additionally assessed plasma and CSF antiviral cytokine concentrations and designed an indirect ELISA to measure anti-dsRNA antibody levels using poly(I:C) as the target antigen. Results Plasma dsRNA levels were significantly elevated in MS patients compared to controls and positively correlated with antiviral cytokines, including GM-CSF, IFN-λ1, IFN-λ2/3, IFN-γ, IFN-α2, and IL-12p70. CSF samples exhibited increased IP-10 and IL-8 levels, and the single patient with detectable CSF dsRNA showed among the highest concentrations of both cytokines. A subset of ten patients (14%) with serological evidence of atypical EBV reactivation (EBNA1 IgG+/IgM+) had higher plasma dsRNA and antiviral cytokine levels than the remaining patients. Anti-dsRNA IgM, but not IgG or IgA, correlated positively with plasma dsRNA in both MS patients and controls, yet anti-dsRNA IgM levels were significantly reduced in MS compared to controls. Discussion Our findings identify increased plasma viral dsRNA coupled with reduced anti-dsRNA IgM antibody levels as potential biomarkers for a subpopulation of early MS patients and indicate a dysregulated anti-viral immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e8977be65b30cbe4f96a063b2af89e0a2fd6684e" target='_blank'>
              Double-stranded RNA antiviral signature in early multiple sclerosis
              </a>
            </td>
          <td>
            Vasileios Gouzouasis, Ioannis Sarrigeorgiou, Margaritis Tsifintaris, Nikos Markoglou, Urania Georgopoulou, Peggy Lymberi, M. Anagnostouli, Lesley Probert, Antonis Giannakakis
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Many studies have shown an association between herpes simplex virus type 1 (HSV-1) infection and the development of neurodegeneration processes later in life, such as Alzheimer’s disease. The Fas/FasL death pathway plays an important role in the complex regulation of the local inflammatory response and mounting of the specific antiviral response in HSV-1 infection. Here, we applied a mouse model of latent HSV-1 neuroinfection to Fas- and FasL-deficient mice (lpr and gld) to explore whether the lack of functional Fas/FasL pathway protects from inflammation-related neurodegeneration. The latently infected Fas- and FasL-deficient mice (lpr and gld) were not protected from virus replication despite the accumulation of virus-specific cytotoxic T cells. However, the lack of Fas/FasL pathway decreased neuroinflammation- and neurodegeneration-related markers, including cognitive impairment, amyloid-β protein, and tau hyperphosphorylation. The use of a glucocorticoid, dexamethasone, to decrease neuroinflammation in wild-type mice did not protect from cognitive impairment, despite the improved antiviral response. Our data indicate that excessive neuroinflammation via the Fas/FasL pathway during HSV-1 infection is associated with neurodegeneration. Furthermore, the administration of immunomodulatory agents to ameliorate the outcome of HSV-1 latent infection should be restricted to the peak of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ae344fac498d71f5308786f29214c408bb4c753" target='_blank'>
              Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration
              </a>
            </td>
          <td>
            Magdalena Patrycy, Agnieszka Kauc, Martyna Janicka, Aleksandra Osińska, Andrzej Kowalczyk, Katarzyna Skulska, Małgorzata Antos-Bielska, Marcin Chodkowski, Kristina Eriksson, Małgorzata Krzyżowska
          </td>
          <td>2025-12-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="The role of Toll-like receptor 2 (TLR2) in the central nervous system (CNS) is critical in several conditions including neurological disorders such as pain, and neurodegenerative disorders such as Parkinson’s disease. Therefore, understanding TLR2 function in the CNS is of considerable importance. In this study, we investigated neuronal responses to individual TLR2 ligands. The expression levels of cytokines increased in the culture in the presence of TLR2 ligands. Additionally, increased lactate dehydrogenase (LDH) was noted during lipoteichoic acid (LTA) stimulation. During LTA stimulation, a decrease in the peak amplitude of Ca2 + oscillations was observed. MnTBAP, which is a reactive oxygen species (ROS) blocker, inhibited the LTA-induced cell death but had no effect on the peak amplitude of the Ca2 + spike. Conversely, Pam3CSK4 (P3C) stimulation increased the number of Ca2 + peaks, which was inhibited by a tumor necrosis factor alpha (TNFα) signaling inhibitor. Our study revealed that several TLR2 ligands, each with different specificities, elicited diverse responses in primary cortical cells. In conclusion, TLR1-TLR2 and TLR2-TLR6 signaling reduces the peak amplitude and induces cell death, and TLR1-TLR2 signaling enhances Ca2 + dynamics via a TNFα pathway. P3C stimulation increased the number of Ca2+ peaks, which was inhibited by a TNFα signaling inhibitor. LTA stimulation decreased the amplitude of Ca2+ peaks, and induced cell death via ROS signaling. P3C stimulation increased the number of Ca2+ peaks, which was inhibited by a TNFα signaling inhibitor. LTA stimulation decreased the amplitude of Ca2+ peaks, and induced cell death via ROS signaling.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1cd9b2d491e0bdd08dc565dbdd96bfc617dca92c" target='_blank'>
              Diverse Effects of Various Toll-Like Receptor 2 Ligands on Neuronal Activity and Cell Death
              </a>
            </td>
          <td>
            Futa Sato, Satoshi Hachimura
          </td>
          <td>2025-11-26</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition emerging during the COVID-19 pandemic, strongly associated with prior SARS-CoV-2 infection. Characterized by systemic inflammation affecting multiple organs, MIS-C presents a complex clinical picture including fever, gastrointestinal distress, cardiac dysfunction, and neurological manifestations. Although its exact pathogenesis remains incompletely understood, immune dysregulation is recognized as a central mechanism. This review examines current understanding of MIS-C pathogenesis, focusing on immune dysfunction and viral triggers, particularly SARS-CoV-2. We analyze both innate and adaptive immune responses, cytokine storm dynamics, molecular mimicry, and virus-induced inflammatory cascades. Additionally, we discuss potential immunomodulatory therapeutic strategies and identify future research directions to improve MIS-C management and treatment outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb906afaca8efa1a4927662eab78d7c57c8c42b9" target='_blank'>
              MIS-C pathogenesis: immune dysregulation & viral triggers
              </a>
            </td>
          <td>
            Tiantian Xu, Jiamin Zhang, Xiangyuan Hou, Xinyu Xie, Junye Qi, Chang-bing Wang, Yuqing Yan, Lu Kuang, Bing Zhu
          </td>
          <td>2025-11-26</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="SARS-CoV-2 accessory proteins (APs), particularly ORF3a and ORF9b, have emerged as key modulators of host-pathogen interaction and potential contributors to long COVID. Of the 13 predicted APs, only nine are expressed during infection – termed Infection-related APs – while the remaining are classified as Putative APs. Despite this distinction, extensive gene overlap among APs underscores the remarkable adaptability of SARS-CoV-2 viral genome. This review delves into the diverse roles of the original Wuhan APs and their Omicron counterparts in shaping host immunity, with an emphasis on their ability to suppress type I interferon (IFN-I) signalling, modulate cellular metabolism, and trigger inflammatory/apoptotic pathways. By integrating immunopathological insights with evolutionary dynamics and structural perspectives, this review provides a comprehensive understanding of the mechanism underlying Omicron’s reduced pathogenicity and highlights promising, yet unexplored, therapeutic targets within the SARS-CoV-2 accessory proteome.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6086782319f7c4f70392309ce0b182e4c6409aa6" target='_blank'>
              Hidden players of COVID-19: the evolving roles of SARS-CoV-2 accessory proteins
              </a>
            </td>
          <td>
            Miguel Padilla-Blanco, Tránsito García-García, Juozas Grigas, B. D. López-Ayllón, Juan J Garrido, María A. Oliva, María Montoya
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Since its emergence in late 2019, SARS-CoV-2 has evolved into multiple variants with distinct genetic and clinical features. Among them, the Omicron variant (B.1.1.529) and its sublineages BA.2.75, JN.1.8, and KP.2 have shown enhanced transmissibility and immune evasion, while generally exhibiting reduced lower respiratory tract pathogenicity compared to earlier variants, thereby continuing to pose significant challenges to public health. In India, these variants have significantly shaped the trajectory of the pandemic, necessitating focused evaluation of their biological and clinical impact. This review aims to provide a comprehensive study on the virology, pathophysiology, and systemic manifestations of Omicron and its emerging subvariants upto July 2025. We discuss their mechanisms of entry and replication, interaction with ACE2 and TMPRSS2 receptors, and evasion of host immune responses. Particular emphasis is placed on multi-organ involvement beyond the respiratory system, including neuro-respiratory dysregulation, cardiovascular complications, hepatic injury, gastrointestinal disturbances, and renal dysfunction. Furthermore, we evaluate the effectiveness of available vaccines, antiviral therapies, and diagnostic tools, alongside emerging clinical strategies such as vagus nerve stimulation, thermal modulation, and respiratory muscle training. By integrating molecular insights with clinical outcomes, this review highlights the multifaceted and systemic nature of Omicron-induced disease. We underscore the urgent need for variant-specific immunisation, early intervention strategies, and robust genomic surveillance to mitigate long-term sequelae and guide preparedness for future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b2d3176f67a95b7b0b596b257cf88c32fab7bb85" target='_blank'>
              The virology of Omicron: pathophysiology, immune regulation, and clinical impact of SARS-CoV-2 sub variants
              </a>
            </td>
          <td>
            Nistha Mishra, Tanya Goel, Nisarg Gangani, Heerak Chugh, Bhavesh Kevadiya, Manisha Tiwari, Snigdha Singh, Jai Gopal Sharma, Ramesh Chandra
          </td>
          <td>2025-11-26</td>
          <td>Virology Journal</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="SARS-CoV-2 evolution in persistent infection, which may induce long COVID-19, is predominantly manifested in immunocompromised hosts, who act as the viral reservoirs for future outbreaks. Therefore, understanding the evolutionary mechanisms of novel variants that can evade preexisting immune responses is critical to guide public health measures and develop vaccines tailored for vulnerable populations. We used next-generation sequencing and phylogenetic methods to delineate the evolutionary and mutational profiles of SARS-CoV-2 variants using serial oropharyngeal swab samples from 5 individuals with persistent infections. Our results revealed that the intra-host evolutionary patterns of different variants varied significantly, and the evolutionary rate in 3 immunocompromised hosts was 20 times higher than in 2 other patients. These variations likely stem from differences in immune suppression status, the strength of preexisting immune responses, and the extent of error-generating mutations. There were 15 intra-host single-nucleotide variants (iSNVs) in the spike gene among at least two variants, suggesting convergent evolution. Although most new iSNVs do not reach fixation, some of them belong to lineage-defined mutations in variants of concern (VOCs) and recent variants of interest (VOIs). The observations indicate that persistent infections serve as sources for novel, potentially harmful variants, whereas the viral evolutionary dynamics are impacted by virological, immunological, and genetic factors. Thus, there is an urgent need for individualized monitoring and management of immunocompromised hosts to prevent outbreaks caused by the viral seeds generated from them and to study viral factors associated with post-acute COVID-19 sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ca20fbc7fdbfbfc11987f3d6bbf4523861a9c6a3" target='_blank'>
              Immune Suppression, Preexisting Immunity, and Mutation Tendency Shaped SARS-CoV-2 Evolution in Persistent Infection
              </a>
            </td>
          <td>
            Ming-hui An, Xiaolong Dong, Yang Gao, Jin-ming Ouyang, Haibo Ding, Zheming Zhu, Linan Bao, Yonghui Feng, Wen Tian, Pan Wang, Xiaoxu Han, Hong Shang
          </td>
          <td>2025-11-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Intracellular pathogens must evade cytotoxic immunity to establish persistent infection. Although immune escape is typically viewed through a biochemical lens, the ability of certain pathogens to alter the mechanical properties of infected cells suggests that biophysical mechanisms may also contribute to the process. Here, we show that a subset of CD4+ T cells infected with the human immunodeficiency virus (HIV) resist elimination through a soft phenotype that inhibits killing by mechanosensitive cytotoxic T lymphocytes (CTLs). This phenotype arises from the combined effects of the HIV virulence factor Nef, which remodels the actin cytoskeleton, and intrinsic heterogeneity in the basal cytoskeletal properties of infected T cells. Pharmacological or genetic perturbations that reverse Nef signaling to the cytoskeleton or that stiffen the filamentous-actin cortex sensitize infected cells to CTL-mediated lysis. Taken together, these findings define a novel, biophysical paradigm of immune evasion with implications for HIV cure strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a4f51743a919ef271e4cd1d83a51db2f6165482" target='_blank'>
              HIV Nef amplifies mechanical heterogeneity to promote immune evasion
              </a>
            </td>
          <td>
            Louise Leyre, Farah Mustapha, Alberto Herrera, Esther Lee, Emily Huntsman, P. Zumbo, J. Weiler, Parul Sinha, Ethan Naing, Connor Smith, Colin C. Kovacs, Micheal Galiano, Nada Wahman, D. Betel, Kiera L. Clayton, Morgan Huse, R. B. Jones
          </td>
          <td>2025-12-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="Enterovirus A71 (EV-A71) is a critical global pathogen, primarily causing Hand-Foot-and-Mouth Disease (HFMD) but frequently leading to severe neurological complications, including fatal neurogenic pulmonary edema (PE). This review elucidates the complex interplay between viral pathogenesis and the host immune response. EV-A71 utilizes receptors like SCARB2 and PSGL-1 for entry, while its proteases (2Apro, 3Cpro) efficiently evade innate immunity by cleaving key signaling adaptors (MAVS, TRIF), suppressing Type I IFN response. Critical to disease progression is the age-dependent vulnerability in infants and the subsequent shift toward immunopathology. Severe disease is driven by a systemic cytokine storm and T cell dysregulation, characterized by a loss of control from Treg cells and a profound Th17/Treg imbalance, resulting in high levels of pathogenic cytokines (e.g., IL-17A, IFN-γ). Clinical progression is predicted by specific biomarkers, including Treg depletion, monocyte exhaustion (PD-1/PD-L1), and suppressed regulatory signaling (low cAMP). These findings highlight that effective therapeutic strategies must target host-mediated damage through immunomodulation (e.g., by exploring interventions against key pathogenic axes like IL-6 and IL-1β) and call for the development of next-generation vaccines capable of eliciting balanced cellular immunity to prevent immunopathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c94423fb623958f352400377f15120efff0cd02" target='_blank'>
              The Host Immune Response to Enterovirus A71 (EV-A71): From Viral Immune Evasion to Immunopathology and Prognostic Biomarkers of Severe Disease—A Narrative Review
              </a>
            </td>
          <td>
            Anna Andronik, Dawid Lewandowski, Artur Sulik, Kacper Toczyłowski
          </td>
          <td>2025-11-25</td>
          <td>Viruses</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Complement C3 plays important roles in neuroinflammation and is significantly upregulated in hippocampal tissues from patients with mesial temporal lobe epilepsy (mTLE) that is characterized by neuronal loss and gliosis. However, the temporal and spatial expression of complement C3 in the epileptic brain remain unclear. In this study, we first confirmed the upregulation of C3 in resected hippocampal tissues encompassing the CA1–CA4 regions from patients with mTLE with hippocampal sclerosis (mTLE-HS) using RNA sequencing, and in an mTLE mouse model using microarray data from the GEO database. Using a novel floxed C3-IRES-Tdtomato knock-in mouse line, we identified sustained C3 overexpression mainly in reactive astrocytes within the hippocampal stratum lacunosum-moleculare. This activation emerged 3 days after pilocarpine-induced status epilepticus, progressively extended to the CA1 region by 3 weeks, and highlighted region- and stage-specific dysregulation of C3 during epileptogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/158ea09278bcdb76005084c98a5c43a976cb0b31" target='_blank'>
              Dynamic astrocytic complement C3 activation in the epileptic hippocampus
              </a>
            </td>
          <td>
            Mi Jiang, Alessia Romagnolo, Eleonora Aronica, Yu Wang
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Neurology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Background and Objectives: Coronavirus disease 2019 (COVID-19), due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has expanded rapidly to all over the world. Interleukin-17 is one of the inflammatory cytokines which is highly expressed in the blood of individuals with COVID-19. Our aim in the present survey was to assess the mRNA expression levels of cytokine IL-17A, IL-17F and TNF-α in the blood of COVID-19 patients compared with healthy control individuals. Materials and Methods: A total of 69 patients including 32 mild patients, 20 severe and 17 asymptomatic patients in comparison with 25 healthy controls were evaluated. To measure the expression profile of IL-17A and IL-17F in whole blood, quantitative PCR was used. Results: Asymptomatic, mild, and severe SARS-CoV-2 infections were found to have significantly higher levels of IL-17A and IL-17F mRNAs than the healthy group (fold change IL-17A: 3.778; p= 0.002, 4.003; p= 0.001, 2.608; p= 0.0001 respectively, fold change IL-17F: 2.967; p= 0.003, 3.819; p= 0.001, 2.617; p= 0.0012 respectively). TNF-α mRNA expression was also measured, which shows an approximately similar increase compared to IL-17 (fold change: 2.726; p= 0.002, 2.383; P= 0.001, 2.631; p= 0.001, respectively). Conclusion: SARS-CoV-2 infection severity was associated with blood levels of IL-17A and IL-17F mRNA.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7dd5323376d14acd985d169d0610e78f710aac44" target='_blank'>
              A comparative study on proinflammatory cytokines interleukin-17A and interleukin-17F expressions in whole blood of patients with COVID-19
              </a>
            </td>
          <td>
            Zeynab Rahni, S. Mohebbi, Seyed Masoud Hosseini, Shahrzad Shoraka, Kambiz Nabati, Mahsa Saeedi Niasar, S. Shahrokh, Amir Sadeghi, Mohammadreza Zali
          </td>
          <td>2025-12-01</td>
          <td>Iranian Journal of Microbiology</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background Rhinovirus (RV) is the most common trigger of viral-induced pediatric asthma exacerbations. The impact of IL-13-driven inflammation, common in pediatric asthma, on airway epithelial antiviral and inflammatory responses to RV remain unclear. Objective Determine how IL-13-driven T2 inflammation modulates pediatric bronchial epithelial cell responses to RV infection. Methods Bronchial epithelial cells (BECs) were collected from children with (n=50) and without (n=11) asthma. They were differentiated at an air-liquid interface for 21 days, pretreated with IL13 (10ng/mL) for 7 days to model T2 inflammation, then infected with RV-A16 (MOI 0.5). RNA sequencing of BECs was performed prior to and on days 2, 4, 7, and 10 post infection. Linear and generalized additive models partnered with pathway analysis identified differentially expressed gene clusters. Results RV infection, IL-13 stimulation, and their interaction each induced differentially expressed genes (7,808; 10,251; and 7,095 genes, respectively; FDR<0.05). IL-13 pretreatment did not alter RV load or a cluster enriched for interferon response and regulation genes, including IFNB1, IFNL1-3, STAT1/2, and CXCL10/11. In contrast, IL-13 reduced expression of distinct antiviral effectors (e.g. MX1/2, RSAD2, IFITM1-3; FDR=1.85×10⁻⁴) and increased a secondary proinflammatory response cluster enriched for IL-15, TNF, ER stress, and cell-death pathways (FDR=3.63×10⁻⁶). These clusters correlated with viral load in RV-infected cells, but IL13 pretreatment eliminated those associations. Conclusions IL-13 does not modify viral load or interferon induction but selectively suppresses epithelial antiviral effector programs and enhances secondary inflammatory pathways during RV infection. These findings provide mechanistic insight into how T2 inflammation contributes to viral-triggered asthma morbidity. Key Messages – IL-13 did not alter rhinovirus viral load or epithelial interferon induction but selectively suppressed antiviral effector programs. This indicates that T2 inflammation reshapes antiviral defenses downstream of interferon signaling rather than impairing interferon production itself. – IL-13 enhances a distinct secondary proinflammatory cluster enriched for IL-15, TNF signaling, ER stress, and cell-death pathways. These late-phase responses may contribute to the heightened airway inflammation and injury observed during viraltriggered exacerbations in T2-high pediatric asthma. – IL-13-driven changes decouple epithelial immune responses from viral load, revealing mechanisms that may persist even with anti-IL-4Rα/IL-13 therapy. These findings identify epithelial antiviral effector pathways and IL-15/TNF-associated inflammatory programs as potential therapeutic targets for patients who experience breakthrough viral exacerbations despite IL-13 blockade. Capsule Summary IL-13 did not alter rhinovirus load or epithelial interferon but selectively suppressed antiviral effectors and amplified secondary inflammatory pathways, revealing how T2-inflammation may worsen viral-triggered asthma exacerbations and contribute to breakthrough exacerbations despite IL-4Rα/IL-13-targeted therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8534d6df54bf150ef5da348dfd8ea2420fc6c8b1" target='_blank'>
              IL-13 Modulates Antiviral Effector and Proinflammatory Pathways in Rhinovirus-Infected Pediatric Bronchial Epithelium
              </a>
            </td>
          <td>
            P.C. Dela Cruz, Basilin Benson, N. Jayavelu, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, M. White, Nyssa B. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Gail H. Deutsch, Matthew C. Altman, Jason S. Debley
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is the most common cause of acute bronchiolitis and pneumonia in children under 5 years of age. RSV infection is characterized by lung inflammation, viral expansion, and airway barrier destruction. The crosstalk between neurons and immune and non-immune cells develops from early life onwards. The lungs and airways are densely innervated by sympathetic neurons where they secrete the neurotransmitter noradrenaline (NA) at homeostasis and following injury in adult mice. NA, once secreted into the lungs, can act on immune and non-immune cells through β-adrenergic receptors (β-ARs). However, it is unknown whether NA-β-AR signaling axis regulates antiviral immunity during early-life infections. In a mouse model of neonatal RSV infection, we find that stimulation of adrenergic signaling via β2-AR agonist increases viral clearance, anti-inflammatory responses, and disease recovery. By contrast, loss of sympathetic neurons and β2-AR increases the RSV viral load and immunopathology in neonates. Stimulating β2-AR signaling has several downstream effects, including reduced airway mucus secretion and protection from endothelial barrier disruption, which together prevent airway blockade, respiratory failure, and facilitate control of RSV infection. Collectively, our studies demonstrate that sympathetic neurons and β2-AR signaling protect neonates from viral expansion and lung barrier breakdown, promoting antiviral defense. RSV is the most common cause of respiratory infections in infants and young children. Here, the authors used a neonatal mouse RSV infection model and uncovered a role of sympathetic neurons and β2-adrenergic signaling in protecting neonates from viral expansion and immunopathology to promote antiviral defense.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1080e6779c79237f286db40fc699be83e24e36f" target='_blank'>
              β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection
              </a>
            </td>
          <td>
            Sandeep Adhikari, Camille Carrier, P. Joshi, Pankaj Baral
          </td>
          <td>2025-12-01</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Background: COVID-19 has taken millions of lives and continues to affect people worldwide. Post-Acute Sequelae of SARS-CoV-2 Infection (also known as Post-Acute Sequelae of COVID-19 (PASC) or more commonly, Long COVID) occurs in the aftermath of COVID-19 and is poorly understood despite its widespread effects. Methods: We created a machine-learning model that distinguishes PASC from PASC-similar diseases. The model was trained to recognize PASC-dysregulated metabolites (p ≤ 0.05) using molecular descriptors. Results: Our multi-layer perceptron model accurately recognizes PASC-dysregulated metabolites in the independent testing set, with an AUC-ROC of 0.8991, and differentiates PASC from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Lyme disease, postural orthostatic tachycardia syndrome (POTS), and irritable bowel syndrome (IBS). However, it was unable to differentiate fibromyalgia (FM) from PASC. Conclusions: By creating and testing models pairwise on each of these diseases, we elucidated the unique strength of the similarity between FM and PASC relative to other PASC-similar diseases. Our approach is unique to PASC diagnosis, and our use of molecular descriptors enables our model to work with any metabolite where molecular descriptors can be identified, as these descriptors can be generated and compared for any metabolite. Our study presents a novel approach to PASC diagnosis that partially circumvents the lengthy process of exclusion, potentially facilitating faster interventions and improved patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3e99799d2fa814d4b81df362f165d526e759988b" target='_blank'>
              Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Ethan Cai, V. Kouznetsova, Igor F. Tsigelny
          </td>
          <td>2025-12-01</td>
          <td>Metabolites</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="The systemic inflammatory response syndrome (SIRS) is a complex and multifactorial life-threatening reaction triggered by trauma or infection (sepsis). Since the dynamics of immune cells, cytokines and novel markers such as circulating extracellular vesicles (EVs) remain incompletely elucidated, we aimed to provide a comprehensive multiparametric characterization of this severe response, to identify potential prognostic and therapeutic targets. We conducted a multiparametric and sequential quantification of up to 25 immune cell circulating populations using next-generation flow cytometry, assessed plasma cytokine levels with Luminex technology, and the characterized and quantified EVs and their microRNA content. Peripheral blood samples were taken at 0, 24 and 72 h after SIRS onset from 25 patients with polytrauma-induced SIRS (PT group) and 25 developed SIRS from other origins, such as pulmonary or urinary infections (NP-denoting non-polytrauma group). Samples from 21 healthy donors (HD) were analysed as a control group. Statistical analyses were performed to compare experimental groups (PT, NP, HD) and to evaluate correlations between experimental findings and patients’ outcomes for potential prognostic markers discovery. SIRS patients exhibited increased leukocyte counts driven by neutrophil mobilization combined with a reduction of dendritic cells and lymphocytes early after the SIRS. The PT group showed an increase in classical monocytes, myeloid-derived suppressor cells (MDSCs), and mesenchymal stromal cells compared to HD. These dynamics occurred alongside substantial chemokine release, including IL-8, G-CSF, CCL2 in both SIRS groups, MIF in PT and CCL4 in NP. Both SIRS groups experienced a pronounced cytokine storm with simultaneous release of both pro- and anti-inflammatory cytokines, and increased of plasma EV levels. Our findings suggest that elevated IL-8 concentrations and increased counts of circulating monocytes and MDSCs are associated with worse prognosis and may serve as valuable prognostic indicators in SIRS patients. Our study demonstrates the dynamic kinetics of multiple cell subsets, cytokines and EVs during SIRS, highlighting differences between SIRS initiated by polytrauma versus non-polytrauma events and identifying correlations between biological findings and patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/678d0938855cd21885f7e9dce3eb4d79dc760ecc" target='_blank'>
              Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis
              </a>
            </td>
          <td>
            Gerardo J. Martí-Chillón, S. Muntión, J. Flores-Montero, Javier González-Robledo, Luís Corchete, Julio Pozo, L. Osugui, S. Preciado, M. Gómez-Redondo, Juan F. Blanco, A. Navarro-Bailón, V. Sagredo, Julia Almeida, A. Orfao, F. Sánchez-Guijo
          </td>
          <td>2025-11-21</td>
          <td>Journal of Translational Medicine</td>
          <td>1</td>
          <td>29</td>
        </tr>

        <tr id="Background/Objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be documented globally, exerting a sustained influence on the worldwide economy and social structures. Contemporary SARS-CoV-2 variants, while associated with a reduced propensity for severe acute pathology, retain the capacity to induce long-term post-COVID syndrome, including in ambulatory patient populations. This clinical phenomenon may be attributable to potential autoimmune reactions hypothetically triggered by antiviral antibodies, thereby underscoring the need for developing novel, universal vaccines against COVID-19. The nucleocapsid protein (N), being one of its most conserved and highly immunogenic components of SARS-CoV-2, presents a promising target for such investigative efforts. However, the protective role of anti-N antibodies, generated during natural infection or through immunization with N-based vaccines, alongside the potential adverse effects associated with their production, remains to be fully elucidated. In the present study, we aim to identify potential sites of homology in structures or sequences between the SARS-CoV-2 N protein and human antigens detected using hyperimmune sera against N protein obtained from mice, rabbits, and hamsters. Methods: We employed Western blot analysis of lysates from human cell lines (MCF7, HEK293T, THP-1, CaCo2, Hep2, T98G, A549) coupled with mass spectrometric identification to assess the cross-reactivity of polyclonal and monoclonal antibodies generated against recombinant SARS-CoV-2 N protein with human self-antigens. Results: We showed that anti-N antibodies developed in mice and rabbits exhibit pronounced immunoreactivity towards specific components of the human proteome. In contrast, anti-N immunoglobulins from hamsters showed no non-specific cross-reactivity with either hamster or human proteomic extracts because of the lack of autoreactivity or immunogenicity differences. Subsequent mass spectrometric analysis of the immunoreactive bands identified principal autoantigenic targets, which were predominantly heat shock proteins (including HSP90-beta, HSP70, mitochondrial HSP60, and HSPA8), histones (H2B, H3.1–3), and key metabolic enzymes (G6PD, GP3, PKM, members of the 1st family of aldo-keto reductases). Conclusions: The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict possible autoimmune consequences in COVID-19 convalescents and are of critical importance for the rational design of future N protein-based, cross-protective vaccine candidates against novel coronavirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/313d9d3a801fa8c844cca98ae433671df465c85a" target='_blank'>
              Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties
              </a>
            </td>
          <td>
            A. Rak, Y. Zabrodskaya, P. Wong, I. Isakova-Sivak
          </td>
          <td>2025-12-22</td>
          <td>Antibodies</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Heart injury triggers a robust cellular response in zebrafish, characterized by neovascularization, immune cell activation, and the infiltration of proliferative cardiomyocytes that collectively lead to scarless regeneration. Upon injury, damage-associated molecular patterns are released by dying cells and injured extracellular matrix. These molecules bind to pattern recognition receptors on various cell types, promoting inflammation and immune cell recruitment by upregulating chemokines and pro-inflammatory cytokines. We previously identified the activation of injury-induced interferon signaling as a distinguishing feature between the regenerative zebrafish and non-regenerative medaka. Here, we establish interferon-Φ1 (IFN□1) as the primary driver of interferon signaling after zebrafish heart injury. IFN□1 expression is induced hours after injury and directs interferon-stimulated gene expression, which peaks at 72 hours post-injury. This response is lost in ifnphi1 mutants, which disrupt IFN□1 expression. ifnphi1 mutants have reduced neutrophil recruitment to the injured myocardium, while macrophages and neovascularization are unaffected. By studying later stages of regeneration, we find that ifnphi1 mutant hearts have a modest defect in scar resolution. Collectively, these findings uncover a critical early signaling cascade during the inflammatory response to heart injury and provide new insights into the mechanisms that choreograph zebrafish heart regeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/675164a06e9522cfc2bd5648b36fc42575e714a5" target='_blank'>
              Interferon signaling promotes early neutrophil recruitment after zebrafish heart injury
              </a>
            </td>
          <td>
            Alexis V. Schmid, James A. Gagnon
          </td>
          <td>2025-11-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Aging is a major risk factor for increased morbidity and mortality following acute respiratory virus infections. To elucidate the immune determinants underlying viral pathogenesis and delayed lung repair in the aged lung, a comprehensive time-course study was conducted. Single-cell RNA sequencing (scRNAseq) and high-dimensional flow cytometry were utilized to compare lungs from young and aged mice infected with influenza A virus (IAV). Aged hosts displayed diminished alveolar macrophage (AM) and dendritic cell (DC) but elevated monocyte-derived macrophage (MoM) and interstitial macrophage (IM) presence following infection. Additionally, enhanced accumulation of adaptive immune cells, including CD4+ tissue-resident helper (TRH) cells, CD8+ tissue-resident memory (TRM) cells, and a B cell subset resembling age-associated B cells, was observed in the memory phase. Pathway analysis revealed that elevated type I and II interferon (IFNα/γ) signaling, especially in MoM/IM subsets, distinguished the aged hosts from the young. Inhibition of IFNα/γ signaling after viral clearance improved long-term respiratory outcomes and reduced both IM and TRH populations in aged mice. These findings highlight the pivotal role of IFNα/γ signaling, likely within MoM/IM subsets, in driving the exuberant persistence of adaptive immune cells and chronic immunopathology in the aged lung following acute viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79fbb4abcb1eeb6127549b886296b47a4c3b2fa0" target='_blank'>
              Temporal single-cell analysis reveals age-associated delay in immune resolution after respiratory viral infection
              </a>
            </td>
          <td>
            Yue Wu, Chaofan Li, Jinyi Tang, Xiaochen Gao, I. Cheon, Bibo Zhu, Ruixuan Zhang, C. Fain, S. Hu, H. Narasimhan, Gislane de Almeida Santos, K. Ayasoufi, Aaron J. Johnson, Hui Zong, Chongzhi Zang, Haidong Dong, Jie Sun
          </td>
          <td>2025-12-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Dendritic cells (DCs) are among the first immune cells to detect viral invasion and play a central role in initiating and shaping antiviral immune responses. Many innate and adaptive immune functions of DCs are regulated by cathepsins, proteolytic enzymes primarily found in acidic endolysosomal compartments. Different DC subsets exhibit distinct cathepsin expression patterns, influencing their functional capacities and interactions with viruses. In DCs, cathepsins contribute to virus sensing through innate receptors, regulate cytokine production and DC migration, and are essential for viral antigen degradation and loading onto MHC molecules for T-cell activation. Many viruses, however, have evolved mechanisms to alter cathepsin expression and activity, thereby subverting DC function and promoting their own persistence. Indeed, cathepsins can facilitate viral entry into DCs, promote viral replication, and support immune evasion strategies. In this review, we summarize recent advances in understanding the role of cathepsins in DC–virus interactions, emphasizing both how DCs exploit cathepsins to generate protective immune responses and how viruses manipulate cathepsin activity to their advantage. We particularly focus on clinically relevant viral pathogens, including HIV, influenza virus, hepatitis C virus, human cytomegalovirus, Ebola virus, and SARS-CoV-2, to illustrate the multifaceted influence of cathepsins on DC biology during viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f204dbe234ec6ae69c3dd26a69324c54dc0602cf" target='_blank'>
              Shaping the Immune Response: Cathepsins in Virus-Dendritic Cell Interactions
              </a>
            </td>
          <td>
            Adrianna Niedzielska, Magdalena Bossowska-Nowicka, Zuzanna Biernacka, K. Gregorczyk-Zboroch, F. Toka, L. Szulc-Dąbrowska
          </td>
          <td>2025-12-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Numerous studies report cognitive impairment in COVID-19 patients from the acute to post-acute phases, linked to blood inflammation affecting blood–brain barrier (BBB) permeability and causing leakage of glial and neuronal proteins. However, a clear classification of these cognitive deficits and molecular blood events over time is still lacking. This narrative review summarizes the neuropsychological consequences of COVID-19 and evidence of altered cytokines and BBB disruption as potential mediators of cognitive impairment across post-infection phases. Post-COVID-19 cognitive dysfunction appears to follow a temporal course, evolving from acute focal deficits in attention, working memory, and executive function to more persistent multidomain impairments. We reviewed key cytokines released into the blood during COVID-19 infection, including antiviral (IFNγ, CXCL1, CXCL10), inflammatory (IL-1β, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, GM-CSF, TNFα), and monocyte chemoattractants (MCP1/CCL2, MCP3/CCL7, MIP-1α/CCL3, GM-CSF, G-CSF). This analysis shows that several inflammatory and viral cytokines remain elevated beyond the acute phase and are associated with cognitive deficits, including IL-6, IL-13, IL-8, IL-1β, TNFα, and MCP1 in long-term post-COVID-19 patients. In addition, we examined studies analyzing changes over time in neurovascular unit proteins as biomarkers of BBB disruption, including extracellular matrix proteins (PPIA, MMP-9), astrocytes (S100β, GFAP), and neurons (NFL). These proteins are elevated in acute COVID-19 but generally return to control levels within six months, suggesting BBB restoration. However, in patients followed for over a year, BBB disruption persists only in those with cognitive impairment and is associated with systemic inflammation, with TGFβ as a related biomarker. Although cognitive sequelae can persist for over 12 months after SARS-CoV-2 infection, further studies are needed to investigate long-term neurocognitive outcomes and their link to sustained proinflammatory cytokine elevation and brain impact.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4fb013c3f3c6ebd3f776a435e4fa286d2050e4fb" target='_blank'>
              Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review
              </a>
            </td>
          <td>
            Ana Barajas, Gemma Riquelme-Alacid, América Vera-Montecinos, Belén Ramos
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are two post-viral diseases, which share many common symptoms and pathophysiological alterations. Yet a mechanistic explanation of disease induction and maintenance is lacking. This hinders the discovery and implementation of biomarkers and treatment options, and ultimately the establishment of effective clinical resolution. Here, we propose that acute viral infection results in (in)direct endothelial dysfunction and senescence, which at the blood-brain barrier, cerebral arteries, gastrointestinal tract, and skeletal muscle can explain symptoms. The endothelial senescence-associated secretory phenotype (SASP) is proinflammatory, pro-oxidative, procoagulant, primed for vasoconstriction, and characterized by impaired regulation of tissue repair, but also leads to dysregulated inflammatory processes. Immune abnormalities in ME/CFS and long COVID can account for the persistence of endothelial senescence long past the acute infection by preventing their clearance, thereby providing a mechanism for the chronic nature of ME/CFS and long COVID. The systemic and tissue-specific effects of endothelial senescence can thus explain the multisystem involvement in and subtypes of ME/CFS and long COVID, including dysregulated blood flow and perfusion deficits. This can occur in all tissues, but especially the brain as evidenced by findings of reduced cerebral blood flow and impaired perfusion of various brain regions, post-exertional malaise (PEM), gastrointestinal disturbances, and fatigue. Paramount to this theory is the affected endothelium, and the bidirectional sustainment of immune abnormalities and endothelial senescence. The recognition of endothelial cell dysfunction and senescence as a core element in the aetiology of both ME/CFS and Long COVID should aid in the establishment of effective biomarkers and treatment regimens.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05f509ceb8b137061e93b7aab33e7a19306f4d96" target='_blank'>
              Virus-induced endothelial senescence as a cause and driving factor for ME/CFS and long COVID: mediated by a dysfunctional immune system
              </a>
            </td>
          <td>
            Massimo Nunes, Loren Kell, Anouk Slaghekke, Rob Wüst, B. Fielding, D. Kell, E. Pretorius
          </td>
          <td>2026-01-09</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d03f6c7701fb82cda454df504a0ff34a1e58052" target='_blank'>
              Comparison of human cerebral organoids infected with wild-type Zika versus attenuated DN-2 virus strains uncovers differences in host immune responses.
              </a>
            </td>
          <td>
            Yun Ying Choo, Tuan Zea Tan, S. Zhang, H. Tan, E. Ooi, John Jia En Chua
          </td>
          <td>2025-12-16</td>
          <td>Cell communication and signaling : CCS</td>
          <td>0</td>
          <td>73</td>
        </tr>

        <tr id="Post-translational modifications (PTMs) are crucial chemical alterations occurring on proteins post-synthesis, impacting various cellular processes. During viral infections, PTMs are shown to play a multitude of roles in viral replication, host interaction, and immune evasion. Thus, these modifications can influence infectivity, with direct impact on the anti-viral host immune responses and potentially viral adaptation across species. This field is still scarcely explored, whilst understanding PTMs is not only important to advance the knowledge of virus pathology but also potentially to provide insights for vaccine development. In this review, we attempt to summarize the latest findings mainly published over the last 10 years, focusing on the roles of PTMs involved in virus infection and anti-viral immune responses, in the context of relevant human respiratory infections: influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2. We decided to concentrate on these three viruses because they currently represent a global health problem due to recurrent outbreaks and pandemic potential. A deeper characterization of the PTMs may help in understanding virus–host interaction with possible implications on curative strategies. Further, we will report on cutting-edge technologies to study in vitro virus infection in different cellular-based systems. In particular, we describe and discuss the application of 2D and 3D lung organoid cell-culture systems as in vitro models to mimic respiratory environments and to study the PTMs in a controlled setting. Finally, we will discuss the importance of PTMs in the context of next-generation vaccine design, especially for their potential role to offer effective protection against respiratory viruses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c72b9eede6254de6ff7547a590df16f919d1f6ca" target='_blank'>
              Post-Translational Modifications in Respiratory Virus Infection: Recent Insights into the Development of In Vitro Models
              </a>
            </td>
          <td>
            Emna Ben Khlifa, Alessia Campese, Andrea Corsi, C. Bombieri, Maria Grazia Romanelli, M. Valenti, D. Zipeto, Matteo Castelli, Patricia Marie-Jeanne Lievens, Alessandra Ruggiero
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Simple Summary Coronaviruses, including severe acute respiratory syndrome coronavirus 2, employ sophisticated strategies to evade the host innate immune system, which serves as the first line of defense against viral infections. These pathogens suppress antiviral responses by encoding proteins that interfere with pattern recognition receptors, inhibit mitochondrial antiviral signaling function, and disrupt interferon (IFN) production and signaling. Key mechanisms include downregulation of major histocompatibility complex class I molecules, conformational shielding of the receptor-binding domain to avoid immune detection, and exploitation of host proteases for viral entry. Additionally, non-structural proteins and accessory proteins (e.g., ORF6, ORF8) antagonize IFN pathways and impede nuclear translocation of immune signaling molecules. Understanding these escape mechanisms is critical for developing broad-spectrum antiviral therapies and vaccines that target conserved viral elements, enhancing our ability to combat coronavirus infections and mitigate future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80e4a34d0664d51c2f82d8a17236e7f4824f8e83" target='_blank'>
              A Comprehensive View on the Mechanisms of Coronavirus Escaping Innate Immunity
              </a>
            </td>
          <td>
            Yichen Liu, Hao Lu, Jinyuan Li, Yuqing Xie, Gaowei Hu, Shengmei Pang, Siqi Lian, Jiaqi Liu, Guoqiang Zhu, Xueyan Ding
          </td>
          <td>2025-12-01</td>
          <td>Veterinary Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="ABSTRACT Microglia are the main innate immune cells residing in the brain parenchyma. Their activation and resulting neuroinflammation have emerged as major pathogenic mechanisms in neurodegenerative disorders, particularly in Alzheimer's disease (AD). The accumulation of amyloid‐β oligomers (AβOs) and microglia activation play crucial roles in the pathogenesis of AD. In a second vein, the development of innate immune memory in response to different stimuli is a vital mechanism that enables microglia to adjust their response to subsequent inflammatory challenges. While there is increasing evidence that repeated bouts of peripheral inflammation lead to training or tolerance in microglia, the impact of tolerance on the inflammatory response induced by AβOs remains to be determined. In this study, we investigated whether lipopolysaccharide (LPS)‐induced tolerance affects microglial responses to AβOs. For that, organotypic hippocampal cultures were repeatedly challenged with LPS before being exposed to AβOs. We measured cytokine levels and evaluated changes in microglial activation and morphology following exposure of cultures to AβOs. A significant decrease in cytokine production was observed when hippocampal slice cultures were repeatedly challenged with LPS. Interestingly, microglial activation and the resulting inflammatory response induced by AβOs were prevented when these cultures had been previously challenged with LPS. Moreover, the changes in microglial morphology and cytokine production resulting from repeated LPS stimulation were associated with reduced activation of nuclear factor kappa B (NF‐κB). These results indicate that preconditioning microglia with LPS induces a physiological immune tolerance response rather than pathological inflammation, which may have implications for developing therapeutic strategies for AD aimed at modulating innate immune memory.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f30b28f24e182dd29b261967df3617b845598fe7" target='_blank'>
              Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
              </a>
            </td>
          <td>
            Rafaela Rodrigues Valerio, Áquila Rodrigues Costa Santos, Ana Helena Larangeira Nóbrega, Raquel Martins, F. D. De Felice, Sérgio T. Ferreira, Wilson Savino, Adriana Bonomo, Andressa Bernardi, R. Frozza
          </td>
          <td>2026-01-01</td>
          <td>Journal of Neurochemistry</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="This study examined the long-term transcriptomic reprogramming in peripheral blood mononuclear cells (PBMCs) of severe COVID-19 patients and its effects for cancer development. RNA sequencing was conducted on PBMCs obtained from healthy controls, COVID-19 patients without pneumonia, and COVID-19 patients exhibiting severe pneumonia one year post-infection. Differential gene expression analysis identified a sustained pro-oncogenic molecular signature, especially among severe COVID-19 patients. Functional enrichment analysis revealed a substantial enrichment of cancer-associated pathways, encompassing apoptosis, viral carcinogenesis, and transcriptional dysregulation. Notably, the autophagy-related gene SQSTM1/P62 was recognized as a distinctive hub gene within the severe COVID-19 patients, interacting with pivotal genes associated with inflammation, apoptosis, and cancer advancement. Survival analysis demonstrated that elevated expression of COVID-19-associated hub genes correlated with unfavorable prognosis in various cancer types, including adrenocortical carcinoma, bladder urothelial carcinoma, and brain lower-grade glioma. These findings indicate that severe COVID-19 infection may establish a systemic milieu favorable to cancer development or recurrence, highlighting the necessity of prolonged oncological monitoring in these patients. Finding specific molecular targets and pathways can help us understand how COVID-19 might be linked to a higher risk of cancer.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/09c3b7e4ee48aa0d27cd4639fd934da7bf0f81ea" target='_blank'>
              Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes
              </a>
            </td>
          <td>
            Pelin Duru Çetinkaya, Ozgecan Kayalar, Vahap Eldem, Serap Argun Barış, N. Kokturk, Selim Can Kuralay, Hadi Rajabi, N. Konyalilar, Deniz Mortazavi, S. Korkunç, S. Erkan, Gizem Tuşe Aksoy, Gul Eyikudamaci, Pelin Pınar Deniz, Oya Baydar Toprak, Pinar Yildiz Gulhan, Gulseren Sagcan, Neslihan Kose Kabil, Ayşegül Tomruk Erdem, F. Fakili, Onder Ozturk, I. Basyigit, H. Boyacı, Emel Azak, Tansu ULUKAVAK ÇİFTÇİ, I. Oguzulgen, H. Ozger, Pınar Aysert Yildiz, Ismail Hanta, O. Ataoglu, M. Erçelik, Ç. Çuhadaroglu, Hacer Kuzu Okur, M. Tor, Esra Nurlu Temel, S. Kul, Y. Tutuncu, O. Itil, Hasan Bayram
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c98081e2d94c1f8f3d01731f5e992ad893a30f3e" target='_blank'>
              Acute systemic inflammation induces region-specific morphological remodeling of astrocytes and microglia concurrent with depression-like behavior
              </a>
            </td>
          <td>
            An-Qi Zhang, Meng-Meng Zhang, Ling-Jie Li, Mei-Xue Yuan, Rong-Yu Liu, Peng Chen, Chen-Wei Wang, Yu Wang, Jiang Zhou, Qing-Hong Shan, Xinya Qin
          </td>
          <td>2025-11-28</td>
          <td>Histochemistry and Cell Biology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Simple Summary Infectious bronchitis virus is a major threat to poultry farming, causing severe economic losses, and current vaccines have limitations. This study investigated whether baicalin, a natural compound from a medicinal plant, could fight this virus. We found that baicalin effectively reduced virus replication in chicken kidney cells, especially when given after infection. It worked by boosting the cells’ own early antiviral defenses, specifically the type I interferon pathway. At the same time, it carefully controlled the inflammatory response, preventing excessive harm that can be caused by the immune system itself. A key protein, IRF3, was identified as crucial for both the anti-inflammatory and antiviral effects. Our results suggest that baicalin could be developed as a promising natural treatment to help control infectious bronchitis in poultry, potentially reducing the reliance on antibiotics and improving animal health and food production.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eaa8e361a12057c653043be02e293b36554a0e9c" target='_blank'>
              Temporal Modulation of Type I Interferon and NF-κB Signaling by Baicalin Suppresses Infectious Bronchitis Virus Replication and Inflammatory Response
              </a>
            </td>
          <td>
            Jiongjie He, Ling Wang, Yong Zhang, Shengyi Wang
          </td>
          <td>2025-11-25</td>
          <td>Animals : an Open Access Journal from MDPI</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Early-life infections can produce durable changes in immune function and behavior. We propose a mechanistic hypothesis positioning the mechanistic target of rapamycin (mTOR) as the link between peripheral inflammation and central nervous system dysfunction in pediatric post-infectious syndromes. Based on clinical, translational, and experimental literature, we outline a stepwise pathway. First, sustained mTOR activation skews T-cell and macrophage differentiation toward pro-inflammatory and autoimmune states. Second, endothelial mTOR signaling weakens tight junctions and increases vesicular transport, compromising blood–brain barrier integrity. Third, cytokines and sometimes autoreactive cells enter the brain and engage mTOR in microglia and neurons, driving neuroinflammation, impaired synaptic maintenance and plasticity, and neurotransmitter disruption. This framework accounts for features observed in Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and pediatric acute neuropsychiatry syndrome (PANS/PANDAS) and yields testable predictions on pathway activity and barrier permeability. It also motivates targeted interventions that modulate mTOR-related processes in immune and endothelial compartments and within neural circuits in children. So, this article aims to outline a mechanistic framework linking infection-driven mTOR activation to post-infectious neuropsychiatric syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b2799fce36a305b1d54001a243bb97442880817" target='_blank'>
              Proposed Mechanistic Axis of Infections and mTOR Hyperactivation: A Multidisciplinary Review of Immune, Rheumatologic, and Psychiatric Links
              </a>
            </td>
          <td>
            Giovanni Fronticelli Baldelli, Danilo Buonsenso
          </td>
          <td>2025-11-25</td>
          <td>Children</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="COVID-19 has caused millions of deaths worldwide since 2019. Vaccination has reduced both transmission and disease severity. However, emerging viral variants have weakened vaccine effectiveness, highlighting the need for new antiviral therapies. This study examines how the SARS-CoV-2-Spike protein (SARS-2-S) induces the VSIR-ISX signaling pathway, leading to metabolic disturbances that may worsen disease progression. Using RNA sequencing, we found that SARS-2-S expression in pulmonary cells activates genes involved in tryptophan and arachidonic acid (AA) metabolism, altering bioactive mediators like kynurenine and prostanoids, which are crucial for inflammation and immune responses. Mechanistically, the ACE2-MYD88 pathway, activated by SARS-2-S, enhances the VSIR-ISX axis through NF-κB signaling, driving these metabolic disruptions. Chromatin immunoprecipitation and genome sequencing revealed that ISX, activated via VSIR-MAPK signaling, upregulates enzymes involved in AA metabolism by binding directly to their gene promoters. Notably, disrupting the VSIR-ISX axis using shRNA interference or NF-κB inhibitors effectively mitigated these metabolic disturbances. Our findings suggest that the VSIR-ISX pathway could be a promising therapeutic target for treating COVID-19 by addressing virus-induced metabolic disruptions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1db37c340568fba373a179f1ff4697d0067aea93" target='_blank'>
              Spike protein–induced VSIR–ISX signaling disrupts metabolic homeostasis and promotes COVID-19–related immune dysfunction
              </a>
            </td>
          <td>
            Li-Ting Wang, Shen-Nien Wang, Shyh-Shin Chiou, Chee-Yin Chai, Shih-Hsien Hsu
          </td>
          <td>2025-12-19</td>
          <td>Cell Biology and Toxicology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a major cause of severe respiratory tract infections in infants, older adults, and immunocompromised individuals. Despite decades of research, effective therapies are limited, largely due to an incomplete understanding of how infected cells and immune responses interact to shape disease outcomes. Recent evidence indicates that RSV activates multiple regulated cell death (RCD) programs-including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy-associated cell death which interact through shared molecular mediators to form a multimodal cell death (MMCD) network. This integrated system regulates the balance between viral clearance and immunopathological injury. Central mediators such as caspase-8, RIPK3, and NLRP3 act as molecular hubs coordinating these death programs and amplifying inflammatory responses. Understanding how MMCD shapes RSV immunopathogenesis provides a unified framework linking cell death to immune dysfunction. This review summarizes recent progress in elucidating the MMCD network, highlights its role in death-inflammation feedback loops, and discusses potential strategies for therapeutic modulation. Conceptualizing RSV disease through the lens of MMCD may guide the development of precision interventions that restore immune homeostasis while preserving antiviral defense.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e48caf42a43b176c4dbbd30d2ec467dfbc9dd6c6" target='_blank'>
              Multimodal cell death drives the immunopathogenesis of RSV infection
              </a>
            </td>
          <td>
            Tianxiang Yang, Zhizhong Mi, Zhao-Min Li
          </td>
          <td>2025-12-12</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Type I interferons (IFNs), particularly IFN-α, occupy a central paradox in HIV-1 infection: they provide an essential early antiviral barrier that limits initial dissemination, yet their sustained activation contributes to chronic immune activation, CD4+ T-cell dysfunction, and incomplete viral control. This duality—protective in acute infection but pathogenic during chronic disease—remains a major unresolved challenge for interferon-based therapeutic strategies in HIV-1. Recent advances in ISG functional profiling, IFN-α subtype–specific antiviral potency, and the development of targeted innate-pathway modulators (e.g., STING-selective agonists, ncRNA regulators, TLR7 activators) have renewed interest in reevaluating interferon-centered approaches. These developments make it timely to reassess whether IFN-α can be safely and effectively integrated into modern HIV-1 therapeutic concepts, particularly in early-infection windows or in rationally designed combination regimens. In this review, we synthesize current knowledge of interferon-mediated restriction mechanisms, the hierarchy of key antiviral ISGs (e.g., APOBEC3G, MX2, BST2), and HIV-1 evasion of the JAK–STAT and cGAS–STING pathways. We further analyze how dose, timing, and IFN-α subtype contribute to divergent antiviral versus inflammatory outcomes across different stages of infection. Emerging precision strategies that modulate interferon signaling without triggering systemic inflammation offer promising translational directions. Balancing antiviral efficacy with immune homeostasis will be essential for developing next-generation interferon-based interventions aimed at durable control or functional cure of HIV-1 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e35155a074d508903b12fc5aa14a89c552c7604" target='_blank'>
              Interferons in HIV-1 infection: mechanisms, antiviral potentials, and therapeutic challenges
              </a>
            </td>
          <td>
            Luying Zhu, Jiahao Ji, Jing Xiao, Fuchun Wang, Jiaqi Yu, Yanmin Liu, Yang Zhang, Hao Wu, Bin Su, Xiaofan Lu, Tong Zhang
          </td>
          <td>2025-12-18</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Survivors of COVID-19 can experience long-term lung complications (pulmonary sequelae), but the underlying mechanisms remain unclear. While most patients with COVID-19 lung injury eventually recover essentially completely, some experience significant residual damage. To investigate the underlying differences, we analyzed, using bronchoalveolar lavage fluid (BALF), the alveolar immune cell compartments of a group of patients with post-COVID-19 interstitial lung disease (ILD) six months after acute COVID-19. Patients were categorized into two groups, based on High-Resolution Computed Tomography (HRCT) evaluation a year later: those with persistent HRCT abnormalities compatible with fibrosis (persistent post-COVID-19 ILD, n=6) and those with resolved lung lesions (resolved post-COVID-19 ILD, n=13). Additionally, 6 patients with pre-existing ILD were included in the study, after recovery from COVID-19. Bulk RNA transcriptomics analyses of BALF cells revealed innate immunity and inflammation pathways of neutrophil and monocyte chemotaxis to be enriched in patients with persistent HRCT abnormalities post-COVID-19, consistent with an increase in monocyte-like cell recruitment in the lungs. Pro-fibrotic SPP1 gene expression was significantly upregulated similarly to other fibrotic lung diseases. Conversely, patients with resolved post-COVID-19 ILD showed enhanced BALF cell gene expression signatures indicative of adaptive immune response activation. BALF gene expression patterns of low T-cell activation, high pro-fibrotic macrophage activation and neutrophil chemotaxis were similarly observed in patients with pre-existing fibrotic ILD following COVID-19. These findings suggest that immune response imbalance leading to prolonged activation of innate immunity and subdued adaptive immune responses may be associated with persistent post-COVID-19 ILD and the development of pulmonary fibrosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3f0faca69cfb328bb72907f38427c47bebf12818" target='_blank'>
              BALF gene expression profiling reveals a fibrosis associated innate immune activation bias in persistent post-COVID-19 ILD.
              </a>
            </td>
          <td>
            Katerina M Katerina Antoniou, E. Vasarmidi, A. Galaras, M. Lourou, Ioanna Argyriou, D. Zevla, N. Bizymi, C. Skiadas, I. Lambiri, P. Hatzis, V. Aidinis, Nikolaos Tzanakis, A. Wells, E. Tsitoura
          </td>
          <td>2025-11-14</td>
          <td>American journal of physiology. Lung cellular and molecular physiology</td>
          <td>0</td>
          <td>43</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2025', '2026'],
    y: [6, 1],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>